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Abstract
Freezing and ablating using cryosurgery is becoming a promising surgical tool for the
treatment of tumours. For improving the efficiency of the cryosurgical procedure, different
approaches have been implemented till now. Most of these techniques have focussed on the
freezing process, without giving adequate attention to the damage to the surrounding healthy
tissue. In this study, a novel concept is proposed which achieves the desired freezing while
protecting the surrounding healthy tissue through the use of low thermal conductivity liquid
layer (perfluorocarbons) around the interface of the tumour. Numerical modelling has been
done to determine the location of the ice fronts in the presence of this perfluorocarbon layer
around the boundary of the tumour. It is noticed that this method leads to a higher ablation
rate substantially reducing the surgical time. Also, an optimal offset, i.e. the minimum
distance between the tip of the cryoprobe and the boundary of the tumour, is identified for a
given tumour radius and active length which gives maximum tumour necrosis in minimum
time. It is also observed that for a 2 mm increase in the active length of the cryoprobe, the
decrease in optimal offset is approximately 1 mm. Furthermore, for the tumour with different
radii (between 10 mm and 15 mm), with same active length of the cryoprobe, the time taken
for complete ablation of the larger tumour is nearly 2.7 times the time taken for the smaller
one for every 2.5 mm increase in the tumour radius. The results also reveal that there exists
an optimal thickness of the perfluorohexane layer around the tumour interface. It is also seen
that among perfluorohexane, octafluoropropane and water, perfluorohexane acts as the best
substitute for the formation of an insulating layer around the tumour interface.
Experiments have been performed to prepare pefluorocarbon (perfluorohexane and
perfluorodecalin) emulsions in varied concentration (i.e. 30%, 50%, 70% and 90%
(w/v)) through probe sonication. Further, this study reports the particle size, emulsion
stability, functional group analysis, thermophysical properties of both perfluorodecalin
and perfluorohexane emulsions. With regard to thermal conductivity, it is observed
that perfluorodecalin emulsions possess a marginally lower thermal conductivity than
perfluorohexane emulsions. It is interesting to note that during cryosurgery of gel phantom
in the presence of low thermal conductivity perfluorodecalin emulsion (90% (w/v)), it is
observed that the freezing front is not able to penetrate the gel while in its absence, there is
a temperature of −4oC at the same thermocouple location of 10 mm (in the axial direction).
Cryosurgery of glycine-containing gels is carried out in presence and absence of
vi
perfluorohexane layer, and the thermal history is measured using K-type thermocouples
connected to a data acquisition system. The presence of glycine causes rapid freezing during
cryosurgery with an ice ball depth of 16 mm, while with a perfluorohexane layer at this gel
interface, this depth is 13 mm, indicating the ability of this layer to limit freezing. In this
study, alumina has also been utilised for the preparation of adjuvant containing gel phantoms.
After cryosurgery, it is clearly evident that a temperature decrease is observed in the alumina
consisiting gel phantoms when compared to the agarose gel phantoms. It is also noticed that
with the increase in insertion depth of the cryoprobe (from 1 to 1.5 cm), there is a decrease in
temperature at each thermocouple location in the gel phantoms. This study also demonstrates
that in the presence of perfluorohexane layer, when the alumina consisting gel phantoms
are cryosurgically cooled; even with the increase in insertion depth, the thermocouple
placed axially at 10 mm which is inside the perfluorohexane solution layer indicates a
temperature of 25oC. However, in its absence, the temperature is found to be −5.47oC
at the same position, suggesting that the freezing is limited within the gel. Furthermore, this
work also proposes a new approach that utilises glycine-alumina emulsions as an adjuvant.
After cryosurgery of glycine-alumina containing gel, a substantial temperature decrease is
observed at all thermocouples placed nearer to the probe, thus indicating an enhancement in
freezing. In conclusion, this study proposes novel approaches to improve the cryosurgical
procedure through numerical modelling and experiments in gel phantoms, thus, providing
newer approaches to improve the cryosurgical outcome.
Keywords: Cryosurgery; temperature; perfluorocarbons; emulsions; low thermal
conductivity; perfluorohexane; gel phantoms
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Chapter 1
Introduction
Cryosurgery, commonly referred as cryoablation, is a surgical technique which uses very low
temperature for the destruction of undesirable tissues or tumour [1]. Modern cryosurgery has
come into existence in the early 1960s and grown tremendously in the last two decades.
It is widely gaining acceptance in the medical fields like dermatology, neurosurgery,
oncology and gynaecology [2]. A broad range of solid tumours can be treated using modern
cryosurgery, for example, tumours of the breast, kidney, liver, prostate and pancreas [3–6].
The use of modern cryosurgery to ablate these tumours presents many advantages over
other treatment methods. However, cryosurgery also demonstrates certain inadequacies
which need to be addressed so that this technique becomes a routine clinical practice. This
chapter provides insight into the technique of cryosurgery and addresses the following points:
historical perspective of cryosurgery, advances in cooling techniques, merits and existing
problems pertaining to cryosurgical tumour ablation. This section also provides a historical
perspective of the cryosurgical practices that existed from the early ages to the modern era.
1.1 The use of low temperature in the primitive age
The first report of the medical use of low temperature to cure ailments is said to be
documented in 3500 B.C. in Egypt. The Egyptians used substances like ice that have low
temperature and applied it on wounds, thereby, utilising it as a localised anaesthetic [7, 8].
Further, Hippocrates, in 5th century B.C., suggested the application of cold to relieve pain
in diseases that affect the bones and joints [8]. Throughout, the middle ages, these practices
evolved with time and later in the 17th century cold baths and wet sheets were used to
provide relief from fever and inflammation [2]. In the absence of the modern anaesthetic
tool during the early 18th century, low temperature was used to aid in the amputations. It
was also reported that the bleeding during amputations was controlled if it was covered
with ice [8, 9]. However, the use of cryosurgery that provided a controlled low temperature
was not available until the 1850s. There were phenomenal advances in the research areas
like cryogenics, low-temperature physics and engineering that led to the development of
cryosurgery [1].
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In the early 1850s, Dr. James Arnott, who was a British physician used freezing for
treating cancers. While treating the patients, he used a −12oC solution of sodium chloride
and broken ice cubes to treat the lesions of breast and uterine cavity [10]. After freezing, it
was seen that the lesions were white and hard in appearances and there was minimal blood
loss. Subsequently, advances in this field had to await the development of cryosurgery
devices that provided very low temperatures, and the application of freezing for destruction
of tissue was reported at the culmination of the 19th century. The end of the 19th century
observed several significant advances in the field of cryogenics [11]. In the same context,
Louis Paul Cailletet, a French engineer, produced liquid oxygen by using an adiabatic
expansion system in 1877. The year also led to another breakthrough, Raoul Pictet, a Swiss
physicist, achieved success in producing liquid oxygen by applying a cascade process. In
the early 1880s, a pioneering work was done by S.von Wroblewski and K. Olszenski, who
first liquified nitrogen, which was carried forward further by Carl von Linde. With these
advancements, industrial liquefaction of air was possible and subsequently in the next few
years gases like nitrogen, hydrogen and oxygen were liquefied. Further, a path breaking
development took place in 1892, when James Dewar, a British Professor, developed a
vacuum-jacket vessel for storing cryogenic fluids. These vessels significantly reduced the
evaporation of cryogenic fluids and helped in easy storage for use in therapy and medical
applications.
With these tools available, extreme cold temperature could be provided for therapeutic
applications, and these advances in cryogenics were encouraging for the field of cryosurgery
[1, 2]. Dr. Campbell A. White, for the first time used liquid air to treat skin diseases in 1899
[12]. He collaborated with Professor Charles Tripler who encouraged the use of liquid air
in medical practice and produced liquid air for its use in the treatment of skin diseases.
Liquid air could treat warts, varicose leg ulcers, boils, herpes and epitheliomas. However,
as a cryogenic agent for medical purposes, liquid air was subsequently replaced by solid
CO2 because liquid air was not easily available at a large scale in 1910 as compared to the
widespread availability of solid CO2 [1]. Further, another cryogen, liquid oxygen was used
for treating the skin lesions in 1929, but did not become popular for cryosurgery as it could be
a potential fire hazard [13]. In 1940s, large scale commercial liquefaction of hydrogen and
helium resulted in the production of liquid nitrogen (LN2) as an abundant and low-cost by
product. Liquid nitrogen was used in the clinical practice for the first time by Allington for
treating skin ailments [14]. Since the boiling point of liquid nitrogen is lower than solidCO2
it became a common method of treatment of keratoses, warts and non-neoplastic lesions.
Till date, for use in modern cryosurgery, LN2 is the most effective cryogen. For a better
understanding of its thermal and physical behaviour, the properties of saturated LN2 at 1
atm are provided in Table 1.1 [11].
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Table 1.1: Properties of liquid nitrogen at 1 atm [11]
Property at 1 atm Unit Value
Normal boiling point K 77.36
Density kg/m3 807.3
Latent heat kJ/kg 199.3
Specific Heat kJ/kg.K 2.05
Viscosity Pa.s 158× 10−6
Thermal Conductivity W/m.K 0.1396
1.2 Cryosurgery in the modern era
In 1961, Dr Irving Cooper fabricated the first cryoprobe which is attributed as the birth of the
modern cryosurgery [15]. This design of cryosurgical probe was a closed probe which had
a continuous circulation of LN2 in the inner region of the probe for its cooling. The initial
objective of this design was treating neural disorders like Parkinson’s and it was observed
that the cryoprobe was highly effective in destroying solid tumours seated at depth inside
the body. Thus, after the introduction of the first cryosurgical probe (cryoprobe), a rapid
growth took place in the field of cryosurgery and numerous novel applications emerged in
the 1960s. Rand et al. used cryosurgery in treating neural diseases [16]; Marcover and Miller
utilised cryosurgery for orthopedics [17]; Torre and Zacarian et al. worked extensively on
cutaneous cryosurgery [18, 19]; Cahan et al. applied the cryosurgical probe to uterus that had
a heating element which helped in easy release from the operated tissue [20]. Constant efforts
have been made by researchers which led to remarkable advances in the 1970s. However,
only till the late 1980s, the cryosurgical technique was well received by the surgeons as an
effective surgical technique. The primary opposition to this technique by the surgeons was
the inability of this procedure to monitor the ice formation precisely [1].
Unlike conventional surgery, the surgeon is unable to determine the lateral and axial
spread of ice visually. The inability to visualise ice makes it difficult for the surgeons
in making an accurate judgement on the extent of ice formation [21]. More cooling or
lesser cooling ideally causes inadequate freezing or over-freezing. Insufficient freezing
does not cause complete cancerous cell destruction, making the treatment less effective;
while over-freezing causes complications like destruction to the surrounding healthy tissue
and vascular complications. Although the cryoprobes could be placed at a particular
location, the understanding of the effect of cooling on the target tissue remains poor. Owing
to the problems mentioned earlier, cryosurgery was mainly applied to dermatology and
gynaecology [1].
To visualise the thermal history during freezing and the extent of ice formation different
cryosurgical monitoring techniques are available. The thermal history measurement during
cryosurgery is carried out by measuring the temperature profile during cryosurgery at
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Cryoprobe
Thermocouple (TC)
TC junction
Frozen tissue
Unfrozen tissue
Figure 1.1: Schematic diagram of cryoprobe inserted in a tissue along with thermocouple
finite points in the tissue, where thermocouples are inserted in the region of temperature
measurement. Figure 1.1 shows a schematic representation of the temperature measurement
during cryosurgery using thermocouples at specific or desired location. In another study,
researchers have used the variation in the electrical impedance of the tissue during freezing
and also investigated the movement of the freezing front [22]. After a decade, in the late
1970s, it became a routine practice to use thermocouples for measuring temperature during
cryosurgery at desired locations [23]. The determination of temperature at specific sites aids
Figure 1.2: Monitoring ice ball during cryosurgery [24]
in a better understanding of the lethal front (−40oC isotherm) propagation in the target tissue.
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However, there are few problems associated with this process of thermal measurement.
Since it is invasive, the thermocouple needs to be placed inside the tissue or region to
be measured. Further, the temperature is measured at some discrete locations which is
inadequate to monitor the temperature of the whole tissue. The developments in the field
of medical imaging have helped in the visualising the extent of freezing during cryosurgery
(e.g. nuclear magnetic resonance (NMR), computerised tomography (CT) and ultrasound)
[25, 26]. Figure 1.2 depicts the practical use of ultrasound during the process of cryosurgery.
This figure illustrates that ultrasound can be used to distinguish between the frozen and
unfrozen region of the tissue [24] (Figure 1.2(A) and (B), reproduced with permission from
Wiley and sons, licence no: 3903701204848). The arrows in the figure 1.2(A) demarcate the
presence of the ice ball margin and the frozen part of the tissue generally appears darker in
the ultrasound image as compared to the unfrozen one. In comparison to the frozen region,
the lighter shaded ablated region is seen after thawing (Figure 1.2(B)). Thus, the technique
of ultrasound can aid in the real time propagation of freezing front with more accuracy.
Magnetic Resonance Imaging (MRI) is another method that is being used for monitoring the
Figure 1.3: Ice ball visulaisation during MRI aided cryosurgery [27]
ice ball formation during cryosurgery. Figure 1.3(b) shows the MRI assisted cryosurgery of
liver metastasis and it can be seen the edge of the ice ball is clearly discernible as indicated by
the arrows (Figure 1.3(a) and (b), reproduced with permission from Wiley and sons, licence
no: 3903710673566) [27].
1.3 Methods of cryosurgical cooling
Cooling is required during cryosurgery as it leads to the generation of a heat sink in the
desired tissue that aids in subsequent tissue freezing. Before the 1960s, the methods of
cryosurgical cooling had less efficacy. For example, the cotton swab dipped in LN2
technique was used for treating skin ailments. In this procedure, as seen in Figure 1.4
(Image courtesy: Richard Usatine, reproduced with permission from CRC press, licence
no. 3985261071126 [28]), small skin warts or superficial lesions were treated as the depth of
penetration during freezing was not more than 2 mm [2, 28]. A study carried out by Zacarian
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Figure 1.4: Cotton swab soaked in liquid nitrogen being applied to skin surface [28]
showed a higher penetration of freezing [19, 29]. In his work, he utilised a cylindrical copper
disc that was dipped in LN2 apriori to its placement over the skin surface. It was seen that
a freezing depth of 7 mm could be achieved using this method. However, the freezing of a
large volume of tissue or tissue that is anatomically placed deep rooted inside the body was
not easy which resulted in the use of cryosurgery being limited to the fields of dermatology
and gynaecology before 1960s [1].
1.3.1 Cryospray
The fabrication of the first cryospray device for application in medicine was suggested by
Whitehouse in the year 1907 [30]. A simple spray bottle was designed to spray liquid air on
the skin surface for the treatment of skin lesions. Subsequently, the cryogenic fluid, liquid air,
was substituted byLN2. Later, in 1969, a commercial hand-held spray device was developed
by Zacarian [31]. Figure 1.5 depicts a cryospray unit (CS1) manufactured by SMT Praha,
Czech Republic, a reputed maunfacturer in the field of cryospray and cryosurgery devices
(Image reproduced with permission from SMT Praha, Czech Republic). A cryospray device
has the following key components:
• a dewar tank for storing liquid nitrogen,
• a delivery pipe,
• a trigger that initiates the cryospray and,
• nozzles of variable diameter.
While using this device, the nozzle to skin surface distance is usually maintained between 1
to 1.5 cm, aiming the centre of the target specified. A cone can be used to limit the spray to
the desired region as it prevents splashing to the surrounding tissue and shields the healthy
area. Initially, as the spray nozzle is triggered, a combination of fine LN2 droplets and
gaseous nitrogen strike the skin surface resulting in a swifter freezing of the desired region.
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Figure 1.5: A cryospray CS1 system manufactured by SMT Praha, Czech Republic
1.3.2 Cryosurgical probe
In comparison to the cryospray, the history of cryoprobe development is short and is available
in limited types by the cryogenic fluid. There are two types of systems available, the more
prominent one uses liquid nitrogen for cooling; while the other system uses nitrous oxide as
a cryogen.
Liquid nitrogen based cryoprobe
The year of 1961 marks the birth of modern cryosurgery as Cooper et al. developed the first
modern cryoprobe that could use liquid nitrogen and carried out experiments using their
cryosurgical probe to ablate brain tumours [15]. Figure 1.6(a) shows the schematic diagram
of the cryoprobe. It consists of three long concentric tubes. There is a presence of vacuum in
the gap between the outer and middle tubes and this gap is provided in such a way that there is
a thermal insulation. The innermost tube provides liquid nitrogen from a reservoir to the tip
of the cryosurgery device, which is made from metal so that there is an efficient heat transfer
between the probe and the surrounding tissue that is to be removed using cryosurgery. Since
the probe is closed, the liquid that returns after coming in contact with the tip of the cryoprobe
needs space. Hence, there is an annular gap between the middle and inner tubes. Further,
there is an outer tube that encloses these two concentric tubes. Also, the constant flow of
LN2 leads to a lower temperature at the tip of the cryoprobe. This lower temperature causes
7
Chapter 1 Introduction
liquid2nitrogen2tube
Vacuum2Insulation2
Gaseous
nitrogen
Vent2for2nitrogen2gas2
Delivery2tube2
Thermocouple2
Metal2freezing2tip2
Liquid2N222vaporising
Heat2transfer2between2tip2and2tissue2
(a) Liquid nitrogen cryoprobe
IceLformation
ProbeLtip
ExpansionLchamber CapillaryLtube
NITROUSLLOXIDELLOUTLETLTL=L-10L
NITROUSLLOXIDELLINLETLLLTL=L-20
NITROUSLLOXIDELLOUTLET
o
C
o
CoC-80
Insulation
(b) Nitrous oxide cryoprobe
Figure 1.6: Different types of cryoprobe for modern cryosurgery
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freezing of tissues, and the ice front propagates from the surface of the probe to the desired
tissue. A promising development took place in the 1990s that allowed the use of sub-cooled
liquid nitrogen to reduce the gaseous gap (N2) between the probe wall and liquid nitrogen
[32]. The subcooling is carried out by passing the pressurised LN2 through a cooling coil
that is dipped in the semi-solid slush of nitrogen at −209oC. The flow of nitrogen helps
in single phase flow during the cryosurgical ablation that produces a low temperature at
the cryoprobe tip. In earlier systems, the boiling of LN2 released a tremendous volume of
gaseous nitrogen that affected the flow of the incoming liquid nitrogen. The primary reason
for the development of cryoprobe with a larger outer diameter (OD) before the 1990s was
to have a continuous flow of liquid nitrogen in spite of the presence of the gaseous nitrogen.
However, a larger OD of the cryoprobe made it less accessible to a particular and specified
region as the surface area of contact was more. The usage of subcooled LN2 decreased the
boiling point thus helping in a compact design of a cryoprobe having diameter in the order
of 3.4 mm.
Nitrous oxide based cryoprobe
TheN2O based cryoprobe applies Joule-Thomson effect to create a low temperature. Figure
1.6(b) schematically depicts that the shaft of the cryoprobe is insulated. The gaseous N2O
is provided from a source that is high pressure, e.g., 50 bars that pass inside the inner tube.
The inner tube has a very tiny orifice of nearly 0.08 mm that helps the pressurised N2O
pass through the expansion chamber where there a pressure drop to 1 bar. The unexpected
expansion results in cooling of N2O and a temperature of −80oC is achieved inside the
chamber. While cryosurgery is being performed, the expansion chamber is in contact with
the desired region to be ablated, and a low temperature within the chamber results in freezing
and destruction of tissues.
1.4 Advantages of modern cryosurgery
Modern cryosurgery utilises low temperature to destroy undesirable tissue. The basic
principle of this technique and the outcome of cryosurgical ablation is different as compared
to other treatment methods. This technique is minimally invasive and demonstrates the
following advantages over its counterparts such as chemotherapy, surgical ablation and
radiation:
1. Cryosurgery is a localised treatment modality. In comparison to other methods of
treatment, the use of cryosurgery helps in restricting the low temperature to a specified
region, thereby, helping in the minimal destruction of the surrounding healthy tissue.
Thus, this merit of cryosurgery has led to its use in removal of tumours of liver, brain,
lung and prostate [1].
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2. It requires a short duration for the treatment of tumours. A very low temperature is
achieved in a single freeze cycle duration during cryosurgery. Even in the case of
multiple freeze-thaw cycles, it does not require more than twenty minutes for tumour
ablation.
3. There is minimal bleeding during this process since there is no tissue resection carried
out in this procedure. It is of significance especially in the case of cryosurgery of
hepatic tumours as these tumours are generally located close to major blood vessels
[32].
4. Cold serves as a local therapeutic and hence there is no requirement of general
anaesthesia during this procedure.
5. This technique provides patient comfort as it is applied for a very short duration of
time. Thus, this treatment method improves the quality of patient care considerably.
1.5 Limitations of cryosurgery
Although there have been remarkable developments in the past decades that have improved
cryosurgery, still shortcomings exist and need to be addressed accordingly. Currently, the
advancement in technique of cryosurgery is stalled because of the following deficiencies:
1. In a real time scenario, it is still a challenging task to monitor the process of cryosurgery
continuously. The use of intraoperative ultrasound has aided in visualising the tumour
during the freezing of tissue [33]. However, the technique has shortcomings. During
freezing, it is not easy to get the fine details behind the edge of the ice ball because the
ice ball produces acoustic shadowing.
2. The freezing front can be monitored using current day imaging techniques. But it is the
exact location of lethal front (−40oC) isotherm that is required for complete cancerous
cell destruction [32]. Therefore, studies need to be performed to determine the spread
of lethal front propagation in real time during the cryosurgery process.
3. Novel strategies are required to improve the efficacy of cryosurgery process. A
successful cryosurgical ablation is one which calls for an optimal planning protocol
that is capable of predicting the thermal history inside the tissue and improves the
efficiency of cooling.
This thesis mainly deals with novel approaches to improve the outcome of cryosurgery
through numerical and experimental studies in gel phantoms. Currently, the standard
treatment modality of tumour cases includes the use of surgery, radiation, chemotherapy,
hormonal therapy, radiofrequency ablation and cryosurgery. Cryosurgery, or tissue
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destruction by using very low temperature is an efficient and minimally invasive technique
that can be improved immensely by newer methods. This thesis provides an overview of
the steps that can be taken to improve the effectiveness of the cryosurgery process through
a preliminary study.
1.6 Objectives of the thesis
The primary objectives of this thesis are:
1. To propose a new concept of low thermal conductivity layer around a tumour interface
and carry out a parametric study of the freezing process during cryosurgery using
numerical modelling.
2. To formulate low thermal conductivity emulsions of perfluorocarbon for effective use
as a barrier during cryosurgery.
3. To carry out experiments on gel phantoms using a cryosurgery system and propose a
novel concept of adjuvant enhanced cooling in presence of perfluorocarbon layer.
1.7 Scope
The scope of this thesis is as follows:
1. In this study, a parametric analysis of heat transfer process is carried out during
cryosurgery of two dimensional (2D) axisymetric spherical tumour in the presence and
absence of a low thermal conductivity perfluorocarbon (liquid) layer using numerical
modelling. Parameters like offset, i.e (distance between the tip of the cryoprobe and
tumour interface), the time taken for complete tumour ablation, the effect of tumour
radii on cooling, the effect of a low thermal conductivity layer of perfluorocarbon
around the tumour interface, the gap in tumour ablation (i.e. the distance between
the lethal front and the tumour interface with respect to time) are optimised. The
concept of low thermal conductivity liquid around the tumour interface is new and
finds significant practical implications in cryosurgery.
2. Emulsions of perfluorocarbons can be used as an insulation during cryosurgical
ablation. Hence, low thermal conductivity emulsions of perfluorocarbon are
synthesised. The thermal conductivity is analysed and the most suitable
perfluorocarbon emulsion that has the lowest thermal conductivity is chosen for the
proposed applicaton in cryosurgery. The zeta potential is also determined to visualise
the emulsion stability. These emulsions can be used as an insulation during cryosugery
and can prevent the lethal front to cross the gel-perfluorocarbon interface.
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3. New experimental methods have been developed for improving the efficacy of
cryosurgery of gel phantoms using adjuvants like glycine and alumina in presence of
perfluorocarbons, i.e. increased freezing inside a defined geometry due to adjuvants
with perfluorocarbon as a barrier to gel freezing.
1.8 Outline of the thesis
A brief description of thesis chapters is summarised below:
Chapter 1 discusses a general introduction of cryosurgery, its history, the cryogens used
till date, the types of cooling techniques used for cryosurgical ablation, various cryoprobes
used, the advantages and disadvantages of this technique.
Chapter 2 reviews existing literature pertaining to cryosurgery, its advances and the
current directions in this field. This chapter also discusses the following key points
exhaustively:
1. The variation in freezing of tissue during cryosurgery
2. The mechanisms of tissue damage during cryosurgical freezing
3. The studies related to numerical modelling of cryosurgery process
4. Experimental studies on measurement of temperature distribution and its use in
cryosurgery.
5. Perfluorocarbon, its uses, synthesis of perfluorocarbon emulsions and its usefulness
in being used as a low thermal conductivity insulation during cryosurgery
6. Studies directed towards the improvement of cryosurgical process.
Chapter 3 discusses a two dimensional axisymmetric model for a multiblock structured
grid. The developed model is used to study freezing of spherical tumours of different radii at
various active lengths around a single cylindrical cryobrobe. A novel way of calculation of
the distance between the lethal front and tumour interface is presented here. Furthermore, the
effect of a low thermal conductivity barrier of perfluorocarbon around the tumour interface
is evaluated numerically and compared with its absence. A parametric study is carried out
that concerns an optimal cooling configuration (i.e. optimal offset), variation in active length
of the cryoprobe, role of the low thermal conductivity perfluorocarbon (liquid) layer, change
of tumour radii and its effect on cryosurgical freezing, ablation time for optimal offset. This
chapter also highlights the results obtained after varying the perfluorocarbon layer thickness
and the various chemical substances that can be used for formulating this insulating layer.
This chapter also suggests that gap propagation (distance between the lethal front and the
tumour interface) can be used as a tool for determining an optimal offset.
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Chapter 4 proposes designing of highly concentrated perfluorocarbon emulsions that
possess low thermal conductivity and act as an insulation during the cryosurgery process.
In the first half of the chapter, formulation of perfluorohexane emulsions is discussed.
The thermal conductivity of emulsions is optimised by varying the concentration of
perfluorocarbon from (30% (w/v) to 90% (w/v)), an analysis of particle size and zeta
potential is also carried out for these emulsion systems. The role of surfactant change is
also evaluated. In the second half of this chapter, the perfluorocarbon phase, is varied to
perfluorodecalin. The thermal conductivity of the emulsions is measured and subsequently
size, zeta potential, functional group analysis and differential scanning calorimetry studies
are carried out for the optimal perfluorodecalin emulsions. Subsequently, the lowest thermal
conductivity emulsion is utilised as a barrier to gel cooling during cryosurgery of gel
phantom.
Chapter 5 focusses on adjuvant containing gels and the use of perfluorohexane as barrier
to gel cooling using a cryosurgery system. In the first half of the chapter, research is focussed
on the cooling of agarose gel phantoms. To visualise the effect of adjuvant, glycine is added
in the agarose gel solution to form the adjuvant containing gel phantoms and the thermal
history is measured during the cryosurgery process. To verify the effectiveness of insulating
layer, the freezing of glycine containing gels is carried out in presence of perfluorohexane
layer as a barrier to gel cooling. The ice ball is also visualised after the completion of freezing
process and compared to the normal ice ball. In the second half of this chapter, alumina and
alumina-glycine containing gel phantoms are prepared and then cooled using a cryosurgery
system. This part of the chapter highlights the increased freezing due to adjuvants, the role
of insertion depth in enhancement of freezing, the effect of perfluorohexane solution layer
as a barrier to cooling of alumina containing gels. This chapter also discusses the role of
glycine-alumina in decreasing the end temperature after cryosurgery substantially. Apart
from the above mentioned cases, the thermal profile and ice ball images obtained after the
cryosurgery procedure.
Chapter 6 summarizes the key results, lists out the significant inferences and the
importance of this study with respect to the contribution made to the existing knowledge.
This chapter also highlights the limitation of the present study and the future directions that
can be pursued for the betterment of research in this field.
Some of the results of Chapter 3 and Chapter 5 have been published and mentioned
in the dissemination section. Few papers originating from the results of Chapter 4 and
Chapter 5 are either under review or would be communicated to journals shortly (Details
mentioned in the dissemination section). Followed by the introduction section of the thesis,
the review of literature gives a focussed insight on the effect of temperature decrease
during cryosurgery, the mechanisms involved in freezing injury, modelling studies related to
cryosurgical freezing, experimental studies for measurement of temperature profile, studies
related to perfluorocarbon emulsions and studies carried out to improve the cryosurgery
13
process. A lot of numerical and experimental studies have been carried out to improve the
effectiveness of cryosurgery. However, a lot of drawbacks exist and need to be addressed.
This thesis advocates methods to improve the efficiency of cryosurgery procedure through
new approaches. Previously reported literature pertaining to the scope and objectives of this
thesis shall be reviewed exhaustively in the next chapter.
Chapter 2
Review of Literature
Modern cryosurgery is a surgical technique that has gained acceptance in the field of
medicine since its inception in the 1960s. Various research activities have been carried out
in the field of cryosurgery. This chapter discusses the literature of the studies carried out in
the following areas:
1. Variation in the freezing of tissue during cryosurgery
2. Mechanisms of tissue damage during cryosurgical freezing
3. Numerical modelling studies related to freezing
4. Experimental studies on measurement of temperature distribution
5. Studies related to perfluorocarbons and emulsion preparation
6. Studies directed towards the improvement of cryosurgical process
2.1 Variation in the freezing of tissue during cryosurgery
For optimising the cryosurgical tumour ablation, apart from the development of numerical
and experimental studies related to the improvement of the cryosurgical outcome, the effect
of freezing needs to be well understood. Studies demonstrate that there are complicated
physical, physiological and biological responses that occur in the tissue during freezing,
among which these areas deserve significance and exhaustive discussion.
2.1.1 Effect of freezing in tissue at the cellular level
The substantial progress in the low-temperature microscopy has made it possible for
biologists to study the changes in freezing at the level of cells and tissues. Three significant
events that occur during freezing are: extracellular ice formation (EIF), cellular dehydration,
intracellular ice formation (IIF).
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Extracellular ice formation (EIF)
During freezing, there is a drop in temperature, and when the temperature lies in between
the range of sub-zero to around−20oC, there is ice formation at the extracellular space [34].
This phenomenon is termed as extracellular ice formation, and the continuous cooling leads
to the growth of these ice crystals. Further, in the extracellular space, a low osmotic potential
is developed due to freezing that causes the seepage of water present in the intracellular
space. Extracellular ice formation has been observed by many researchers during freezing
of cells. In a study, it has been reported that EIF is initiated at −1.2oC while freezing the
frog muscle [35]. Further, in another work, researchers have suggested that EIF occurs
before intracellular ice formation (IIF) since the liquidus temperature of the extracellular
fluid is higher than the intracellular fluid [36]. With advancement in cryosurgical ablation,
many findings have suggested the presence of EIF in human tissues. In the same context,
Hong et al. have observed large ice crystals around the fat cells after freezing normal
and malignant breast tissue samples in LN2 [37]. Further, researchers have used the
directional solidification method to freeze the normal and malignant liver tissues under
precisely monitored cooling rates, and it has been observed that EIF occurred in both the
cases [38].
Cellular dehydration
Numerous studies carried out by Mazur have reviewed the cellular dehydration due to
freezing [39–44]. The presence of a slower cooling rate results in cellular dehydration and
the following steps occur during this process. Due to freezing, the temperature decreases
to the liquidus temperature of the extracellular space, initiating EIF that increases the solute
concentration in the unfrozen fraction of the extracellular space. In principle, a cell adjusts
the concentration of water and solute to maintain the chemical equilibrium with the outside
surroundings in the absence of any metabolism [45]. Due to selective permeability of the cell
membrane, water can pass it while solutes remain outside. This water movement results in a
solute concentration difference across the plasma membrane forming an osmotic pressure
that drives water transport from inside to outside of cell membrane. At slower cooling
rates, sufficient time is available for the water transport and therefore, cellular shrinkage
and dehydration eventually occurs. To analyse the freezing within a liver tissue, Rubinsky
et al. have used directional solidification [46]. It is seen that the liver cells dehydrate when
cooled at a rate of 4oC/min. At lower cooling rates, due to the presence of extracellular
ice formation, there is cellular dehydration [47]. Furthermore, a comparison of cellular
morphology at different cooling rates suggests that decreasing the cooling rate causes an
increased cellular dehydration.
16
Chapter 2 Review of Literature
Intracellular ice formation (IIF)
During the freezing process, as the temperature decreases to −40oC or lower, there is
intracellular ice formation [48, 49]. This happens when there is a rapid cooling rate owing
to which the freezing water is unable to leave the cells, thereby, causing IIF [34]. It has also
been reported that these ice crystals may pass across the cells through intercellular channels
[50]. In several studies, Mazur has studied the IIF inside the cells exhaustively [39–44].
In comparison to the dehydration of the cell, IIF usually occurs when the rate of cooling
is very high. This leads to the nucleation and growth of ice intracellularly. Early in vitro
investigations on IIF in animal tissues have been studied in detail by Love [51]. Mazur
has observed IIF in yeast, mouse sperm and human red blood cells [40, 41]. In the last
two decades, research groups of Rubinsky and Bischof have carried out studies on IIF in
tissues. Under high cooling rates, intracellular ice formation has been observed in normal
and malignant breast tissue samples, AT-1 rat prostate tumour [38, 46, 52, 53].
2.1.2 Effect of freezing at the macro level
Considering freezing as a macro level process, a cryosurgical process begins with the cooling
of tissue using the cryosurgical probe that causes a decrease in the temperature in the region
surrounding the probe. After initial decrease in temperature, phase change occurs and the
tissue begins to freeze leading to the formation of ice ball. With time, the cooling progresses
and the ice ball encloses the entire volume of the tissue causing damage to the undesired
tissue.
Heat transfer in the tissue
Studies related to heat transfer in a biological tissue have fascinated many researchers since
1876 [49]. Numerous research studies have been carried out to quantify the role of blood
perfusion and metabolism on the heat transfer in tissue. Some significant reports of heat
transfer inside the tissue has been reported by various researchers [54–57]. However, it
was Pennes in 1948 who developed the first quantitative bioheat transfer model describing
heat flow in tissue [58]. He evaluated the temperature distribution in the human forearm
experimentally including the heat conduction terms with two more terms namely the thermal
effects of blood perfusion and metabolism. This is one of the most seminal works in the field
of bioheat transfer and is also referred to as the “Pennes bio heat transfer equation”. Over the
last fifty years, Pennes bio heat transfer equation has been successfully used as an important
analytical tool. As an analytical tool for bioheat transfer, it finds important application in
cancer hyperthermia and thermal models of complete body under environmental stress [59–
62]. Till date, Pennes bio heat transfer equation is the most popular and widely utilised
equation for solving heat transfer problems related to biological applications and remains an
integral part of bioheat transfer [63].
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Freezing temperature range of biological tissue
The exact amount of ice and water during freezing at a specific temperature affects the
cryosurgery process. In a study, Plank determined ice and water proportion during the
freezing of beef muscle at different temperatures by using calorimetry [64]. In another study,
Moran found out that the amount of water that converted into ice during freezing of beef,
mutton and pork by dilatometry technique [65]. Further, the amount of ice formed during
freezing of animal tissues at various temperatures has been determined by the technique of
flotation and histology [51]. All these studies are indicative of the fact that freezing in the
tissue does not occur at a particular temperature, but at a range of temperature. Generally,
the phase change in most biological tissues lies in the range of 0oC to −10oC [51].
Vascular stasis during tissue freezing
The first information of the effect of freezing on circulation in tissue has been reported in
clinical and experimental works related to frostbite. The tissue cooling during cryosurgery
initially results in vasoconstriction i.e., a decrease in the flow of blood in the tissue [34]. The
progress in modern cryosurgery in the 1960s led to the beginning of in-vivo studies on the
cryosurgery of mammalian tissues. In 1970, Rothenborg carried out experiments to study
the cryosurgical cooling of human and rabbit skin by LN2 cryogen spray [66]. The results
of this study suggested that since the diffusion of cooling during cryosurgery is quicker, the
walls of capillary have little time to contract before the freezing of blood. The rate of blood
perfusion through capillary is constant during cooling and then becomes zero at the start of
freezing.
2.2 Mechanisms of tissue damage during cryosurgical
freezing
Cryosurgery uses low temperature and freezing to cause tissue destruction. Earlier, the
mechanism of tissue destruction was poorly understood, and these shortcomings had
prevented the use of cryosurgery by surgeons for treating tumours and other malignancies.
The mechanism of tissue destruction has been a topic of discussion among researchers for
decades. Till date, many theories have been advocated by scientists. However, the most
widely acclaimed views are direct cell injury and vascular injury [34, 48]. These mechanisms
are illustrated in Figure 2.1, where elliptical shape indicates healthy cells and star shape
suggests the extracellular and intracellular ice.
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Figure 2.1: A schematic diagram of tissue injury mechanism during cryosurgery
2.2.1 Direct injury to cells
The tissue destruction through direct cell injury occurs primarily due to biophysical events
that take place during freezing, i.e. intracellular ice formation and cellular dehydration. The
damaging effects of cellular dehydration and solute concentration are termed as the solution
effect. Apart from these mechanisms of cellular injury, Ablin has suggested a hypothesis of
freezing-initiated immunologic injury [67]. However, there is still controversy surrounding
the existence of this mechanism, and therefore this hypothesis is not accepted widely.
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Solution effect
As mentioned earlier, freezing of tissues under low cooling rate causes cellular dehydration
and a high concentration of solutes, and this is coined as the solution-effect. In the presence
of higher concentration of solutes, the enzymatic machinery is destroyed, and there is a
destabilisation of the cellular membrane [48]. Further, Gage et al. have advocated that
solution effect can injure a cell through several ways. However, a defined interval of freezing
during cryosurgery leads to a limited time for the solution effect to occur making it less lethal
for the cells [34].
Effect of intracellular ice formation
A higher rate of cooling provides no time for water to move across the cell membrane
and causes IIF in the desired tissue. It has been observed that IIF is lethal to cells and
this is owing to the fact that these ice crystals aid in disrupting the intracellular cell
organelles and membrane [34]. At very low temperatures, smaller ice crystals re-crystallise
to form larger ones thereby minimising free energy and surface area. Further, this ice
recrystallisation increases the chances of intracellular ice damaging the plasma membrane
and other organelles [48].
2.2.2 Vascular injury
The primary cause of vascular injury is anoxia and tissue necrosis due to vascular stasis.
In a research work, Cohnheim suggested that frostbite necrosis is a result of hemostasis
[68]. During cryosurgery, there are circulatory changes that cause vascular stasis. As the
ice formation starts, blood circulation ceases and the blood vessel is affected. This damage
includes wall distension and direct cell injury to endothelial cells [48]. Once the ice thaws,
there are a plethora of changes in the micro-circulation e.g. increases in permeability of
the capillary wall, aggregation of platelets and thrombus formation. In the case of freezing,
thrombus occludes the capillary and small blood vessels resulting in vascular stasis [34].
2.3 Numerical modelling studies related to freezing
A good numerical model related to cryosurgery should adequately address all the physical
events during the process of tissue freezing. It should also take into account the thermal
effects such as heat loss due to blood perfusion, the effect of metabolic heat generation,
metabolism inside the unfrozen region of the tissue, release of latent heat during phase
change and heat conduction inside the frozen region of the tissue. Considering above
mentioned requirements, Comini et al. developed the first mathematical model in 1976
[69]. Since then, researchers across the globe have carried out several studies on the
20
Chapter 2 Review of Literature
numerical modelling of cryosurgery process [53, 70–76]. Various numerical strategies and
mathematical models have been used to determine the thermal history during cryosurgical
ablation.
2.3.1 The governing equation
The studies mentioned earlier suggested that the conduction process dominates the heat
transfer within the frozen tissue region. It is understood as there is no blood perfusion
and metabolism in the frozen region. The heat diffusion and the thermal distribution in the
unfrozen tissue can be calculated by Pennes heat transfer equation [53, 69, 71, 72]. Pennes
equation is applied in cases of biological heat transfer especially when the tissue originates
from an animal source, and this equation is popularly termed as Pennes biot heat transfer
equation. For example, this equation has been utilised to study heat transfer in the case of
dunning AT-1 rat prostate tumour, angioma, human brain and tumour in the dorsal skin of a
Copenhagen rat [48, 53, 69, 72].
2.3.2 Boundary conditions
The following boundary conditions have been used by the researchers at the cryoprobe tip,
e.g. constant temperature, transient temperature dependence conditions or constant cooling
rate. [4, 8, 48, 51, 53, 70, 71, 73, 76].
2.3.3 Modelling studies on cryosurgery
The technique of cryosurgery needs very precise control for ablating the tissue. If freezing
is not sufficient enough then it might lead to recurrence of cancer in cases of malignancies,
thus, while extreme over freezing results in more volume of tissue being destroyed lesser
ablation might lead to its recurrence. A numerical study carried out by Comini considered the
practical anatomic structure of angioma on an infant’s head [69]. However, most numerical
studies assume tissue to be isotropic and homogenous, which renders inability to locate
components like blood, nerves in the calculation domain. Advances in imaging techniques
such as magnetic resonance imaging (MRI), ultrasound, X-ray and electrical impedance
tomography (EIT) have facilitated in performing cryosurgeries with ease and made this
technique popular, but each one of them has its limitations [26, 77–80]. Each imaging
procedure available currently helps in visualising the ice ball interface, but it is unable
to predict the exact location of the lethal front or critical temperature isotherm which is
extremely crucial for determining the extent of damage to cancerous cells. To tackle these
problems and provide online monitoring of temperature at a finite number of points within
the tissue, thermocouples are being used. But the exact placement and positioning of these
thermocouples again require details like precise location of critical temperature isotherm.
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To solve this issue, models have been developed not only to determine the temperature
around the cryoprobe but also within the iceball that is formed during this process. The
earliest model that was developed was for a single cryoprobe on a one-dimensional
plane which assumed immediate cooling around the probe [81]. This model proposed
conduction as the significant driving force of heat transfer inside biological tissues. Newer
and complex models were developed later to conduct a parametric study of freezing of
tissue in a two-dimensional and axisymmetric cylindrical cryoprobe using finite difference
scheme. Also, an exact time-dependent location of the ice ball was visualised, but
the temperature within it was not calculated [72]. In the same context, Rewcastle et
al. proposed a three-dimensional finite difference method that simulated freezing and
temperature evolution in a medium with a multiprobe arrangement [73]. In another study,
Deng et al. have carried out a study on selective freezing of tissues. In this numerical work, it
is seen that the injection of solutions of high thermal conductivity results in a better clinical
outcome during cryosurgery [82]. To improve the efficacy of the cryosurgical procedure,
Rossi et al. have suggested a method of computerised planning for prostate cryosurgery that
advocates variation in the insertion depth of cryoprobes [83].
Researchers have recently utilised mathematical tools to reconstruct the temperature field
for wireless temperature sensors. The results of the study demonstrate that this technique
can help in determining the lethal front temperature to a significant degree of certainty
[84]. Another significant research work recreated a database of prostate models that can
later help in computerised planning and training of cryosurgical procedures [85]. Further, a
cryosurgery tutoring aid has been developed that helps in optimising a geometrical constraint
like cryoprobe placement and predicting temperature distribution [86]. A new potential
field analogy method (PFAM) is combined with the temperature field reconstruction method
(TFRM) to determine the temperature profile in the frozen area. The results of this integrated
approach (PFAM and TFRM) suggest that this is an efficient tool to calculate the thermal
history in the frozen region during ultrasound-assisted cryosurgery [87].
2.3.4 Numerical schemes
Several numerical schemes have been utilised for discretising the governing Pennes biot heat
transfer equation and the phase change phenomena is handled as mentioned below.
2.3.5 Discretisation methods for solving the numerical schemes
Several researchers have used the finite difference scheme for solving these problems [48,
53, 71, 72]; while the use of finite element method has been advocated by Budmann et al. ,
Weill et al., and Wan et al. [70, 74, 75]. In another study, Smith et al. have suggested the
use of finite volume based numerical approach to solve similar problems [47].
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2.3.6 Handling the phase change processes
Various numerical methods have been used to handle the tissue freezing process, e.g. front
tracking method [53, 75], source term method [76], enthalpy method [72, 74] and apparent
heat capacity method [70, 72, 73]. The principles of these methods are described in the
following section:
Front tracking scheme
This methodology solves the conduction problem in the frozen region of the domain and the
Pennes equation in the unfrozen region. The boundary condition, i.e., Stefan conditions, are
required to define the temperature continuity and heat flux at the interface. While calculating,
the position of the freezing front has to be updated at each time step, which requires extra
work for grid refresh or local refinement. Further, this method gives superior output for a
pure substance, in which the phase change occurs at a single point in terms of temperature
value. Due to this reason, Bischof et al. assumed the freezing point of dunning AT-1
Rat prostate tumour to be 0oC (273 K), however, tissues generally freeze over a range of
temperature [53, 69, 72].
Enthalpy method
This method uses enthalpy (H) as the variable in the transient term in the heat conduction
equation instead of temperature (T) or the Pennes biot heat transfer equation. The presence
of two dependent variables (H and T), needs an additional equation for addressing the
relationship between H and T. Once the enthalpy at the current time step is determined, H at
the current time is also known, corresponding temperature field can be updated by solving
the additional equation prior to proceeding to the next time step. In comparison to the front
tracking scheme, the enthalpy method helps in solving phase change problem in a fixed grid.
Apparent heat capacity method
This method considers the phase change process by incorporating the effect of latent heat
effect into the change of variation of an apparent heat capacity, thus, the integration of the
specific heat over temperature of phase change is equivalent to the latent heat. This strategy
makes an assumption that the apparent specific heat varies linearly in the region of phase
change [70, 72, 73].
2.3.7 Factors affecting the outcome of cryosurgery
Several studies that have discussed mechanisms of cryo injury to tissue have revealed that
the thermal history has significant impact on cryosurgical injury. In the same context,
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Hoffmann and Bischof have suggested that the thermal history is in turn affected by four
parameters[48]:
1. Rate of cooling
2. End temperature
3. Hold time (Time taken below the lethal temperature)
4. Thawing rate
These parameters have a significant impact over the outcome of cryosurgery. Hence, these
parameters are discussed concisely in the following sections.
Cooling rate
The rate of cooling plays a crucial role in determining the mechanisms of direct cell injury:
Intracellular ice formation (IIF) results in high cooling, while at lower cooling rate solution
effect is dominant. Since IIF is highly fatal to the survival of freezing cells, the cryosurgical
procedure or planning should be designed in such a way that cryosurgery protocol results
in generation of significant IIF. Hence, the cryoprobe should have a higher cooling capacity
to produce an elevated rate of cooling. Due to this reason, the LN2 cryoprobe should be
utilised to ablate invasive tumours [23]. Moreover, it is seen that the method of multiple
cryoprobes can be used for a larger tumour, as a higher cooling rate occurs near the tip of
the cryoprobe [34]. Therefore, further technology improvement needs to de carried out for
developing high performance multiprobe cryosurgery systems. For example, Chang et al.
have developed a novel cryosurgery system using subcooled liquid nitrogen that produces
a lower temperature of −206oC which is better than the conventional cryosurgery systems
[88]. These techniques, i.e. multiprobe and sub-cooled systems provide higher destruction
and produce a higher cooling rate, thus, enhancing the outcome of cryosurgery significantly.
Further, experimental studies show a significant dependence of cooling rate in association
with IIF. In a study, Bischof et al. have revealed that a cooling rate of 50oC/min produces
intracellular ice formation in Dunning AT-1 rate prostate tumour cells[53], while in human
liver tissue IIF occurs at a cooling rate of 22oC/min [47].
Lethal or critical temperature
For a cryosurgical procedure to be effective, the rate of freezing should be optimal so that
the tumour ablation is uniform with minimal damage to the surrounding healthy tissue.
It is well known that lower temperature in the tissue leads to higher destruction and for
a complete destruction a lethal or critical temperature should be achieved. It has been
reported that the critical temperature for cell destruction must be in the range of −400C to
−500C [9, 10, 89–96]. This critical temperature is achieved due to the ice formation during
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Table 2.1: Some important in vivo experimental studies showing lethal temperature for
various tissues
1stAuthor Year Tissue Lethal
temperature
Gage 1966 Osteocytes,
bone, dog
−2oC [97]
Gage 1978 Melanocytes,
skin, dog
−4oC [94]
Gage 1982 Skin, dog −40oC [92]
Neel 1971 Sarcoma,
mouse
−60oC [101]
Rivoire 1996 Liver,pig −15oC [90]
the cooling of tissue. Many cryosurgical studies have been conducted on determining the
lethal temperature and it has been observed that it is a tissue dependent parameter [34, 97].
Moreover, experiments carried out by researchers indicate that malignant cells are more
resistant to freezing induced destruction than the normal cells [98–100]. Considering the
differences in the quantitative values of temperature at which complete cell/tissue destruction
occurs, Gage et al. have suggested that it is safe to lower the temperature between −40oC
to −50oC for achieving the goal of complete cellular damage [92]. Table 2.1 provides the
list of some significant studies that were carried out to determine the lethal temperature.
Thawing rate
Till date, studies point out that a slow thawing rate can strengthen the destructive effect and
cause higher damage [34, 48]. Experiments indicate that longer thaw duration results in
increased solution-effect and higher growth of ice crystals [102, 103]. Some experimental
evidences also reveal that a slow thawing plays a critical role in cell death than rapid a cooling
protocol [101, 104, 105].
Hold time
Hold time is referred to as the time at which the desired tissue has been frozen to a
temperature lower than the lethal temperature [48]. Increasing the hold time actually
results in a higher amount of intracellular ice formation and provides sufficient time for
recrystallisation of intracellular ice crystals [125]. In terms of solution effect, the increment
in the hold time allows the equilibration of the osmosis between the intracellular and
extracellular spaces, thereby, increasing the cellular dehydration. Further, in different in
vivo experiments, the destructive effect of the increase of hold time has been observed by
researchers [91, 94, 96].
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2.4 Experimental studies on determination of temperature
profile during cryosurgery
Temperature plays an important role in determining the tissue injury mechanism and the
clinical outcome of tumour ablation during cryosurgery. Numerous experiments have been
carried out on tissues and tissue mimicking gel phantoms to investigate the temperature
distribution inside the tissue during cryosurgery, which will be discussed in this section of
the thesis.
2.4.1 Experimental studies on tissue mimicking gel phantoms
Researchers have made gel phantoms to mimick the thermophysical properties of tissue
[106]. In this study, agarose has been used to form the tissue mimicking gel phantoms.
Cooper et al. for the first time carried out an experiment to investigate the thermal history
during cryosurgery [7]. A clear gel consisting of 1.5% gelatin and 98.5% water was utilised
for the preparation of tissue phantom and liquid crystal technique aided in the measurement
of temperature distribution in the gel. In this case, the cooling was produced by a single
LN2 cryoprobe. Budman et al. also studied thermal profile in a tissue phantom containing
2% gelatin and 98% water [70]. Cryoprobes of LN2 and pressurized N2O were used to
cool the tissues respectively and temperature is determined by the thermocouples present
at the different locations near the cryoprobe. Experiments have been compared with the
analytical solution, and the numerical findings have been obtained by using finite element
method. Similar kind of experiments have been conducted by Augustynovvicz et al. on the
gelatin gel phantoms of different concentration [107]. The use of gel phantom to mimick
the thermophysical property of tissue makes the real time measurement of temperature at
multiple locations easy since the location of the thermocouple inside the gel is visible through
visual observation. Furthermore, the thermophysical properties of gel phantoms are similar
to that of biological tissue. Therefore, there is no significant difference in heat flow dynamics
during cryosurgery and these results provide a preliminary finding that can be applied in a
real time clinical trial of cryosurgery.
2.4.2 Experimental studies on tissues
Apart from gel phantoms, experiments have also been performed by researchers on tissues
and is discussed in the following section.
In vitro studies
Several tissues (animal and human) have been studied by in vitro experiments to explore the
effect of cryosurgery and analyse the thermal history due to the tissue cooling (Table 2.2).
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Table 2.2: Few significant in vitro experimental studies on tissues during cryosurgery
1stAuthor Year Tissue Parameter
investigated
Onik 1984 Beef liver Temperature
profile and ice
ball [26]
Homasson 1994 Rat tissue
culture, human
serum and
whole blood
Temperature
profile and ice
ball [108]
Augustynovvicz 1985 Beef tissue Thermal
history, rate of
cooling and
ice ball [107]
Lam 1998 Porcine liver Temperature,rate
of cooling and
ice ball [109]
Yang 2000 Mouse
bladder-tumour
cell line
Temperature
distribution,
ice ball [110]
Onik et al. conducted cryosurgical freezing on beef liver [26]. The technique of ultrasound
has been used to monitor the extent of ice formation or the frozen region during cryosurgery.
In a research study, Augustynovvicz et al. utilised cryoprobe to focally freeze beef, muscle
and liver while the tissue was immersed in a water bath at 37oC [107]. Further, this study
measured temperature by placing thermocouples at different locations and the measurement
of cooling curves aided in estimating the thermal history and the iceball growth. A study
carried out by Homasson et al. revealed the use of N2O based cryoprobe for cryosurgical
ablation of rat tissue culture, human serum and blood [108]. In this work, the tissue
impedance and temperature readings have been measured at fixed positions, and the ice
ball growth has been observed and determined visually. Lam et al. have reported the study
of freezing of fresh porcine liver experimentally [109]. In this study, the ice ball growth
and temperature measurements have been carried out exhaustively. Yang et al. cultivated
mouse bladder tumor cell line MBT-2 as the target of the cryosurgical freezing produced by
a LN2 based cryoprobe. Tissue temperature was measured by 16 thermocouples arranged
on a horizontal plane and the temperature distribution and variation were studied [110].
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2.5 Studies related to perfluorocarbons and emulsion
preparation
Perfluorocarbons are chemically inert, non-toxic and find a plethora of applications in
biomedical engineering [111]. These are highly fluorinated compounds that are capable of
dissolving a large amount of respiratory gases like oxygen and carbon dioxide [112, 113]. In
a study, researchers have used perfluorocarbon nanoparticles for molecular imaging while
performing magnetic resonance imaging (MRI) [114]. Nanoemulsions of perfluorocarbons
are currently available that increase the cell labelling efficiency during imaging [115]. Apart
from these applications, perfluorocarbons have been used for supporting liquid breathing
[116]. In another study, Fraker et al. have evaluated the crucial role played by the
particle size of perfluorocarbon emulsions in the oxygen transfer rate[117]. The study
indicated that there is a reduction in oxygen diffusion with the increment in particle size
of the perfluorocarbon emulsions. Recently, researchers have synthesised perfluorocarbon
emulsions that can help in imaging of cells and tissues [118, 119]. Furthermore,
perfluorocarbon nanoprobes have been designed that aid in optical imaging of cells, however,
less light penetration through the tissue prohibits the use of this kind of visual labelling in
non-invasive experiments [120].
Perfluorocarbons are hydrophobic and immiscible with biological fluids like water and
plasma. Therefore, emulsification is necessary and done before it is utilised for in vivo
or biological applications. Emulsification is carried out with the help of surface active
molecules termed as the surfactant. In a study, Freire et al. formulated perfluorocarbon
emulsions of 50% (w/v) to study the ageing processes and a detailed investigation of
mechanism revealed the presence of both coalescence and molecular diffusion in the
emulsions. Generally, with time, the growth of perfluorodecalin emulsion particles occurs
due to two molecular level processes namely molecular diffusion and coalescence [121, 122].
In another significant study, researchers have reported the stabilisation of emulsions with the
help of adsorption of solid particles at the oil and water interface. It has also been seen that
thermal variation in these emulsions leads to surfactants desorption from the oil and water
interface. However, in the case of solid particles, this anchorage at the interface is permanent
[123]. Barnett et al. have utilised perfluorocarbon nanoparticles for non-invasive imaging of
human cadaveric islets. The results presented in the study suggest that both perfluorooctyl
bromide and perfluoropolyether labelled cells are fluorinated efficiently for visualisation
using F-MR (magnetic resonance) imaging. The inner core of perfluorocarbon nanoparticle
can be used for the delivery of melittin in vivo. The results of this study demonstrate that the
use of perfluorocarbon core can help in preventing toxicity to vaginal and sperm epithelium,
yet acting as a potential virucide for the targeted region [124]. In another experiment,
nuclear magnetic resonance technique has been explored to determine the size of an emulsion
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droplet. Further, it can also aid in visualising a single droplet and distinguish it from a
cluster of droplets, thereby, helping in the identification of coalescence from flocculation
[125]. All these studies point out that the perfluorocarbons can be identified easily with the
help of various imaging techniques, thus, suggesting that it can be practically utilised in the
medical applications. In the current study, one unique facet of perfluorocarbon molecule is
explored; the thermal conductivity of perfluorocarbon is low and can be used effectively for
insulating the tumour during cryosurgery. These emulsions can be utilised to formulate new
low thermal conductivity emulsions of perfluorocarbons tailored for use as insulation during
the cryosurgery process.
2.6 Studies directed towards the improvement of
cryosurgical process
A plethora of in vivo and in vitro studies have been carried out to improvise cryosurgery
and increase its effectiveness. Cryosurgery has been used to perform hepatic surgery for
colorectal masses and porcine kidney tumours [126, 127]. Another in vivo study showed
that phosphate buffered saline solution of antifreeze proteins type-I at a concentration of 10
mg/ml can cause cell death and acts as an adjuvant. The spicular nature of ice crystals formed
due to these proteins rupture the cell and cause its membrane to lose integrity [128]. Several
chemical adjuvants, used in chemotherapy, like peplomycin and adriamycin, have been used
along with this procedure and have shown good results[129]. Recently, it has been shown
that eutectic freezing can also elevate tissue damage during cryotherapy [130]. Further,
if a solution of high thermal conductivity or low latent heat is injected into the tumour,
with the same probe configuration, a larger ice ball has been produced [82]. In another
study, experimental results demonstrated that injection of appropriate solution like water,
aluminium oxide nanoparticles in water, ethanol and 10% solution of dimethyl sulfoxide
enhanced the tumour killing during cryosurgery without affecting the freezing process [131].
Studies have been carried out to investigate the role of the vasculature in enhancing
cryosurgical cell death. Pre-conditioning of the tumour before cryosurgery using TNF-α,
which is a vascular cytokine, has shown promising results. The cryo lesions diameter
increased significantly when the cryosurgery was performed after injection of this cytokine
[132]. Thus, showing that even vascular adjuvants increase the efficacy of cryosurgery
significantly. Chua and Chou suggested that employing more number of freeze-thaw cycles
facilitates greater cell destruction within the tissue [106]. These techniques improve the
cryosurgical process to some extent but lack in minimising the damage to the surrounding
healthy tissues. To further enhance cryosurgery by decreasing the healthy tissue damage,
the use of a cryo heather is recommended, a device which aids the cryoprobe by heating
the tissue to shape the freezing of ice ball [133]. A recent numerical study carried out
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by Ramajayam and Kumar has proposed a novel approach for the improvement of the
cryosurgical outcome[134]. The study suggests the use of a layer of perfluorocarbon around
the tumour interface during cryosurgery. This strategy has two benefits: it helps in increasing
the rate of tumour ablation and prevents the destruction to the surrounding healthy tissue.
Furthermore, this parametric study indicates that perfluorocarbon (PFC) can act as a barrier
to heat transfer during the cryosurgery of a tumour.
As discussed previously, researchers have carried out extensive numerical studies for
improving the efficacy of cryosurgery process [1]. Earlier studies have focussed on
developing one-dimensional models for heat transfer process during cryosurgery [69]. With
advances in technology, three dimensional models have been developed to determine the
location of lethal and ice front [73, 83]. Another study carried out by Deng et al has
concluded that injection of solutions of high thermal conductivity can better the outcome
of cryosurgery [82]. In another significant study, a new potential field analogy method
(PFAM) is combined with the temperature field reconstruction method (TFRM) to determine
the temperature profile in the frozen area [84]. However, none of the prominent studies
mentioned above have focussed on a combinative approach that suggests the use of adjuvants
to increase the efficacy of the cryosurgery inside the tumour and at the same time prevent the
damage due to the surrounding healthy tissue using a perfluorocarbon layer. In the present
study, a parametric analysis (offset, time taken for complete tumour ablation etc) of heat
transfer process is carried out for a two dimensional (2D) axisymetric spherical tumour
in the presence or absence of a low thermal conductivity perfluorocarbon (liquid) layer
using numerical modelling during cryosurgery. The concept of low thermal conductivity
liquid layer around the tumour interface is new and finds significant practical implications
in cryosurgery and hence requires investigation similar to the once carried out in this
study. Secondly, although pure perfluorocarbons possess suitable thermal conductivity,
perfluorocarbon emulsions can also be used for the proposed application as it would
help in reducing the amount of the pure perfluorocarbon used without compromising its
lower thermal conductivity significantly. Studies suggest the use of perfluorocarbon based
emulsions in various biomedical applications [115, 117, 120]. However, this study reports
the use of perfluorocarbon emulsions as an insulating layer during cryosurgical tumour
ablation, thus, providing a low cost substitute for improving the efficacy of cryosurgery.
The use of different adjuvants during cryosurgery has been advocated by researchers earlier
[128–130]. However, the use of glycine and alumina as an adjuvant during cryosurgery in
presence of a thermal barrier of perfluorocarbon layer has not been reported. This gap in
literature is filled by this current study which will provide a two-fold benefit of a lower end
temperature inside the gel phantom owing to the adjuvants during cryosurgery and at the
same time limit the freezing to the desired region by using a perfluorocarbon layer. Thus,
providing a combinative strategy for enhancing the freezing while minimising the damage
to the surrounding region. In conclusion, this chapter discusses the indequacies that exist in
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the field of cryosurgery and also proposes the steps that can be taken to improve the efficacy
of cryosurgery. The subsequent chapters shall discuss the results of the new approaches
used to improve the cryosurgical outcome so that this technique reaches clinical practice
and becomes a routine procedure in the near future.
Chapter 3
An approach to improve cryosurgery: a
numerical study
3.1 Introduction
Although a lot of research has been done on improving cryosurgery process but still a lot of
drawbacks exist and to overcome the same, a novel concept is proposed that can improve
the efficacy of modern cryosurgical process substantially. The primary objective of this
chapter is to carry out a parametric study of the freezing process during cryosurgery of
tumours in the presence of a perfluorocarbon (liquid) layer of low thermal conductivity at
the tumour interface by using numerical modelling. It should be noted that the liquid layer
can be made by using perfluorohexane, a perfluorocarbon, which is widely used in the field
of medicine for liquid breathing. This liquid has a very low thermal conductivity of 0.067
W/m.K and very low solubility in water. Tumour cells have unique cell surface receptors
which are quite different from their normal counterparts. Different type of tumour cells
express different antigens; these tumour antigens can be targeted by monoclonal antibodies,
which is already in practice in biological research [135]. It is proposed that this monoclonal
antibody can attach to an adaptor protein on the other end [136]. The adaptor protein used can
bind to a thermosensitive ligand which can bind preferentially at the temperature of tumour
interface. This thermosensitive ligand can then be linked to perfluorocarbon by using an
adaptor. Figure 3.1 mentioned below illustrates a schematic representation of the proposed
approach that can be used in a real time scenario.
For this approach to be successful in the clinics, first, the tumour interface needs to be
identified using the current day imaging technique like Magnetic resonance imaging (MRI),
X-Ray. Subsequently, a thin space can be created around the tumour interface by a surgeon
using laparoscopy which is a minimally invasive technique. This has to be followed by the
injection of perfluorocarbon in the created space around the tumour. The perfluorocarbon
(PFC) will not enter the tumour because it is hydrophobic and the inner environment is
hydrophilic, thereby, preventing the mixing of PFC inside the tumour tissue. Secondly, the
mass diffusivity of PFC is 5×10−5 cm2/s which is very low and this is very favourable for
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Figure 3.1: A proposed approach to improve the efficacy of cryosurgery
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the proposed application as once the PFC is filled in that space, owing to meagre diffusivity, it
would not enter the tumour tissue. One more reason which would make this perfluorocarbon
layer approach successful it the time needed to complete the procedure, generally, a complete
cycle of ablation takes 10-20 minutes and the PFC layer filled in that space surrounding the
tumour needs to be maintained till that particular time. Once the freezing cycle is completed,
PFC can be drained out in a minimally invasive way. After surgery, the removal of PFC
layer will give a measure of the ablated zone. The avidin-biotin interaction for attaching
PFC at the tumour interface can be made reversible. Modified versions of avidin resins and
modified forms of biotin labeling reagents are commercially available which can make the
reaction readily reversible. Therefore, once the cryosurgery process is complete, the bound
avidin-biotin and PFC can be removed and drained out using minimally invasive techniques.
In this chapter, a parametric study is carried out for determining the optimal cooling
configuration (i.e. optimal offset) and the effect of change in active length of the cryoprobe
on the freezing process for various tumour radii. Further, studies have also carried out to
investigate the role of the low thermal conductivity perfluorocarbon (liquid) layer around
the tumour interface, the effect of increase in tumour radii on cryosurgical freezing and the
ablation time for various optimal offsets. The results thus obtained provide a deeper insight
into the fundamentals of heat transfer occuring during this process and also aid in design
of an optimal protocol for cryosurgical planning. The other objective of this chapter is to
numerically evaluate the effect of perfluorohexane layer as an insulation around the interface
of the tumour. Further, the determination of the optimal thickness of perfluorohexane (liquid)
layer is evaluated for the prevention of the destruction to the neighbouring healthy tissue.
Beyond a critical thickness, the increase in thickness of the perfluorohexane layer does not
change the heat transfer characteristics during cryosurgery. On the other hand, decreasing the
thickness below the critical limit leads to the destruction of the healthy tissue present at the
tumour interface. Furthermore, in this study, the effect of a change in thermal conductivity
of the liquid which is used as an insulating layer at the tumour boundary is also determined.
The change in thermal conductivity affects the propagation of lethal front. With the increase
in thermal conductivity of the insulation layer (liquid) at the tumour boundary, the lethal
front is unable to reach the tumour interface. Hence, the propagation of the lethal front is
also studied during the cryosurgical process. The gap between the lethal front and the tumour
boundary can be used in the identification of an optimal offset. This offset is the most optimal
configuration that leads to uniform cooling inside the tumour, thus, reducing the tumour
ablation time. Therefore, the results of this chapter also provide optimised parameters which
will help in improving the effectiveness of the cryosurgical procedure.
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(a) Terminology (b) Boundary conditions
Figure 3.2: Schematic representation of terminology and boundary conditions used in the
study
NOMENCLATURE
c specific heat (J/g.K) mb blood perfusion rate
H specific total enthalpy (J/kg) per m3 of tissue per blood
h specific sensible enhthalpy (J/kg) Subscript
k thermal conductivity (W/m.K) b blood
L specific latent heat (J/g) f frozen tissue
Qm metabolic heat generation (W/m3) l point at which freezing starts
T temperature (oC) s point at which freezing ends
t time (s) u unfrozen tissue
3.2 Mathematical formulation
A two dimensional (2D) axisymmetrical model for a multiblock structured grid is developed
in FORTRAN 77 compiler (in house code). The developed model is used to study freezing
of tumours of three different radii namely 10 mm, 12.5 mm, and 15 mm for three different
active lengths around a single cylindrical cryobrobe of radius 3 mm. The terminology and
boundary conditions used in this study are depicted in Figure 3.2(a) and Figure 3.2(b). In
Figure 3.2(a), it can be seen that a cryoprobe is inserted into a tumour of particular radius.
The lethal front is the −40oC temperature isotherm which ensures complete cancerous cell
destruction. The term “gap ”mentioned in this study is the distance between the −40oC
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isotherm and the tumour interface. Further, active length is the length of the cryoprobe
which provides the cooling to the tissue. For each active length of the cryoprobe, an offset
(the minimum distance between the interface of the tumour and the tip of the cryoprobe) is
identified, termed as the optimal offset. This optimal offset provides a uniform cooling
of the cancerous tissue, thereby, destroying the complete tumour at a particular interval
of time. The boundary conditions that are considered here are realistic and practical. A
condition of axisymetry exists around the cryoprobe which is inserted into the tumour. In
other words, it means that only one half of tumour is being considered and the other half is
just the exact match of it in terms of geometry of the tumour, insertion of depth of cryoprobe
and the boundary conditions assumed. The region near the active length of the cryoprobe
has sub cooled temperature as this is the region that provides cooling to the tumour. The
region of the cryoprobe which faces the healthy tissue and is just below the active length has
adiabatic conditions because below the active length, the cryoprobe is insulated and hence
the temperature gradient between the insulated surface and the surrounding healthy tissue
which is in contact is zero. The upper boundary, lower boundary and the right hand side of
the domain has temperature equivalent to 37oC which is the core body temperature. This
is due to the fact that the tissue surrounding the tumour which is healthy and metabolising
properly has temperature equal to the core body temperature. It is very important to note that
there exists a perfluorocarbon (liquid) layer around the interface of tumour which possesses
very low thermal conductivity and which is mathematically defined as the sum of the radius
of the tumour and the thickness of that layer.
3.2.1 The governing equation
The classic Pennes bio heat transfer equation has been used to study the heat transfer
dynamics during cryosurgery. The equation in its usual form is given as
∂(ρH)
∂t
= ∇ · (k∇T ) + m˙bcb(Tb − T ) + Q˙m (3.1)
where ρ is the density of the tissue, H = h +
∫
c dT , is the total specific enthalpy, h
is the specific sensible enthalpy, c is the specific heat at constant pressure, m˙b is the blood
perfusion rate, T is the temperature, and Q˙m is the volumetric metabolic heat generation rate
which is taken as 10890.0 W/m3. The thermophysical properties of rat prostate tissue have
been listed in Table 3.1.
The Pennes equation is similar to the general heat diffusion equation with exception of the
second and the third terms appearing in the right hand side of equation 3.1. The second and
third terms on the right hand side of the equation represent the internal heat sink due to blood
flow and heat generated due to metabolism, respectively. It has been assumed that blood
enters the target tissue with fixed temperature Tb. It has been observed that for a particular
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Table 3.1: Thermo-physical properties of biological tissue [137]
ρu 1000 kg/m3 L 194× 103 J/kg
ρf 998 kg/m3 cb 4200 J/kgoC
cpu 3347 J/kgoC ku 0.50208 W/moC
cpf 1673. J/kgoC kf 1.7528 W/moC
Tl −1◦C Ts −8◦C
body mass and activity, the heat generated due to metabolic process is relatively constant.
The numerical solution of equation 3.1 is obtained for the following assumptions: heat
transfer in the tissue is purely by diffusion; phase transition occurs over a wide temperature
range between -1oC (upper limit) and−8oC (lower limit) [138]; thermal conductivity varies
drastically with the temperature; blood perfusion acts as heat sink and metabolism is the heat
source for the unfrozen tissue. Further, researchers working on cryosurgery generally use
the Pennes bio heat transfer equation that is based on the fourier model of heat conduction
owing to a prolonged exposure time (10-20 minutes) that is sufficient enough to reach
thermal equilibrium without a thermal lag. Therefore, non-fourier based model may not
be appropriate in this particular case.
The method proposed by Voller and Prakash uses the following approach [139]. In this
method, the enthalpy is associated with the liquid fraction in the mushy zone where the
general form of local solid fraction (fs(T )) varies as f(T ) =L, whenT >Tl; f(T ) =L(1−fs)
when Tl > T ≥ Ts; and f(T ) = 0 when T < Ts where ΔH is the enthalpy, L is the latent heat
of fusion, Tl is the temperature at whoch the freezing starts i.e. liquidus temperature, Ts is
the temperature at which the freezing ends i.e. the solidus temperature, the transition region
temperature lies between the solidus and the liquidus temperature.
3.2.2 Solution approach
The computational domain with variation in grid densities is shown in figure 3.3. It should
be noted that Figure 3.3 corresponds to the configuration when the central probe is also
present. Different colours of the boundary are representative of the different blocks used
in the simulation. The axis of the physical domain is also shown in the figure. The axial
length of the computational domain is taken as 100 mm while radial distance is taken equal
to 60 mm. The above mentioned distances are found sufficient to impose the basal body
temperature, 37oC, condition at the extremities of the domain. It should be noted that grids
are laid in such a way that grid density is higher near the large temperature gradient zone
(i.e. near the cryoprobes) and it is lower at the extremities of the domain. A multiblock
grid system having three blocks of 57×66, 57×34, and 30×34 control volumes is found
sufficient to resolve the temperature fields and the frozen and the unfrozen fronts during the
freezing process for the case of configurations with a single cylindrical cryoprobe around a
tumour. For example, Figure 3.4 shows the variation of gap between the lethal front and the
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Figure 3.3: The computational domain with multiblock orthogonal structured nonuniform
grid
radius of tumour with time for two sets of grid densities, fine and coarse. It can be noticed
that with increase in the number of control volumes the change in predictions is almost
negligible. The diffusion equation with phase change, blood perfusion, and metabolism is
discretised on a structured multiblock orthogonal grid system using finite volume approach.
The diffusive term and the unsteady term are discretised using central difference scheme
and the implicit three time level method (a quadratic backward approximation) respectively
giving rise to second order accuracy in space as well as in time. Detailed discussion about
implicit three time level scheme and the structured multiblock grid system adopted here
can be found in Ferziger and Peric [140]. Fixed grid enthalpy method given by Voller
and Prakash [139] is utilised to solve the phase change problem. This method suggests an
enthalpy formulation based on fixed grid for the numerical solution of convection-diffusion
controlled phase change problems where phase change occurs at a distinct temperature range
which is true in case of biological tissues. The defect or gap between the radius of the tumour
and the lethal front is quantified in terms of an angle (θ) , which is calculated as follows:
Figure 3.5 shows the different parameters which are used to calculate the angle (θ). It
should be noted that first the coordinate of the centre of the circle (because of the spherical
tumour) (xc, yc) is determined to calculate the angle (θ); xc is the coordinate of the leftmost
part of the computational domain, which is equal to zero in this study. Further, it should be
noted that for all the cases considered in this study, the tip of the cryoprobe is placed at the
same axial location of 0.066m from the bottom of the computational domain. Let us consider
a case for which the active length of the cryoprobe is equal to y (in metre) and the offset is
equal to x (in metre) as shown in Figure 3.5. Then the vertical coordinate of the centre, i.e.
yc is given as
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Figure 3.4: Grid independency test
yc = 0.066 + x−Rt (3.2)
where Rt is the radius of tumour. The points of intersection of lethal front with the
control volume faces are explicitely calculated after each time step. Such an intersection
point is represented by a cross mark (×) in Figure 3.5 with a coordinate of (xl, yl). Once the
point of intersection and the centre of the tumour are known, the angle (θ) is easily calculated
using the following formula,
θ = arctan
(
xl-xc
yl-yc
)
(3.3)
This approach is new and quite effective because, it not only predicts the gap between
the lethal front and tumour interface efficiently but also provides the angular position at
which this is occuring (Equation 3.3). This information is really important for the surgeons
to manipulate the surgical parameters (i.e. the active length of the cryoprobe, offset of the
cryoprobe etc) so as to make this process more effective. Generally, defect is calculated using
the volume enclosed by the lethal front (Equation 3.4) and is quantified by the following
relationship [83]:
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0.066m
y(xc,yc) Tissue
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Figure 3.5: Different parameters used to calculate θ
G =
1
Vt
∫
Vs
wdVs; (3.4)
where w = 1, when T < −40oC and w = 0, when T > −40oC. Even the above mentioned
approach is used to get an idea of the defect volume but the new method proposed in the
present study also accounts for the angular position, thus, providing a new approach to
calculate the gap between the lethal front and the tumour boundary (Equation 3.3).
3.2.3 Code validation
The present numerical code is validated by comparing the numerical predictions with the
published experimental results of Rewcastle et al.[141]. They considered a tissue-simulating
gel (1.4% gelatin solution) in a cylindrical perspex geometry where the temperature of a
freezing gel was recorded by placing thermocouples at a distance of 10 mm from the axis
of the probe. The phase change took place in the temperature interval of [−1oC, −8oC].
Further, blood flow and metabolic heat generation were absent for the gel. Figure 3.6 shows
a comparison between the computed temperatures, at the location of thermocouples having
coordinates (10 mm, 36 mm), (10 mm, 46 mm), (10 mm, 56 mm), and (10 mm, 66 mm) and
the experimental temperatures obtained by Rewcastle et al. These numerical results agree
very well with the experimental results.
40
Chapter 3 An approach to improve cryosurgery: a numerical study
Figure 3.6: Validation of the code by experimental result depicting variation of temperature
with time
3.3 Results and discussion
The governing 2D-axisymmetric equations for a single cyilndrical cryoprobe inserted into
tumour of different radii covered by a layer of a low thermal conductivity liquid (called as
perfluorocarbon (liquid) layer in the subsequent sections) are discretised using finite volume
method. The parametric study has been done for tumour radii of 10 mm, 12.5 mm, and
15 mm with the varying active length of the cryoprobe. For a tumour radius of 10 mm,
the studied active lengths are 6 mm, 8 mm, and 10 mm while for tumour radii of 12.5
mm and 15 mm these activelengths are 8 mm, 10 mm, and 12 mm and 10 mm, 12 mm,
and 14 mm respectively. The perfluorocarbon (liquid) layer thickness is 1 mm for all the
studied cases but the variation in offset led us to conclude an optimal offset for each set.
The gap is presented in a novel way with the help of angle (θ); i.e. the difference between
the−40oC isotherm and the interface of the tumour corresponding to each angular location.
The thermophysical properties considered for the numerical simulation are listed in Table
3.1. The parameters which are kept constant for the entire numerical computations are: the
radius of the probe (3 mm) and the thickness of the perfluorocarbon (liquid) layer (1 mm).
In all the contour plots, the lethal (−40oC) and freezing (0oC) fronts are represented by a
dashed line and a solid line respectively. The time required to destroy the tumour completely
and the corresponding optimal offset positions of the cryoprobe are determined for various
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cases.
3.3.1 Ablation of the tumour in the absence or presence of
perfluorocarbon (liquid) layer
For studying the role of perflurocarbon (liquid) layer on tumour ablation the parameters
considered are: radius of tumour = 12.5 mm, active length of the cryoprobe 10 mm, and the
offset = 8 mm. The variation of gap between the lethal front and the radius of the tumour
during cryosurgical freezing in the presence and absence of perfluorocarbon layer is shown
in Figure 3.7. It is observed that the variation of gap is almost similar in the beginning of the
freezing process, i.e. at t = 20 s and t = 100 s (Figure 3.7(a) and 3.7(b)).
This is expected, as at the start of freezing process there is a substantial difference
between the temperature of the cryoprobe and tissue. Hence, the cooling is fast. After few
seconds, more volume of tissue is frozen and the lethal front progresses further towards
the boundary of the tumour. But eventually the gap ceases to decrease further which can
be visualised in Figure 3.7 for the time instances of t = 800 s and t = 950 s. This is due
to the fact that the healthy tissue surrounding the tumour acts as a heat sink; initially, the
heat transfer rate is high but there is a particular point in time when the heat given off
by the surrounding healthy tissue is equal to the cooling provided by the cryoprobe in the
tumour. This leads to a gap of approximately 2 mm between the lethal front and the tumour
boundary for the case when the solution layer is not present (Figure 3.7(a)). This issue needs
to be addressed because not only does it require higher surgical time but it also leads to
ineffective tissue destruction of tumours. In this current study, a liquid layer of specific
thermophysical property like perfluorocarbons is injected at the boundary of tumour. This
liquid layer has low thermal conductivity and low mass diffusivity. Thermal conductivity is
a crucial parameter in the cryosurgical process. This novel approach is really beneficial as
it will help the physicians in ablating the tumours with more precision without any damage
to the surrounding healthy tissue.
The lethal front does not reach the boundary of the tumour even after 950 s of freezing in
the absence of perfluorocarbon (liquid) layer but in the presence of this layer the gap reduces
to zero within 210 s of the freezing process as seen in Figure 3.7(b). This implies that the
lethal front has reached the interface of tumour. Furthermore, if the tumour is continued to
cool even till 950 s, it is clearly seen that the gap is still zero. There is slight decrease in the
gap between t = 210 s and t = 850 s but there is hardly any change in the value of gap between
t = 850 s and t = 910 s. This reflects that the lethal front is unable to penetrate through the
perfluorocarbon (liquid) layer because of its distinct thermophysical property. Comparison
of Figures 3.7(a) and 3.7(b) depicts the key role played by the perfluorocarbon layer during
the heat transfer process in cryosurgery. In the former case, the tumour ablation is incomplete
whilst in the latter one, perfect tumour destruction occurs very swiftly in comparatively lesser
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(a) Without perfluorocarbon layer at the tumour interface
(b) With perfluorocarbon layer at the tumour interface
Figure 3.7: Comparison of gap between lethal front (−40oC) and radius of tumour (m) with
respect to θ (degree) in the absence or presence of solution layer; parameters considered for
this case are: radius of tumour = 12.5 mm, active length = 10 mm and offset = 8 mm.
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time interval. Also, in presence of perfluorocarbon (liquid) layer across the tumour interface
there is minimal or no heat transfer to the nearby healthy tissue. Thus, encapsulation of the
tumour with a perfluorocarbon (liquid) layer not only reduces the surgical time drastically
but also prevents the damage to the tissue surrounding it.
3.3.2 Identification of an optimal offset
The parameters that have been utilised in this study are: radius of tumour = 12.5 mm, active
length of the cryoprobe = 10 mm, and offsets = 7 mm, 9 mm and 8 mm. Offset is the
distance between the tip of the cryoprobe and the interface of the tumour and active length
of the cryoprobe is that length of cryoprobe which provides the cooling. The variation in
offset at constant active length of the cryoprobe and fixed size of tumour leads to a change in
the depth of insertion inside the tumour. During cryosurgery, the surgeon finds it difficult to
place the cryoprobe at an offset which provides the most symmetrical ice front propagation.
The study of various offsets would help the cryosurgeons in optimising this process in a
better way.
When the offset is less, the probe is inserted deeper into the tissue, hence, the change in
temperature is more in upper half of tumour. Here, it is expected that upper half of the tumour
should be cooled faster than the bottom half which can be seen in figure 3.8(a). At t = 100
s, it is noticed that a gap of around 5 mm exists between the lethal front and the bottom half
of tumour while the in the upper half this gap is 1 mm. Due to this particular offset, cooling
is non-uniform inside the tumour which leads to uneven tumour destruction as mentioned
earlier. With time, the gap is reduced to zero in around 210 s in case of optimal offset (Figure
3.7(b) whilst in this case there exists a gap of 3.2 mm in the bottom half of the tumour at the
same time point (Figure 3.8(a)). The lethal front remains inside the perflurocarbon (liquid)
layer even at the end of a freezing cycle of 950 s. As mentioned earlier, this layer acts as a
barrier to heat transfer between tumour and surrounding healthy tissue.
In case of an offset of 9 mm, the cooling is more profound in the bottom half of the
tumour with a gap of 2.6 mm and in the upper half of the tumour, there exists a gap of
nearly 4.6 mm as seen in Figure 3.8(b) after a freeze time of 100 s. As the offset is more
than the earlier case, the depth of probe insertion is less inside the tissue which leads to
non-uniformity in cooling inside the tumour thereby cooling the bottom half of the tumour
more faster than the upper half of the tumour. After a freezing time of 210 s, the tumour
is still not completely ablated as it is in the case of optimal configuration (Figure 3.7(b)).
A gap of 1.4 mm exists between the lethal front and the upper tumour interface as seen in
Figure 3.8. One noteworthy inference which can be made from the comparison of Figures
3.8(a) and 3.8(b) is that between these two offsets there exists an offset at which tumour
receives homogenous or uniform cooling throughout its whole volume. This particular offset
is termed as an optimal offset for that configuration. In this case, the optimal offset for the
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(a) Offset = 7 mm
(b) Offset = 9 mm
Figure 3.8: Comparison of gap between ice front (−40oC) and radius of tumour (m) with
respect to θ (degree) when radius of tumour is 12.5 mm, active length is 10 mm
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corresponding configuration is identified to be 8 mm. The determination of an optimal offset
would enable the cryosurgeons to reduce the surgical time greatly, thereby increasing the
comfort level for patients and making it a more popular treatment modality. Figure 3.7(b)
illustrates the symmetrical nature of gap between the lethal front and the tumour interface
when the offset is optimal. In other words, it implies that the gap at both the upper and
bottom half of the tumour is nearly the same. Eventually when the gap is zero at 210 s, the
tumour is enclosed by the lethal front perfectly. The ablation is not only uniform throughout
the tumour due to the optimal offset but it is also quicker in comparison to other offsets for
the similar configuration keeping other parameters same.
The ice front propagation is a significant aspect of this study which can be visualised
by the contour plots. Figures 3.9 (a)-(d) illustrate the propagation of the lethal (−40oC) and
freezing (0oC) fronts with time. As mentioned earlier, the dashed and the solid line represent
the lethal (−40oC) and freezing (0oC) front respectively. The shaded portion shows the
perfluorocarbon (liquid) layer of thickness 1 mm. When the freezing starts inside the tissue,
ice fronts are formed which move with certain velocity. These fronts, namely the lethal and
the freezing fronts, have nearly same velocity initially (Figure 3.9(a)). With the passage of
time, the freezing front, owing to higher velocity than the lethal front moves swiftly and
reaches the boundary of the tumour as seen in Figure 3.9(b). Later on, near the end of the
ablation period, the lethal front moves faster than the freezing front (Figure 3.9(c)). It is
expected as in the beginning of the freezing process the temperature gradient near the probe
is quite high which results in the propagation of ice fronts with almost same speed. With
time, this gradient decreases and there is also an increase in the thermal conductivity of the
tumour (tissue) with the decrease in temperature. Therefore, when a certain amount of tissue
is frozen, the thermal conductivity of the frozen volume increases resulting in less resistance
to the heat transfer by the frozen volume. And, the heat has to be given off by the tissue ahead
of the freezing front; as a consequence, the freezing front moves faster than the lethal front
in the middle of ablation period. Because of the distinct properties of the perfluorocarbon
(liquid) layer, heat diffusion across the perflurocarbon (liquid) layer is very less. Therefore,
after reaching the boundary of this layer, the freezing front ceases to advance further. But,
on the other hand, with the passage of time the distance between the boundary of tumour and
the lethal front decreases suggesting an increase in temperature gradient. Hence, the lethal
front moves faster at the end of ablation period. The ablation period for this case is 210 s
which has earlier been seen in Figure 3.7(b). Another interesting point which can be noted
is that even after 400 s, the lethal front is unable to cross the tumour boundary due to the
presence of the perfluorocarbon (liquid) layer which has unique thermophysical property as
stated earlier (Figure 3.9(d)). The propagation of the freezing front (0oC) and lethal front
(−40oC) with respect to time gives a clear idea about the velocity of these fronts inside the
tumour at different intervals of time.
Figure 3.10 shows the propagation of freezing front and lethal front with respect to time
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(a) Ice front at t = 2 s (b) Ice front at t = 150 s
(c) Ice front at t = 200 s (d) Ice front at t = 400 s
Figure 3.9: Ice front propagation for the radius of tumour = 12.5 mm, active length = 10
mm and optimal offset = 8 mm, dashed line and solid line represent lethal and freezing front
respectively
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Figure 3.10: Evolution of freezing front (0oC) and lethal front (−40oC) inside the tumour
with respect to time when radius of tumour is 12.5 mm, active length is 10 mm and optimal
offset is 8 mm
when radius of tumour is 12.5 mm, active length is 10 mm and optimal offset is 8 mm.
The plot is obtained for an axial location coinciding with the tip of the cryoprobe, i.e. at
an angular location of θ = 90o. At the start of freezing, it is noticed that both the freezing
front as well as the lethal front possess the same velocity, as stated earlier. However, one
significant observation can be made from Figure 3.10. It is observed that, initially, the fronts
which were moving with the same velocity now travel different distances with respect to
time, thereby attaining different velocites. The freezing front moves faster than the lethal
front and the reason for this has been mentioned earlier. One key inference which can be
noted from the figure is that the lethal front moves faster at two intervals of time. Initially,
when the freezing begins it has a high velocity, loses little pace in the middle region of the
tumour, but as it nears the interface of the tumour there is a steep increase in the velocity
of the lethal front. This is because of the high temperature gradient which exists at the
beginning of freezing and in the end when the lethal front is near the interface, as explained
previously. At 210 s, the lethal front reaches the boundary of the tumour and its velocity
becomes zero. Owing to distinct properties of the perfluorocarbon (liquid) layer, the lethal
48
Chapter 3 An approach to improve cryosurgery: a numerical study
front ceases at the interface and the healthy tissue necrosis around the tumour boundary is
prevented. Therefore, the identification of an optimal offset not only lessens the surgical
ablation time drastically but also leads to a uniform lethal front propagation which causes
complete tumour necrosis.
3.3.3 Non uniform cooling due to increase in active length
The parameters that have been used for this discussion are: radius of tumour = 15 mm with
an active length of 10 mm, 12 mm, and 14 mm with their respective optimal offsets. As
stated earlier, active length is that length of cryoprobe which provides cooling to the tissue.
Hence, its increase leads to a faster ablation of the tumour. But the faster ablation of the
tumour is achieved with the non-uniform cooling of the tumour. The change in active length
implies a variation in insertion depth of the cryoprobe inside the tissue. The region closer to
the cryoprobe receives the maximum cooling due to a large temperature gradient and the heat
diffuses out towards the boundary of the tumour with the increase in duration of freezing. For
this particular tumour radius of 15 mm, with an optimal offset of 10.65 mm corresponding
to the active length of 10 mm, the variation of gap between the lethal front (−40oC) and the
radius of tumour with time is illustrated in Figure 3.11(a).
In the beginning of freezing at t = 40 s, the ice formation leads to a decrease in gap
and the value of gap is 7 mm near the bottom and upper half of the tumour and around 8
mm in the middle of the tumour. The ice formation is more or less uniform througout the
angular position (θ) inside the tumour. The uniformity, in the way ice forms, is due to the
proper placement and positioning of the cryoprobe inside the tumour. If this positioning is
improper, it leads to certain region of the tumour receiving more cooling than the rest leading
to non-uniform distribution of heat inside the whole volume of the tumour. With time (at t
= 400 s), the lethal front inches towards the boundary of tumour thereby decreasing the gap.
This gap reduces to zero at t = 580 s. It means that the lethal front has reached the interface
ensuring a perfect ablation. Even if freezing is continued beyond this point, the lethal front
stays inside the perfluorocarbon (liquid) layer preventing the surrounding tissue from harm’s
way.
When the active length of the cryoprobe is changed to 12 mm for the same radius of
tumour, the gap between lethal front and tumour interface is non-uniform as seen in Figure
3.11(b). Initially, at t = 40 s itself, it can be seen that the gap is around 6 mm near the bottom
and upper half of the tumour. But in the middle of tumour, the gap is more pronounced and is
about 8 mm in magnitude. It is expected as the increase in insertion depth of probe inside the
tissue leads to a higher temperature difference over a comparatively smaller distance along
the axial direction as compared to along the radial direction. At around 450 s, complete
tumour necrosis is achieved as the lethal front coincides with the boundary of the tumour.
Even after 600 s, the lethal front does not cross the tumour boundary and the perfluorocarbon
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(a) Active length = 10 mm (b)Active length = 12 mm
(c) Active length = 14 mm
Figure 3.11: Comparison of gap between lethal front (−40oC) and radius of tumour (m)
with respect to θ (degree) for different active lengths with their respective optimal offsets
(i.e. 10.65 mm, 9.8 mm and 8.88 mm) for a tumour radius of 15 mm
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(liquid) layer prevents its advancement. Similarly, further increase in active length to 14
mm yielded the same outcome which is clearly noticed in Figure 3.11(c). One significant
inference which can be made from Figures 3.11(a)-(c) is that as the active length increases
there is a bump in the gap profile in the middle region of the tumour. This bump becomes
more pronounced with further increase in the active length.
The ice front locations, at a particular point of time during freezing, at t = 300 s, depicts
the uneven ice formation which can be seen in Figure 3.12. When the active length of
cryoprobe is varied for the same tumour radius of 15 mm with its respective optimal offsets,
the ice ball formation becomes more uneven inside the tumour with the increase in active
length of the cryoprobe. For an active length of 10 mm (Figure 3.12(a)), the ice ball formation
is almost spherical as reflected by almost a circular arc. This is quite obvious as for the
given configuration, the cooling zone is almost at the same distance from the periphery of
tumour. But, with the increase in active length of the probe, keeping other parameters same,
the distance between the cooling zone and the tumour boundary decreases along the axial
direction. Therefore, heat is diffused quickly in that direction as compared to heat diffusion
along radial direction. As a result, the shape of ice ball becomes elliptical with major axis
along axial direction. This is the reason for the presence of a bump in the middle of gap
profiles in Figures 3.12(b) and 3.12(c). It should be noted here that the figures correspond to
the optimal offsets for the respective configurations. And, as per definition of optimal offset,
these configurations give maximum tissue ablation in minimum freezing time with uniform
(as much as possible) ice formation. So, it can be concluded that when the cryoprobe is
inserted deeper into the tumour with a larger active length, though the tumour ablation is
faster, the temperature gradient is more along the axial direction as compared to the gradient
along radial direction leading to non-uniform ice formation. It can, hence, be said that for a
particular tumour radius lower active length ensures a more uniform ice ball formation.
3.3.4 Effect of variation of tumour radii on its ablation
This part of the study is carried out using the following parameters: radius of the tumour =
10 mm, 12.5 mm, and 15 mm with active length of 10 mm. The effect of variation of tumour
radius on its ablation has been studied for each active length. This aspect is crucial for the
surgeons as more the volume of tumour, higher is the surgical time required for its ablation.
For a cryosurgery to be really effective, the surgical time should be preferably less as it helps
in avoiding vascular and other surgical complications. Hence, it becomes important to study
the effect of variation of tumour radii on its ablation. The increase or decrease in radius
implies a change in volume of the tissue that is to be frozen. When tumour of radius 10 mm
is ablated using an active length of 10 mm, the optimal offset is identified to be 5.5 mm.
Figure 3.13 shows the gap between the lethal front and the radius of tumour for the
above mentioned parameters. When the freezing begins, the gap between the lethal front
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(a) Active length = 10 mm (b) Active length = 12 mm (c) Active length = 14 mm
Figure 3.12: Ice front propagation in tumour radius of 15 mm for various active lengths with
their respective optimal offsets (10.65 mm, 9.8 mm and 8.8 mm) at t = 300 s
and interface starts to reduce. At t = 20 s, this is 2.4 mm for the top and bottom part of
the tumour, except in the middle region where it is more and about 4 mm in magnitude.
This causes a marginal bump in the gap profile. With time, at around 80 s, the lethal front
reaches the tumour boundary making the gap between the lethal front and tumour interface
zero. Beyond this point, as mentioned earlier, the perfluorocarbon (liquid) layer present at
the interface prevents the propagation of the lethal front further and hence even after 200 s
the gap remains zero. When a comparison is done between different tumour radii of 10 mm
(Figure 3.13(a)), 12.5 mm (Figure 3.13(b)) and 15 mm (Figure 3.13(c)) for the same active
length of 10 mm, an interesting inference can be made: the bump in the gap profile decreases
with increase in the tumour radius for the respective optimal configurations, keeping the
active length same. Similarly, a comparison of gap profile with respect to angular location
θ (degree) for different tumour radii of 10 mm, 12.5 mm, and 15 mm with an active length
of 10 mm yielded the same result.
Figures 3.14(a)-(c) shows the location of ice fronts at a time instance of 0.8 times the
corresponding total ablation time for the respective tumours with their optimal parameters,
i.e. at t = 64 s, 168 s, and 464 s for tumour radii of 10 mm, 12.5 mm, and 15 mm respectively
corresponding to their optimal offset. It is observed that as the radius of tumour is increased
from 10 mm to 12.5 mm, the time taken by the lethal front to ablate the tumour is more. This
is understood as the volume of tumour increases with increase in its radius. Similar results are
obtained when the radius is further increased to 15 mm. In the former case (Figure 3.14(a)),
the lethal front is near the tumour interface and touches the top and bottom part of the tumour
interface but in the other two cases (Figure 3.14(b) and Figure 3.14(c)) the front has to still
travel a considerable distance to reach the boundary of tumour. This clearly depicts that the
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(a) Radius= 10 mm, Offset = 5.5 mm (b) Radius= 12. 5mm, Offset = 8 mm
(c) Radius = 15 mm, Offset = 10.65 mm
Figure 3.13: Comparison of gap between lethal front (−40oC) and radius of tumour (m)
with respect to θ (degree) for different tumour radii of 10 mm, 12.5 mm, and 15 mm for their
respective optimal offset (5.5 mm, 8 mm and 10.65 mm) at the same active length of 10 mm
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(a) Tumour radius = 10 mm (b) Tumour radius = 12.5 mm (c) Tumour radius = 15 mm
Figure 3.14: Ice front propagation in tumour radii of 10 mm, 12.5 mm, and 15 mm for the
same active length of 10 mm with their respective optimal offsets (5.5 mm, 8 mm and 10.65
mm) at an instance of 0.8 times the total ablation time
front propagation is faster in the former one owing to the lesser volume of the tumour. When
a comparison is done between the shape of ice ball enclosed by the lethal front, an important
and significant inference can be made; the shape changes from an ellipsoid to spherical
with the increase in the tumour radius for a given active length of the cryoprobe with their
optimal offsets. Also, the determination of optimal offset corresponding to various radii
becomes really crucial for a surgeon as it will help in determining an optimised cryosurgical
treatment protocol.
3.3.5 Decrease in distance between the lethal front and tumour
interface (gap) suggesting an optimal offset
The results of gap propagation have been obtained using the following parameters: radius
of tumour = 10 mm with an active length of 6 mm, and an offset of 6 mm, 7.6 mm and
10 mm respectively. The gap in tumour ablation corresponding to an offset indicates the
distance between the lethal front and the tumour interface. In the case of an offset of 6
mm, in Figure 3.15(a), it is seen that with time, the gap decreases linearly. Also, when
the offset is less, i.e. 6 mm, the cryoprobe is inserted deep into the tumour, therefore, the
upper half of the tumour receives more cooling than the lower half. Furthermore, the gap in
lethal front and interface of the tumour is due to inefficient cooling in the lower half of the
tumour. On the contrary, when the offset is more i.e. 10 mm, the cryoprobe insertion is less
deep into the tumour (Figure 3.15(b)); this lesser cryoprobe insertion means that the lower
half of the tumour receives more profound cooling than the upper half, thereby, leading to
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Figure 3.15: Reduction in gap in tumour radius of 10 mm with an active length of 6 mm,
offset of 6 mm, 7.6 mm and 10 mm respectively
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Table 3.2: Variation of optimal offset due to change in activelength for different tumour radii
Radius of tumour = 10 mm
Active length (mm) 6 8 10
Optimal offset (mm) 7.6 6.6 5.5
time (s) 122 100 80
Radius of tumour = 12.5 mm
Active length (mm) 8 10 12
Optimal offset (mm) 9 8 7
time (s) 270 210 180
Radius of tumour = 15 mm
Active length (mm) 10 12 14
Optimal offset (mm) 10.65 9.8 8.88
time (s) 580 450 380
a gap in tumour ablation. From these results, it can be observed that there exists an optimal
configuration between these two offsets where the cooling is uniform throughout the whole
tumour leading to a faster ablation. In Figure 3.15(c), it is seen that the distance between
the lethal front and tumour boundary is zero in a lesser time interval of 120 s at an offset
of 7.6 mm (also an optimal offset in comparison to other offsets of 6 mm and 10 mm for
the same tumor radius of 10 mm). The gap at the tumour boundary is zero in a lesser time
interval as compared to offsets of 6 mm (Figure 3.15(a)) and 10 mm (Figure 3.15(b)) which
ablate completely at 180 s and 220 s respectively. At the optimal offset of 7.6 mm, the whole
volume of tumour receives uniform cooling. Thus, the calculation of “gap”would help the
surgeon in identifying the most optimal configuration (i.e. optimal offset) for faster and more
efficient ablation of tumours.
3.3.6 Ablation time for optimal offset
The ablation time for different configurations with optimal offset for the studied cases are
reported in Table 3.2. It is seen that for a tumour of a particular radius as the active length
of the cryoprobe increases, the time taken for ablation decreases suggesting that increased
sub-cooled surface area of cryoprobe provides a higher cooling rate for cell destruction.
However, higher cooling rate comes at the cost of non-uniform propagation of the ice front
in most cases. In general, due to the increase in active length the non-uniformity in gap
profile is elevated. A noteworthy observation which can be concluded from the results is
that for a 2 mm increase in active length, the decrease in optimal offset is approximately 1
mm, i.e. optimal offset decreases linearly with an increase in the active length for a given
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radius of the tumour. With increase in radius, the time taken for complete necrosis increases
for the same active length of the cryoprobe. This is understood from the fact that if the
volume of tumour is more, corresponding to it the time taken to reach the critical isotherm
or lethal temperature is more. Also, the most important inference which can be made from
this study is that for different tumour radii, with the same active length, the time taken for
complete ablation by the larger tumour is nearly 2.7 times the time taken by the smaller one
for every 2.5 mm increase in the tumour radius. For example, if we compare the ablation
time for tumour radii of 10 mm and 12.5 mm for the same active length of 8 mm, we can
notice that the time taken for ablation of a tumour having a radius of 12.5 mm is 2.7 times
the time taken for ablation of a tumour of 10 mm (270 s for 12.5 mm tumour and 100 s for
10 mm tumour).
3.3.7 Optimisation of perfluorocarbon layer thickness
This section of the study has been carried out for a radius of 10 mm with the varying active
length of the cryoprobe. For a tumour radius of 10 mm, the active lengths of 6 mm and 8
mm were used in this study. The perfluorocarbon layer thickness is changed from 0.5 mm
to 1 mm and subsequently to 3 mm. One interesting inference which can be drawn is the
existence of an optimal thickness of perfluorohexane (perfluorocarbon) layer. Below this
layer thickness, the freezing front (0oC temperature isotherm) crosses the tumour interface.
The parameter which is kept constant for the entire study is the radius of the probe (3 mm). In
all the contour plots, the lethal (−40oC isotherm) and freezing (0oC temperature isotherm)
fronts are represented by a dash line and a solid line respectively. The time required for
the destruction of the tumour completely and the corresponding optimal offset positions of
the cryoprobe are determined for various cases, however, only a few important results are
discussed in this study.
For studying the role of perfluorohexane (liquid) layer thickness on tumour ablation
the following optimised parameters are considered: radius of tumour = 10 mm, the active
length of the cryoprobe = 8 mm, and the offset = 6.6 mm [134]. The ice front propagation
is a significant aspect of this study, which can be visualised by the contour plots. These
contour plots help in determining the location of the ice fronts at various intervals of time.
Figure 3.16(a) illustrates the propagation of the lethal (−40oC isotherm) and freezing (0oC
temperature isotherm) fronts with time. The shaded portion shows the perfluorohexane layer
of thickness 0.5 mm, 1 mm and 3 mm. When the freezing starts inside the tissue, ice fronts
are formed which move with a certain velocity. After a few minutes, the ice ball encloses
the whole volume of tumour reaching its interface. Figure 3.16(a)-(c) present the lethal
and freezing front propagation when the layer thickness is 0.5 mm. Initially, at around 20
s, the results present the lethal front to be located near the probe surface (Figure 3.16(a)).
With time, at around 100 s, Figure 3.16(b) shows that the lethal front reaches the tumour
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(a) t = 20 s (b) t = 100 s (c) t = 200 s
Figure 3.16: Ice front propagation in tumour radii of 10 mm, active length = 8 mm and
optimal offset = 6.6 mm for a perfluorohexane layer thickness of 0.5 mm
interface. Although the lethal front is at the tumour interface, the freezing front which should
have ceased at the interface due to the presence of thermal barrier of perfluorohexane layer
penetrates the healthy tissue near the tumour margin as seen at 200 s (Figure 3.16(c)). This is
due to the lesser thickness of the perfluorohexane layer (i.e. 0.5 mm). Owing to the imperfect
insulation of perfluorohexane (which has low thermal conductivity), the freezing front cools
the healthy tissue around the tumour interface.
(a) t = 20 s (b) t = 100 s (c) t = 200 s
Figure 3.17: Ice front propagation in tumour radii of 10 mm, active length = 8 mm and
optimal offset = 6.6 mm for a perfluorohexane layer thickness of 1 mm
When the thickness of the perfluorohexane layer is increased to 1 mm keeping all the
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other parameters same, an interesting observation is made (Figure 3.17(a)-(c)). Although,
earlier results presented the freezing front affecting the healthy tissue near the tumour
interface after 200 s, Figure 3.17(c) suggests that the increase in layer thickness to 1 mm
results in cessation of the freezing front at the tumour boundary. Thus, suggesting that
owing to the increase in its thickness, a good insulation is provided by the perfluorohexane
layer. Similar to the presentation in Figure 3.17, results demonstrate that further increment
in the perfluorohexane layer thickness to 3 mm also leads to a perfect insulation (Figure
3.18(a)-(c)). With time, it can be seen that the lethal front reaches the tumour interface
(at 100 s approximately, Figure 3.18(b)). At 200 s, the freezing front remains inside
the perfluorohexane layer. This is in contrast to the findings obtained earlier when the
perfluorohexane layer thickness is 0.5 mm. At 200 s, in this particular case, (Figure 3.16(c)),
the freezing front penetrates the neighbouring tissue surrounding the tumour, whereas in the
case of a layer of 1 mm and 3 mm, the freezing front is unable to cross the tumour margin
at the same time point (Figure 3.17(c) and Figure 3.18(c)). The increase in thickness of the
perfluorohexane layer beyond 1 mm has no change in velocity of the ice fronts. Below
this thickness, owing to freezing, there might be the destruction of the healthy tissue at
the tumour boundary. Therefore, to summarise, all results obtained in this section of the
study suggest a perfluorohexane layer thickness of 1 mm or more at the tumour interface for
perfect insulation during the cryosurgical freezing. Practically, since imaging techniques
like CT can provide a lower spatial resolution of 3 mm and micro-CT up to 10 µm, it will
be possible to measure the perfluorohexane layer experimentally. Therefore, any thickness
of perfluorohexane layer which is beyond 1 mm can be used in clinical practice.
(a) t = 20 s (b) t = 100 s (c) t = 200 s
Figure 3.18: Ice front propagation in tumour radii of 10 mm, active length = 8 mm and
optimal offset = 6.6 mm for perfluorohexane layer thickness of 3 mm
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3.3.8 Variation in the thermal conductivity of liquid layer around the
tumour interface
The liquid layer around the interface of the tumour should possess low thermal conductivity.
In this particular section of the study, the emphasis is put on the identification of various
chemical substances that can be used as an insulation at the tumour boundary during the
cryosurgical process. Figure 3.19 shows the role that thermal conductivity of the liquid
at the tumour interface plays during cryosurgical freezing. The comparison of “gap” with
respect to θ (degree) is studied using the following optimised parameters; active length = 6
mm, optimal offset = 7.6 mm, the radius of tumour=10 mm and the liquid layer thickness=1
mm. The parameter that is varied is the thermal conductivity of the liquid layer at the tumour
margin. In the first case, (Figure 3.19(a)) the liquid layer is maintained at the tumour interface
using perfluorohexane (k = 0.067 W/m.K) layer. Results demonstrate that at t = 40 s, the
gap is found to be 3.8 mm approximately from the upper and lower boundary of the tumour.
With the passage of time, the gap reduces and is zero at 140 s. This is due to the increase
in the volume of ice ball with respect to time. Beyond this point, the lethal front does not
cross the tumour boundary. The low thermal conductivity acts as a barrier to heat transfer,
preventing the damage to the neighbouring healthy tissue. When octafluoropropane (i.e. k =
0.12 W/m.K nearly twice of perfluorohexane) is used for maintaining the layer at the tumour
boundary, the gap reduces to zero at t = 170 s (Figure 3.19(b)). This is due to the increase
in thermal conductivity of the liquid layer which leads to more heat loss to the surrounding
healthy tissue. Hence, more time is required for complete ablation of the tumour. When the
thermal conductivity is further increased (water, k = 0.596 W/m.K) an interesting inference
can be made, i.e. even after 300 seconds, a gap of 1.4 mm exists in the upper and lower half of
the tumour. Further, results presented show that at 950 s the upper and lower boundary of the
tumour is not completely ablated (Figure 3.19(c)). This is owing to the thermal conductivity
of water, which is very high when compared to perfluorohexane and octafluoropropane.
The heat loss to the surroundings is more and the tumour ablation is incomplete. Thus, the
thermal conductivity of the liquid layer around the tumour interface plays a crucial role in
increasing or decreasing the rate of freezing inside the tumour.
Figure 3.20 shows the distance travelled by the lethal front with time in the presence of
a layer of perfluorohexane, octafluoropropane and water at the tumour boundary. The slope
of this graph depicts the velocity of the lethal front. In the case of perfluorohexane as a
layer (solid line in Figure 3.20), the thermal conductivity is low, leading to a high velocity
of the lethal front. Initially, a large thermal gradient results in the high velocity of the lethal
fronts. Subsequently, as the front travels further, due to a decrease in temperature gradient
its velocity lessens (Figure 3.20). Results indicate an interesting trend when the layer of
liquid at the tumour interface is made of octafluoropropane. As the thermal conductivity of
octafluoropropane is higher than perfluorohexane, there is a gradual decrease in the velocity
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(a) Perfluorohexane layer (b) Octafluoropropane layer
(c) Layer of water
Figure 3.19: Comparison of gap between lethal front (−40oC) and radius of tumour (m) with
respect to θ (degree) for different substances at the tumour interface
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Figure 3.20: Distance travelled by the lethal front with time when the liquid layer around
tumour interface is made of perfluorohexane, octafluoropropane and water θ = 90o
(i.e. a marginal decrease in slope as seen in dash lines in Figure 3.20 which represents the
distance travelled by lethal front when octafluoropropane is used as the insulating layer),
which becomes constant later. Further, when water is used as a layer around the tumour
interface (dotted lines in Figure 3.20), the velocity decreases considerably due to its higher
thermal conductivity which results in substantial heat loss to the surrounding healthy tissue.
This heat loss leads to incomplete ablation of the tumour. The results also suggest that
the velocity of the lethal front is drastically reduced in the case of water as compared to
the velocity of lethal fronts obtained in the presence of a layer of perfluorohexane and
octafluoropropane. Therefore, it can be concluded that the thermal conductivity of the liquid
layer affects the velocity of lethal front significantly.
3.4 Summary
In this chapter, a novel approach is proposed which utilises perfluorocarbon (liquid)
layer as an insulating barrier at the tumour interface during cryosurgery. The developed
2D-axisymmetric model for a single cylindrical cryoprobe inserted into tumours of radii 10
mm, 12.5 mm, and 15 mm covered by a layer of a low thermal conductivity liquid is used
to study the heat transfer characteristics during cryosurgery process. It is observed that for
each tumour radius with a given active length of the cryoprobe there exists an optimal offset
which gives maximum tumour necrosis in less time. The important conclusion which can
be drawn from this study is that for a 2 mm increase in activelength, the decrease in optimal
offset is approximately 1 mm, i.e. optimal offset decreases linearly with an increase in the
active length for a given radius of the tumour. Also, the time taken for complete ablation
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by the larger tumour is nearly 2.7 times the time taken by the smaller one for every 2.5 mm
increase in the tumour radius with same active length of the cryoprobe. The absence or
presence of a perfluorocarbon (liquid) layer of low thermal conductivity around a tumour
affects the heat transfer process during cryosurgery immensely. In its absence, the time
taken for ablation is more or sometimes the risk of healthy tissue surrounding the tumour
being damaged is greater. During its presence, the time taken to achieve lethal temperature
is reached quickly and even after a long interval of time the lethal front is unable to cross
the perfluorocarbon layer suggesting that using this cryosurgical protocol a surgeon will
be ablate the tumour faster without causing any damage to the surrounding healthy tissue.
Practically, this appproach can be implemented using the following methodology. Each
cancerous tumour expresses a unique type of protein through its surface receptor. It is
suggested that if this protein can be used in binding to its complementary one (a lock and
key type binding) which has an affinity for the perfluorocarbon solution layer then a layer
can be maintained around the surface of the tumour. This would help in selectively targeting
different cancers at the molecular level using cryosurgery thus improving the effectiveness
of the cryosurgical treatment tremendously.
From this study, it is also observed that for a particular tumour radius with a given active
length of the cryoprobe there exists an optimal configuration which gives a lesser defect
and a faster tumour ablation. The other important conclusion that can be drawn from this
study is that there exists an optimal perfluorohexane layer thickness which not only leads to a
faster tumour ablation, but it also prevents the damage to the healthy cells around the tumour
interface. This optimal thickness is found to be 1 mm. Further, the increase in thickness of
perfluorohexane layer does not affect the velocity of these ice fronts. The most suitable
substance for making the liquid layer around the tumour boundary is perfluorohexane when
compared to octafluoropropane and water. The decrease in gap is evident and is least in
the case of an optimal offset of 7.6 mm at a minimum ablation time. Thus, identifying the
optimal thickness of the layer, the exact substance needed for making the liquid layer and the
calculation of gap would help the surgeons in determining the most optimal configuration.
Furthermore, the use of these optimised parameters during cryosurgery will increase the
efficiency of the tumour ablation significantly.
Chapter 4
Designing emulsions for improving the
efficacy of cryosurgery
4.1 Introduction
Perfluorocarbons have been earlier used for many biological applications. However, one
unique aspect of this material that has not been explored is its suitable thermophysical
properties. This study proposes to utilise the perfluorohexane and perfluorodecalin
emulsions for a novel application in cryosurgery. Perfluorocarbons possesses very low
thermal conductivity (0.057 W/mK, perfluorodecalin, and 0.067 W/mK, perfluorohexane).
Perfluorocarbon-like perfluorodecalin and perfluorohexane have low thermal conductivity
and can be emulsified with the help of a surfactant. Emulsion systems of perfluorocarbons
are required as inside a biological system there is an existence of a hydrophilic environment;
emulsification of perfluorocarbons results in oil in water emulsion, which is hydrophilic
as water is the outer continuous phase [121]. In this regard, this study reports the
formation of novel materials (low thermal conductivity emulsions of perflurohexane and
perfluorodecalin) for use as a barrier to cooling during cryosurgery. Hence, it is crucial
to evaluate the thermophysical properties of these perfluorohexane and perfluorodecalin
emulsions as seen earlier in the previous chapter. Two crucial aspects have been studied
in this chapter. The first aspect is the study of thermal conductivity. After determining the
optimal emulsion that has lower thermal conductivity, particle size analysis, zeta potential,
functional groups and specific heat of the optimal emuslion formulations are analysed; the
other important aspect of this chapter is the application of this emulsion in cryosurgery of
gel phantoms.
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4.2 Materials and methods
4.2.1 Materials
Perfluorohexane (95% C6F14 Sigma-Aldrich) and Perfluorodecalin (C10F18, 95% pure,
Sigma-Aldrich), a perfluorocarbon, is utilised as the primary phase for the preparation
of emulsions. For emulsion preparation, a surfactant is needed and the role of the
surfactant is to reduce the interfacial tension that exists between the dispersed and the
continuous phase. In this study, Span 20 (Sorbitan Monolaurate, Loba Chemie) and lecithin
(L-α- Phosphatidylcholine from egg yolk,60% (TLC)) is utilised as the surfactant for the
formulation of the perfluorocarbon emulsions. Deionized double-distilled water is the other
phase required for the preparation of these emulsions.
Figure 4.1: Schematic representation of emulsion preparation
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Table 4.1: Composition of perfluorohexane emulsions
Concentration
(w/v)
Emulsion Weight of
perfluorohexane
(g)
Surfactant
(5%)
Weight of
surfactant
(g)
Volume of
water (ml)
30% PFH 30 2.4 Span 20 0.4 8
50% PFH 50 4 Span 20 0.4 8
70% PFH 70 5.6 Span 20 0.4 8
90% PFH 90 7.2 Span 20 0.4 8
30% PFHL 30 2 Lecithin 0.4 8
50% PFHL 50 4 Lecithin 0.4 8
70% PFHL 70 5.6 Lecithin 0.4 8
90% PFHL 90 7.2 Lecithin 0.4 8
4.2.2 Preparation of perfluorocarbon emulsions
The preparation of perflurocarbon based emulsions of different concentration (i.e. 30%
(w/v), 50% (w/v), 70% (w/v) and 90% (w/v)) is carried out by using probe sonication
(Vibrionics Ultrasonic processor, India). The concentration of the surfactants is 5% (w/v)
and the surfactants used for emulsion formulation are Span 20 and lecithin. The other phase
that is utilised for emulsion preparation is water. The emulsion preparation requires three
cycles of probe sonication: the first cycle consists of sonication for two minutes, followed
by a gap of a minute. The second cycle is carried out for a minute, followed by another gap
of a minute and the third and final cycle consists of a minute of sonication.
During this entire process of sonication, ice cubes are kept in a tray and the sample
tubes are placed on ice to avoid the excess heat generation due to sonication. After carrying
out trials for optimising the duration of sonication, it is seen that 4 minutes is sufficient
for homogenous mixing of the two phases. The operating frequency of probe sonicator for
emulsion preparation is 20 kHz. The sample preparation is carried out in three independent
trials for checking the consistency of method of emulsion formulation and the mean values
of the measurements are reported. The standard deviation of the measurements is also
mentioned along with the mean values. Table 4.1 and Table 4.2 summarises the composition
of the various perfluorohexane and perfluorodecalin emulsions prepared for use as an
insulating layer during cryosurgery. The schematic diagram of the emulsion preparation
is shown in Figure 4.1.
4.2.3 Experimental verification of thermal conductivity of emulsions
The determination of thermal conductivity for perfluorocarbon based emulsions is carried
out experimentally using the KD2 Pro Thermal analyser (Decagon Devices Inc, US). This
probe utilises the principle of line source method for estimation of thermal conductivity of
the emulsion samples. The thermal conductivity measurements are carried out in triplicates
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Table 4.2: Composition of perfluorodecalin emulsions
Concentration
(w/v)
Emulsion Weight of
perfluorohexane
(g)
Surfactant
(5%)
Weight of
surfactant
(g)
Volume of
water (ml)
30% PFD 30 2.4 Span 20 0.4 8
50% PFD 50 4 Span 20 0.4 8
70% PFD 70 5.6 Span 20 0.4 8
90% PFD 90 7.2 Span 20 0.4 8
30% PFDL 30 2 Lecithin 0.4 8
50% PFDL 50 4 Lecithin 0.4 8
70% PFDL 70 5.6 Lecithin 0.4 8
90% PFDL 90 7.2 Lecithin 0.4 8
using a KD2 probe thermal analyser. Subsequently, the mean, standard deviation is
calculated, based on that the uncertainty in thermal conductivity is obtained and mentioned
along with the mean value in the results section.
4.2.4 Estimation of particle size and zeta potential using Zetasizer
system
Dynamic light scattering (DLS) is carried out to evaluate the particle size after
perfluorohexane and perfluorodecalin emulsion preparation (Zeta sizer Nano ZS system,
Malvern Instruments, US). This apparatus helps in calculating the hydrodynamic radius
of the particle through the Stokes-Einstein equation. Since these emulsions are highly
concentrated, samples are diluted before this measurement to avoid the effects of multiple
scattering. Three independent trials of the experiment are carried out for reliability and
reproducibility in measurements. The mean values of the size measurements are reported
and the standard deviation is also noted down. The Nano ZS system measures particles in
the size of 0.3 nm to 10 µm. For this analysis, 0.1 ml of perfluorodecalin emulsion is taken in
a sample tube and diluted to 10 ml with the addition of deionized water. After dilution, 2 ml
of the sample is placed in the measurement cell and a particle size distribution of reasonable
accuracy is obtained.
In this study, the zeta potential of perfluorohexane and perfluorodecalin emulsions
are calculated by using the same Zetasizer Nano ZS system. This instrument measures
the electrophoretic mobility of the perfluorodecalin emulsions and then automatically
determines the zeta potential using Schmoluchowski equation. In this current work, the
zeta potential of the perfluorocarbon emulsions is analysed after its preparation. For the
measurement of zeta potential, the emulsions are diluted with deionized water (0.1 ml of
perfluorohexane or perfluorodecalin emulsion is diluted to 10 ml in water). Further, for
any practical use as insulation during cryosurgery perfluorohexane and perfluorodecalin
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emulsions should possess consistent thermophysical property and therefore, phase separation
should not occur in the emulsions. Also, the study reported by Riddick provides the nature of
colloidal stability for various values of zeta potential [142]. It suggests reasonable stability
of emulsion for a zeta value of −60 to −40 mV . The stability is moderate if zeta potential
is between −40 to −30 mV , a threshold of light dispersion for a zeta value of −30 to −15
mV and precipitation in the case of zeta value lying between −15 to −5mV .
4.2.5 Thermal conductivity estimation theoretically
The theoretical estimation of thermal conductivity of the perfluorocarbon emulsions is done
using Maxwell equation (Equation 4.1)[143, 144].
keffective
ko
=
kp + 2ko + 2φ(kp − ko)
kp + 2ko − φ(kp − ko) (4.1)
where kp is the particle phase, in this case, perfluorocarbon (perfluorodecalin
or perfluorohexane), ko is water phase, φ is the phase volume fraction
(perfluorodecalin/perfluorohexane) and keffective is the effective thermal conductivity
of the perfluorocarbon emulsions.
4.2.6 Measurement of specific heat using differential scanning
calorimetry
Using a differential scanning calorimeter (DSC) DSC200 F3 Maia system, Netzsch,
Germany, the specific heat of the most optimal emulsion samples (i.e. PFD 30, PFD 50,
PFD 70, PFD 90) are estimated. Further, the differential scanning calorimetry uses Cp ratio
method for the estimation of specific heat [145]. During the analysis, a nitrogen environment
is maintained at a flow-rate of 40 ml/min and a cooling rate of 10.0oC/min is specified in the
temperature range of 40oC to 0oC. In reality, the temperature of the emulsion layer around
the tumour interface must be equivalent to the core body temperature of 37oC. With the help
of values of thermal conductivity, average density and specific heat of the perfluorodecalin
emulsions, the thermal diffusivity of the emulsions is also evaluated at 37oC.
4.2.7 Cryosurgery of gel phantoms in presence of emulsion layer
Cryosurgery of 1% (w/v) agarose gel which has a thermal conductivity of 0.541 W/m.K is
performed in presence of an emulsion layer of perfluorodecalin as a barrier to gel cooling.
This is further illustrated in Figure 4.2. The cooling is carried out with the help of cryosurgery
set up (KCH 450A, SMT Praha, Czech Republic) and the thermal history is recorded with
the help of thermocouples coupled with the data acquisition system (NI USB 9213). The
real time monitoring of the freezing process is done using LABVIEW (NI Systems, USA).
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Figure 4.2: Schematic diagram of experimental set up for performing cryosurgery of gel
phantoms in absence and presence of perfluorocarbon emulsions
The complete arrangement of radially and axially placed thermocouples are shown in Figure
4.2. Further, it can be seen that an acrylic fixture is inserted before pouring the agarose gel
inside the acrylic container. The thermocouple fixture contains four thermocouples placed
at the probe and radially at 5 mm, 10 mm and 15 mm from the probe and one thermocouple
is placed axially at 5 mm from probe, inside the solidified gel. After the removal of the
acrylic fixture, there is a cavity formed as seen in Figure 4.2. This cavity is filled with
perfluorocarbon emulsion layer and a second thermocouple fixture is placed which contains
the thermocouples placed at 10 mm and 15 mm axial location from the probe. Subsequently,
after the placement of these thermocouples in the emulsion layer, the cryosurgery system is
used for cooling the gel phantom.
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(b) Repeatability in ice ball measurement
Figure 4.3: Repeatability in freezing to verify the accuracy of measurement
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Repeatability of freezing in gel phantoms during cryosurgery
The repeatability of temperature measurements during cryosurgery is important and to ensure
the same, freezing experiments of 1% (w/v) agarose gels are carried out in duplicates.
The mean temperature is obtained with respect to time and standard deviation from mean
is calculated to verify the closeness of the obtained values at each thermocouple location
(Figure 4.3(a)). A good similarity is seen in the temperature values obtained in the two trials
of freezing during cryosurgery.The measurements suggest that the temperature is nearly
the same at each thermocouple location in the two freezing trials, therefore, reproducible
measurements of temperature can be obtained using this experimental design. The bar graph
depicting the repeatability in obtaining the ice ball measurements is shown in Figure 4.3(b).
This clearly indicates that repeatable neasurements of temperature and ice ball are obtained
with the help of current experimental set up.
4.3 Results and discussion
In the first half of this section, efforts have been made to optimise the formulation of
low thermal conductivity emulsion using perfluorohexane as the primary phase with the
other phase as water. Followed by these experiments, the amount of perfluorohexane
has been varied and perfluorodecalin has been utilised. From the aspect of thermal
conductivity, although investigation has been done on perfluorohexane emulsions but
perfluorodecalin emulsions seem to posses better thermophysical properties and stability.
Therefore, after a preliminary investigation on perfluorohexane emulsions, a deeper analysis
of perfluorodecalin emulsions has been carried out for application in cryosurgery process.
Figure 4.4: Images of perfluorohexane emulsion samples obtained through a digital camera
(SONY, WX 80)
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Table 4.3: Experimental thermal conductivity measurement of perfluorohexane emulsions
Sample Thermal
conductivity
(W/mK)
PFH 30 0.51 ± 0.01
PFH 50 0.42 ± 0.01
PFH 70 0.36 ± 0.003
PFH 90 0.30 ± 0.01
PFHL 30 0.51 ± 0.003
PFHL 50 0.45 ± 0.006
PFHL 70 0.41 ± 0.01
PFHL 90 0.37 ± 0.009
4.3.1 Size analysis of perfluorohexane emulsions in presence of
different surfactants
The particle size analysis using dynamic light scattering reveals that PFH 30, 50, 70 and
90 emulsions (Span 20 based) have a z-average diameter of 245.3 nm, 339.4 nm, 427.8
nm and 517.2 nm respectively (The z-average diameter is calculated by DTS 5.0 software,
provided by Malvern Instruments, US). Figure 4.5(a) shows the particle size distribution for
PFH emulsions after its preparation. It is interesting to observe that with the increase in
concentration of perfluorohexane (from 30% (w/v) to 90% (w/v)), there is peak broadening
indicating a wider particle size distribution and a larger particle size. From the figure, it is
clear that there is a concentration dependent increase in z-average diameter. Further, the shift
of the peak maxima to the right hand side of horizontal x-axis indicates a higher particle size
which corroborates well with the z-average diameter mentioned earlier.
The change of surfactant to lecithin reveals that PFHL emulsions (i.e., 30% (w/v), 50%
(w/v), 70% (w/v) and 90% (w/v)) have a z-average diameter of 205.9 nm, 258.9 nm, 441.6
nm and 483.8 nm. Figure 4.5(b) shows the particle size distribution when lecithin is used as
a surfactant at various concentration of perfluorohexane. It is observed that the increase of
concentration of perfluorohexane leads to increase in the peak height and a marginal shift
to the right hand side of the horizontal x-axis. When compared to PFH emulsions, PFHL
emulsions also have a similar z-average diameter. The presence of an ionic surfactant instead
of a non ionic one does not affect the emulsion formation. After the characterisation of the
emulsion particle size, the most important property with regard to heat diffusion, i.e. thermal
conductivity is determined. Based on the most optimal thermal conductivity, the suitable
emulsions are screened out and further analysis is carried out on the emulsions that possess
lower thermal conductivity.
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(a) Perflurohexane emulsions made using Span 20
(b) Perfluorohexane emulsions made using lecithin
Figure 4.5: Effect of change of surfactant in particle size of perfluorohexane emulsions
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4.3.2 Optimisation of thermal conductivity of perfluorohexane
emulsions
The thermal conductivity of the emulsions is determined using KD2 pro thermal analyser
and the values are reported in Table 4.3. It is observed that the thermal conductivity of
perfluorohexane emulsion prepared with Span 20 is lower than the ones prepared with
lecithin. The value of thermal conductivity for the emulsions prepared with Span 20, i.e.,
PFH 30, 50, 70 and 90 are found to be 0.51± 0.01 W/m.K, 0.42± 0.01 W/m.K, 0.36± 0.003
W/m.K and 0.30± 0.01 W/m.K respectively. On the other hand, as stated earlier, the thermal
conductivity of PFHL emulsions (with lecithin) is higher than PFH emulsions and found
to be 0.51 ± 0.003 W/m.K, 0.45 ± 0.006 W/m.K, 0.41 ± 0.01 W/m.K and 0.37 ± 0.009
W/m.K. From all the thermal conductivity measurements, a common trend is observed; the
thermal conductivity decreases with the addition of perfluorohexane in the emulsion system.
It is obvious as the phase that has low thermal conductivity is increasing in concentration
and contributing to the lowering of thermal conductivity of the bulk emulsion. In terms of
practical application as an insulating barrier, lower thermal conductivity emulsions would
be more useful than the ones with higher thermal conductivity, therefore, perfluorohexane
emulsions with Span 20, at the highest concentration, i.e. 90% (w/v) would be more suitable
as compared to perfluorohexane emulsions based on lecithin as the surfactant. Therefore,
for further analysis, PFH emulsions are formulated at different concentration with specific
interest towards formulating low thermal conductivity emulsions.
4.3.3 Theoretical estimation of thermal conductivity for
perfluorohexane emulsions
The thermal conductivity values of perfluorohexane emulsions have also been estimated
using maxwell equation as stated earlier in the methodology section. The value of kp, i.e.
the thermal conductivity of perfluorohexane which is the dispersed phase is 0.067 W/m.K
and the value of ko, i.e. the thermal conductivity of water (which is the other phase) is
0.596 W/mK. φ is the volume fraction of the dispersed phase, which is 0.3, 0.5, 0.7 and
0.9 (30% (w/v), 50% (w/v), 70% (w/v) and 90% (w/v)). Using these values of thermal
conductivity and volume fraction, keffective is determined and the values are reported in
Table 4.4. It is clearly seen that the thermal conductivity of the emulsion decreases as
the concentration of perfluorohexane is increased. PFH 30 emulsions possess a thermal
conductivity of 0.50 W/mK. With increase in perfluorohexane concentration to 90% (w/v),
the thermal conductivity is found to be 0.37 W/m.K. This is understood as the amount of
perfluorohexane is increasing in the emulsion system.
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Table 4.4: Theoretical determination of thermal conductivity for perfluorohexane emulsions
Sample Thermal
conductivity
(W/mK)
PFH 30 0.50
PFH 50 0.44
PFH 70 0.40
PFH 90 0.37
Table 4.5: Experimental determination of thermal conductivity for perfluorodecalin
emulsions
Sample Thermal
conductivity
(W/mK)
PFD 30 0.505 ± 0.01
PFD 50 0.408 ± 0.04
PFD 70 0.35 ± 0.004
PFD 90 0.29 ± 0.003
PFDL 30 0.526 ± 0.003
PFDL 50 0.463 ± 0.006
PFDL 70 0.40 ± 0.01
PFDL 90 0.37 ± 0.009
4.3.4 Analysis of zeta potential of perfluorohexane emulsions
The zeta potential of PFH emulsions is subsequently determined using Zetasizer ZS (Malvern
instruments, US) as it is a good indicator of suspension stability. Figure 4.6(a)-(d) indicate
the graphs of zeta potential measurements for PFH emulsions at different amount of
perfluorohexane (30% (w/v),50% (w/v), 70% (w/v) and 90% (w/v)). When the concentration
of perfluorohexane is 30% (w/v), the zeta potential is found to be -32.7 mV . Figure
4.6(a) shows that the peak is narrow and has a highly negative charge. As stated earlier in
methodology, higher magnitude of charge results in a higher repulsion between emulsion
droplets, thus, preventing coalescence or merger, improving stability. With increase in
amount of perfluorohexane in the emulsions to 50% (w/v), the zeta potential is -41 mV
suggesting higher charge at surface of emulsion droplet (Figure 4.6(b)). Further addition
of perfluorohexane in the emulsions to 70% (w/v) and 90% (w/v) reveals a zeta potential
measurement of -52.1 mV and -60.7 mV (Figure 4.6(c)-(d)). Hence, it is clearly evident
that with rise in the perfluorodecalin concentration, the magnitude of negative charge is
increasing indicating a higher stable perfluorohexane emulsion.
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(a) Zeta potential- PFH 30
(b) Zeta potential- PFH 50
(c) Zeta potential- PFH 70
(d) Zeta potential- PFH 90
Figure 4.6: Determination of surface charge of perfluorohexane emulsions
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4.3.5 Optimisation of thermal conductivity of perfluorodecalin
emulsions
In the earlier half of the chapter, research has been carried out for the formulation of
low thermal conductivity emulsion systems of perfluorohexane. However, apart from
perfluorohexane, there are other perfluorocarbons that can be used for the same purpose,
even perfluorodecalin that has lower thermal conductivity i.e. 0.057 W/m.K can be utilised
for the formation of low thermal conductivity fluids. Hence, perfluorodecalin emulsions
have been formulated that can help in acting as a barrier to gel cooling during cryosurgery
(Figure 4.8). The determination of thermal conductivity of perfluorodecalin emulsions is
carried out by KD2 pro thermal analyser and the values are shown in Table 4.5. The thermal
conductivity for the perfluorodecalin emulsions prepared with Span 20, i.e., PFD 30, 50,
70 and 90 are found to be 0.505 ± 0.01 W/m.K, 0.408 ± 0.01 W/m.K, 0.35 ± 0.004
W/m.K and 0.29 ± 0.03 W/m.K respectively. On the other hand, the thermal conductivity
of PFDL emulsions (with lecithin) is higher than PFD emulsions and determined to be
0.526 ± 0.003 W/m.K, 0.463 ± 0.006 W/m.K, 0.40 ± 0.01 W/m.K and 0.37 ± 0.009
W/m.K. From the thermal conductivity values, it is evident that its value decreases with
the increase of perfluorodecalin in the emulsion. It is understood as the phase that
possesses lesser thermal conductivity (perfluorodecalin) is contributing to the lowering of
its magnitude. Further, it is seen that the perfluorodecalin emulsion prepared with Span
20 has lower thermal conductivity than the ones prepared with lecithin. With regard to
its application as an insulating barrier during cryosurgery of gel phantoms, lower thermal
conductivity emulsions would be more useful than the ones with higher thermal conductivity.
Hence, perfluorodecalin emulsions with Span 20, at 90% (w/v) would be more apt for the
cryosurgical application as compared to perfluorodecalin emulsions made by using lecithin
as the surfactant. Therefore, for further studies, PFD emulsions are analysed in depth with
respect to its prospective application in cryosurgical practice.
4.3.6 Effect of perfluorodecalin concentration on the particle size
Particle size analysis of these perfluorodecalin emulsions (PFD 30, 50, 70 and 90) are
carried out after the emulsion formulation. Before the particle size measurements, the
perfluorodecalin emulsions are diluted as mentioned in the methodology section. A
comparison of the particle size of PFD 30, 50, 70 and 90 emulsion demonstrates a marginal
increment in the z-average diameter of the emulsions with the rise in the concentration
of perfluorodecalin (Figure 4.7). The results demonstrate that PFD 30 emulsion shows a
maxima at 190.1 nm (12.73% intensity). Further, in this case, the z-average diameter of PFD
30 is found to be 170.5± 10.69 nm (DTS 5.0 software, z- average diameter is obtained from
cumulants analysis of the measured correlation curve). With the rise in perfluorodecalin
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Figure 4.7: Effect of perfluordecalin concentration on the particle size of emulsions after
preparation (Span 20 as surfactant)
concentration to 50% (w/v), PFD 50 emulsion suggest a maxima at 220.2 nm (13.63 %
intensity) and the z-average diameter for PFD 50 emulsion is 191.7 ± 3.98 nm. With
more addition of perfluorodecalin phase in the emulsion to 70% (w/v) and 90% (w/v), the
maxima is observed at 220.2 nm (12.86 % intensity and 14.8 % intensity respectively) and
the z-average diameter is determined to be 199.1 ± 4.01 nm and 206.1 ± 5.1 nm. Hence,
even in these case, with rise in the amount of perfluorodecalin, there is a marginal increase
in z-average diameter. Another significant observation reveals that for PFD 90 emulsions,
there is a mild broadening in the particle size distribution in comparison to PFD 30, PFD 50
and PFD 70 emulsion.
The dynamic light scattering studies (particle size analysis) also provide the values of
polydispersity index of the perfluorodecalin emulsions. The polydispersity index points
out the very low heterogeneity in the particle size distribution of the emulsions. In this
study, the polydispersity index is found to be 0.186 ± 0.008 for PFD 30 emulsion at the
day of preparation. Also, with rise in perfluorodecalin phase in emulsion, polydispersity is
marginally lower for PFD 50 emulsion and determined to be 0.164± 0.052. Further increase
of perfluorodecalin to 70% (w/v) and 90% (w/v) results in a value of polydispersity index
that is similar to the previous cases. Hence, for all perfluorodecalin emulsions (PFD 30,
PFD 50, PFD 70 and PFD 90), it is evident from the polydispersity index values that the
emulsions are monodisperse in nature.
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(a) PFD emulsions
(b)PFDL emulsions
Figure 4.8: Images of perfluorodecalin emulsions with Span 20 (PFD) and lecithin (PFDL)
as surfactant (obtained through a digital camera (SONY WX 80))
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(a) Zeta potential- PFD 30
(b) Zeta potential- PFD 50
(c) Zeta potential- PFD 70
(d) Zeta potential- PFD 90
Figure 4.9: Determination of surface charge of perfluorodecalin emulsions
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4.3.7 Variation in the surface charge of perfluorodecalin emulsions
The surface charge of the perfluorodecalin emulsions (PFD 30, PFD 50, PFD 70 and PFD
90) is determined using zeta potential apparatus. Figure 4.9 shows the zeta potential of PFD
emulsions. It is found that the zeta potential measurement of PFD 30 emulsion after its
preparation is determined to be −37.6 ± 1.6 mV. The zeta value suggests that a negative
charge exists in the perfluorodecalin emulsion droplets in spite of the presence of a non
ionic surfactant like Span 20. It has been already reported that in the presence of non ionic
surfactants in the emulsions there might be an absorption of hydroxyl ions at the oil/water
interface that results in a negative charge [146]. These hydroxyl ions are released by the
dissocation or association of the water molecules adsorbed at the oil/water interface [147].
Therefore, the slight negative charge in the PFD 30 emulsion is well understood. When the
concentration of perfluorodecalin is increased to 50% (w/v), in this case, only the non polar
phase of emulsion is enhanced. Hence, there is a very marginal change in the zeta potential
measurement to −38.7 ± 4.6 mV . Further increment to perfluordecalin to 70% (w/v) and
PFD 90% also shows a similar trend; the zeta potential for PFD 70 and PFD 90 emulsions are
determined to be −40 ± 2.2 mV and −39.4 ± 1.2 mV . The results of all perfluorodecalin
emulsions (i.e. PFD 30, PFD 50, PFD 70 and PFD 90) demonstrate an interesting similarity
of a slightly negative zeta potential. This can be attributed to the absorption of hydroxyl
ions as mentioned earlier. In accordance with the study reported by Riddick [142], a zeta
potential measurement closer to −40 mV that is found in these perfluorodecalin emulsions
suggests reasonable colloidal stability.
4.3.8 Analysis of thermophysical properties of perfluorodecalin
emulsions
In this study, the thermophysical properties are estimated for freshly prepared PFD
emulsions. Further, the thermal conductivity values of the perflurodecalin emulsions (i.e.
PFD 30, 50, 70 and 90) are estimated using Maxwell equation [143]. Table 4.6 shows
the theoretically obtained thermal conductivity measurements of all PFD emulsions. The
thermal conductivity of perfluorodecalin (the dispersed phase) i.e., kp is 0.057 W/mK and the
thermal conductivity of water (other component) i.e. ko is 0.6 W/m.K. The volume fraction of
the dispersed phase (φ) is calculated and found to be 0.135, 0.206, 0.266 and 0.319 (i.e. 30%
(w/v), 50% (w/v), 70% (w/v) and 90% (w/v)). Using the values of thermal conductivity of
perfluorodecalin, water and volume fraction, the calculation of theoretical keffective is carried
out. PFD 30 emulsions possess a thermal conductivity of 0.50 W/m.K. Further, for PFD 50
emulsion, with addition of more perfluodecalin phase in emulsion, the thermal conductivity
lessens to 0.452 W/m.K. A similar trend of decrease is evident with more increase in
perfluorodecalin to 70% (w/v) and 90% (w/v) in the emulsion, the thermal conductivity
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Table 4.6: Theoretical determination of thermal conductivity for perfluorodecalin emulsions
Sample Thermal
conductivity
(W/mK)
PFD 30 0.50
PFD 50 0.45
PFD 70 0.41
PFD 90 0.38
is determined to be 0.414 W/m.K and 0.38 W/m.K. Thus, in all perfluorodecalin emulsions
(PFD 30, PFD 50, PFD 70 and PFD 90 emulsions), these thermal conductivity measurements
reveal a decrease with the increase in concentration of perfluorodecalin concentration in the
emulsions. This is understood as with the increment in the perfluorodecalin concentration,
the volume fraction of low thermal conductivity perfluorodecalin phase increases in the
emulsions, thereby lessening its thermal conductivity. The basis of calculation of average
density of the mixture is the volume fraction of each phase at room temperature. The values
of average density of PFD 30, PFD 50, PFD 70 and PFD 90 emulsions are 1.22 g/cm3, 1.36
g/cm3, 1.59 g/cm3 and 1.778 g/cm3 respectively.
The determination of specific heat is carried out byCp ratio method (using DSC, Proteus
software, Netszch, Germany) and the values of specific heat should obtained in this study
are in the sensible heat change region where there is no phase change (i.e. 0oC to 37oC).
During phase change there is lack of thermodynamic equilibrium in the system and hence
specific heat should not be determined during the phase change as the values are unrealistic.
Further, for practical use in cryosurgery, the emulsion would be used as an insulation at the
body core temperature of 37oC. Therefore, the specific heat of PFD 30, PFD 50, PFD 70
and PFD 90 emulsions is measured by differential scanning calorimetry at 37oC and found
to be 3.04 J/g.K, 2.88 J/g.K, 2.41 J/g.K and 2.004 J/g.K respectively.
The results indicate that the value of specific heat decreases with the addition of
perfluorodecalin in the emulsions. Figure 4.10 depicts the variation of specific heat with
temperature for perfluorodecalin emulsions. It is seen that the emulsion with higher amount
of perfluorodecalin, i.e. PFD 90 has a lower specific heat when compared to PFD 70, PFD 50
and PFD 30 emulsions. Thus, suggesting the usefulness of the concentrated perfluorodecalin
emulsions in being used as the solution layer around the tumour interface during cryosurgery.
Using the values of thermal conductivity (experimentally obtained using KD2 Pro system),
average density and specific heat (using DSC), thermal diffusivity is evaluated at 37oC
(Table 4.5). There is a decrease in the thermal diffusivity of emulsions with the increase
in perfluorodecalin concentration to 90% (w/v). In the same context, it is observed that the
thermal diffusivity of PFD 30 emulsion is found to be 1.48 × 10−7 m2/s whereas PFD 90
emulsion possesses a thermal diffusivity of 8.13× 10−8 m2/s. Lower thermal conductivity
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Figure 4.10: Determination of specific heat with the help of differential scanning calorimetry
and thermal diffusivity of the PFD 90 emulsion makes it a potential material for insulation
around the tumour interface during cryosurgery. Thus, this study presents emulsions of low
thermal conductivity that finds potential application in the field of cryosurgery.
4.3.9 Application of perfluorodecalin emulsions during cryosurgery
It can be seen that in the presence of emulsion layer of perfluorodecalin (90% (w/v)) freezing
front is unable to penetrate the gel-perfluorocarbon interface. After cryosurgery of gel
phantom in the absence of perfluorodecalin emulsion layer, the temperature is determined
to be−4oC at the 10 mm axially placed thermocouple from the probe, while with the use of
this emulsion layer, the temperature at the same location is found to be 11oC (Figure 4.11(a)
and Figure 4.11(b)). Thus, proving that this emulsion layer does not allow the freezing
front to cross the thermocouple placed at a position of 10 mm axial location. After cooling
the tissue mimicking gel phantom for 10 minutes, the ice ball shape and size is determined
qualitatively. The images of ice ball obtained after cryosurgery in presence and absence of
the emulsion layer is shown in Figure 4.12. From this figure, it is clearly seen that the ice
ball formed in presence of emulsion layer as a barrier has an axial depth which is lesser by
1 mm as compared to the normal agarose gel ice ball. This further corroborates the fact that
this emulsion acts as a barrier to heat transfer during cryosurgery process.
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(a) Axial gel cooling without emulsion layer
(b) Axial gel cooling in presence of emulsion layer
Figure 4.11: Comparison of axial freezing of agarose gel phantom during cryosurgery in
absence and presence of emulsion layer at gel interface
4.4 Summary
In the earlier part of this chapter, efforts are made to optimise the most suitable
perfluorohexane emulsion that could be used for cryosurgical application as an insulating
layer. The z-average diameter of PFH emulsions and PFHL emulsions are similar but since
perfluorohexane emulsions with Span 20 possess lower thermal conductivity, further studies
are carried out for these emulsions. In the same context, it can be concluded that the value
of thermal conductivity for the emulsions prepared with Span 20 for highest concentration
of perfluorohexane (PFH 90) is found to be 0.30 ± 0.01 W/m.K respectively. Even the
theoretical estimation yields a similar value of thermal conductivity. Zeta potential studies
for these emulsion also indicates a stable suspension.
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c) 1% agarose radial ice ball 
                   
a)  1% agarose ice ball
d) 1% agarose  PFD emulsion 
                     layer 
b) 1% agarose ice ball depth
e) 1% agarose PFD emulsion
            layer ice ball depth 
f) 1% agarose PFD emulsion 
            layer radial ice ball
Figure 4.12: Ice ball formation during cryosurgery with and without perfluorodecalin
emulsion layer (image obtained through a digital camera (SONY, WX80))
The second half of this chapter demonstrates the formation of monodisperse and
homogenous emulsions of another perfluorocarbon, perfluorodecalin. It is found that
perfluorodecalin emulsions (i.e. PFD 30, PFD 50, PFD 70 and PFD 90) possess a z-average
diameter of 170.5 ± 10.69 nm, 191.7 ± 3.98 nm, 199.1 ± 4.01 nm and 206.1 ± 5.1 nm
respectively. The value of suspension stability for all PFD emulsions represented by the
Zeta potential measurements indicate a value between -38 to -40mV that suggests moderate
colloidal stability. It is observed that Span 20 based perfluorocarbon emulsions produces
better heat insulation than other two surfactants (Pluronic F-68 and L-phosphatidylamine)
as the emulsions formed are moderately stable with span and aging is relatively slower. In the
other cases, due to lesser stability, the perfluorocarbon phase separates out, thereby, lowering
the thermal conductivity of the bulk solution. The evaluation of thermal conductivity
theoretically and experimentally suggests that with the increase in perfluorodecalin phase,
the thermal conductivity decreases. The results of specific heat determined through
differential scanning calorimetry study reveals that the addition in perfluorodecalin phase
results in the decrement of specific heat. Furthermore, PFD 90 emulsion present a lower
thermal diffusivity (8.13 × 10−8 m2/s) when compared to PFD 30 emulsion (1.48 × 10−7
m2/s). It can be seen that in presence of low thermal conductivity perfluorodecalin emulsion
(90% w/v), it is observed that the freezing front is not able to penetrate the gel. Normally,
in the absence of perfluorodecalin emulsion layer, the temperature is −4oC at the 10 mm
axially placed thermocouple, while in presence of this emulsion layer, the temperature at the
same location is found to be 11oC. Even the images of ice ball obtained after cryosurgery in
presence of the emulsion layer suggest that these highly concentrated emulsions can be used
effectively as an insulating material. Hence, the preparation of such optimised emulsions of
low thermal conductivity and thermal diffusivity will aid in the increasing of the efficacy
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of cryosurgery process, thereby, improving the therapeutic outcome of the cryosurgical
technique immensely.
Chapter 5
New strategies for improving
cryosurgical outcome in gel phantoms
5.1 Introduction
Cancer cases have drastically risen over the last few decades. Therefore, surgeons are
now looking for other treatment methods like cryosurgery that uses a low temperature in
the order of −196oC to ablate the tumour. Many in-vivo and in-vitro experiments have
been carried out to improve the effectiveness of the cryosurgical protocol. In another
in vivo study, researchers have observed that a higher concentration phosphate buffered
saline solution of antifreeze proteins (10 mg/ml) causes spicular ice formation during
cooling [128]. This ruptures cell membrane resulting in cell death, thus, acting as an
adjuvant. Several chemotherapy adjuvants such as adriamycin and peplomycin have been
used in a combinative manner with cryosurgery and have shown improved clinical outcome
[129, 148]. Further, from the study of Wang et al. [149]; it is evident that the addition
of glycine results in enhancement of destruction in MCF-7 breast cancer cells. Further,
the study of Wang et al. also suggests that glycine causes a depression in freezing point.
Hence, its addition would lead to a shift or lowering of the end temperature achieved
during cryosurgical freezing. However, these studies have been limited to cell suspensions.
Therefore, further work needs to be carried out on solid tissues and gel phantoms.
There are numerous studies as seen earlier in the section of literature review that suggest
improvement in the efficacy of cryosurgery process. However, there are drawbacks that need
to be addressed. To address these issues, the current study proposes a method of increasing
the freezing inside the gel mimicking tissue phantoms during cryosurgery by using an amino
acid such as glycine. Till date, studies have not been carried out to investigate the role of
glycine in lowering the end temperature during cryosurgery of gel phantoms. Hence, glycine
concentration is increased in the agarose gel phantoms and subsequently, the gels are cooled
using the cryosurgery system.
Secondly, since there is increased freezing due to glycine, it would be highly beneficial
if the ice front could be limited to the desired location in the gel phantom. In the same
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context, this study proposes a novel strategy that advocates the use of a perfluorocarbon
(liquid) layer of low thermal conductivity at the gel interface. This layer can be made by
perfluorohexane, a perfluorocarbon that has a low thermal conductivity of 0.093 W/m.K
(experimentally determined using KD2 probe thermal analyser). Therefore, in the current
chapter, experiments are carried out to evaluate the increased freezing in gel phantoms due
to the addition of glycine. Further, a study has also been performed to visualise the role of
a perfluorohexane solution layer as insulation to the glycine consisting gel phantom during
cryosurgical cooling. In a real time scenario, this perfluorohexane layer can be applied in
biological systems using the approach suggested by researchers in a numerical study carried
out recently [134]. Further, this study also suggests that perfluorocarbon molecules can be
attached to the tumour. The surface antigen of the tumour can be targeted by its specific
monoclonal antibody [135]. Biotinylated monoclonal antibodies can be used to conjugate
with avidin. With high specificity to biotin, the antibody-avidin conjugate would attach
to biotinylated perfluorocarbon [136], thus, providing a new approach for the maintenance
of perfluorohexane layer around the tumour interface. On the other hand, glycine can be
injected directly to the tumour site through hypodermal needles.
Till date, alumina emulsions have not been used for increasing the thermal conductivity
of gel phantoms for the betterment of cryosurgical outcome. Hence, this study proposes
to enhance the freezing inside the agarose gels by using alumina as an adjuvant. The
concentration of alumina in the emulsions is varied to obtain the optimal emulsion that
has a higher thermal conductivity. There is an urgent need for a combinative treatment
modality where the freezing in increased in a localised region but does not affect the
region immediately neighbouring it. Therefore, the ability of perfluorohexane layer (i.e
perfluorocarbon liquid layer) to insulate the alumina containing gel phantoms is studied
exhaustively. A parametric study is also carried out to visualise the effect of change in
the insertion depth on the cooling of these alumina containing gels. In addition, experiments
have also been performed to verify the effectiveness of perfluorohexane layer as an insulation
with the increase in insertion depth of the cryoprobe. Also, cooling studies have been carried
out to see the effect of addition of glycine to the alumina containing gel phantoms. The
presence of glycine in alumina containing gel phantom results in a two fold effect: a) the
alumina particles result in a higher thermal conductivity of the gel phantom thereby causing
a faster diffusion of heat and a lower temperature owing to a higher thermal gradient, and
b) during cryosurgery, the addition of glycine in alumina containing gel phantoms causes
eutectic freezing lowering the temperature even more further. Similar to the previous case,
this approach can be implemented by directly injecting the alumina emulsions at a particular
location and susbeuently cooling it using cryosurgery.
Prior to cryosurgery, the tissues can be injected with a defined concentration of adjuvants
(alumina and glycine). For the sake of homogenous distribution of adjuvants multiple
injections can be given so that there is a uniform distribution of adjuvants. Subsequently,
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cryosurgery can be performed for 10-20 minutes. Since this strategy focuses on injecting
solid tumours with adjuvants and the tissue is frozen immediately due to cryosurgery, the
blood flow inside the tumour will be minimal or absent. In the gel phantoms, for maintaining
a uniform composition of adjuvants and for ease of thermal history measurements during
the cryo-freezing process, the gel phantom was made by adding adjuvants prior to gel
solidification instead of injecting the gel with adjuvants. The biocompatibility of alumina is
well known in vivo and it is used as a scaffold for seeding cells in vivo for tissue engineering
applications. Glycine, on the other hand, is and amino acid and naturally available in the
human physiological system. Therefore, the approach proposed in the current study is
practical and quite useful for improving the cryosurgery process.
5.2 Materials and methods
5.2.1 Materials
In the first half of this chapter, glycine (HIMEDIA Chemicals) is used as an
adjuvant. Agarose (Low EEO, HIMEDIA Chemicals) is dissolved in water for making
tissue-mimicking gel phantoms. Perfluorohexane (SIGMA ALDRICH), a perfluorocarbon,
is used for making the insulating layer. Acrylic sheets of a thickness of 5 mm are procured
from a local supplier. The cooling of gel phantoms is carried out by cryosurgery system
KCH 450 A (SMT Praha, Czech Republic). For thermal history measurement, K-type
thermocouples are used and the acquisition of the temperature signals is done through a
data acquisition system, USB 9213 (National Instruments, USA). For the placement of
thermocouples, wooden planks are used to make fixtures as shown in Figure 5.1 and a digital
camera (Sony WX80, Japan) is used to acquire ice ball images after cryosurgery of phantoms.
In the second half of this chapter aluminium oxide (Al2O3, HIMEDIA Chemicals) is
used as the primary phase for the preparation of the emulsions. For the preparation of an
emulsion, a surfactant is needed and in this study, Span 20 (sorbitan monolaurate, Loba
Chemie) is utilised as the surfactant for the formation of alumina emulsions. Deionized
double-distilled water is the other phase required for the preparation of these emulsions.
In this study, glycine (NH2CH2COOH , HIMEDIA Chemicals) is used as an adjuvant in
combination with aluminium oxide. Agarose (Low EEO, HIMEDIA Chemicals) is dissolved
in water for making gel phantoms. The cooling of gel phantoms is also carried out by the
same cryosurgery system KCH 450 A (SMT Praha, Czech Republic). For thermal history
measurement, K-Type thermocouples are connnected to a data acquisition system USB
9213 (National Instruments, USA) which is further connected to a computer as mentioned
earlier. Wooden planks used for fabricating thermocouple fixtures are purchased from local
carpentary units. Perfluorohexane (SIGMA ALDRICH, 95% pure) is used for making the
insulating layer. For thermocouple placement, wooden planks are used to make fixtures
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(Figure 5.1) and immediately after cryosurgery ice ball images are captured using a digital
camera (Sony WX80, Japan) for all studied cases.
5.2.2 Methods
Gel phantom with glycine as adjuvant
1% (w/v) agarose is used for the preparation of the gel phantoms and the concentration of
agarose is kept constant in the entire study. For the formation of gel phantom containing
adjuvants, the weighed agarose in a concentration of 1% (w/v) is added to 650 ml of
water consisting appropriate amount of glycine (i.e. 0.2% (w/v), 1% (w/v) and 5% (w/v)).
Subsequently, the solution is heated for two minutes (900 W) in a microwave oven. Then the
adjuvant (glycine) gel mixture is cooled and poured into the acrylic container of a definite
size (12 cm×12 cm×6 cm). The acrylic container is fabricated using mechanical operations
like cutting, filing and polishing. The thermocouple fixtures that are used are customised
and designed through basic mechanical operations (Figure 5.1). Once the thermocouple
fixture is placed on the acrylic container, the gel consisting of glycine is poured into
the container and allowed for solidification. After gel solidification, freezing is carried
out using the cryosurgery system for 10 minutes. The thermocouples are connected to
a data acquisition system (connected to a computer) for the measurement of temperature
distribution during cryosurgery. LabVIEW 2013 (software by National Instruments, US) is
utilised to record and visualise the temperature signals in the computer. Further, the accuracy
of thermocouples is verified by dipping the thermocouple in liquid nitrogen and recording the
temperature by using LabVIEW 2013. The temperature obtained through the thermocouples
after dipping it in liquid nitrogen for a minute is−194°C. Hence, the error in the temperature
measurement using these thermocouples is in the order of±2oC. It should also be noted that
the thermal conductivity values mentioned in the study are obtained using KD2 probe thermal
analyser (Decagon Devices, US). For confirming its accuracy, the thermal conductivity of
known substance like water has been measured accurately and found to be in close agreement
with the reported literature value of 0.596 W/m.K (at a temperature of 37°C).
Cooling of glycine containing gel in presence of perfluorohexane layer
In presence of perfluorohexane (perfluorocarbon) liquid layer as insulation to the gel with
glycine, there are two parts in the thermocouple fixture (marked as 1 and 2 in the Top view,
Figure 5.1). The first part of the thermocouple fixture contains all radial thermocouples
and a 5 mm axially placed thermocouple. After placing the first thermocouple fixture in
the acrylic container, an acrylic fixture of a fixed size 9 cm×1 cm×12 cm is mounted over
the container. Subsequently, the prepared gel consisting glycine is poured in the acrylic
container. Once the solidification occurs, the acrylic fixture is carefully removed without
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(a) Adjuvant gel cooling (b) Adjuvant gel cooling in presence of perfluorocarbon
(c) Experimental set up
Figure 5.1: Schematic diagram of the adjuvant gel cooling in absence or presence of
perfluorocarbon and experimental design for cryosurgery
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disturbing the earlier placed thermocouples. The cuboidal cavity, thus formed is used for
filling the perfluorohexane solution. Then, the second thermocouple fixture (marked as 2
in Figure 5.1) having 10 mm and 15 mm axially located thermocouples is mounted over
the acrylic container. It should be noted that the thermocouples placed at 10 mm and 15
mm axial locations are placed inside the perfluorohexane layer while rest of the radial and
axial thermocouples are inside the glycine containing gel. Followed by the thermocouple
placement, cryosurgery is performed for 10 minutes and its thermal history is recorded as
mentioned earlier.
Repeatability of freezing during cryosurgery of gel phantoms
The repeatability of temperature measurements during cryosurgery is very crucial and
to ascertain the same, a number of freezing experiments of 1% (w/v) agarose gels are
carried out. It is found that two thermal measurements of freezing are nearly similar.
The mean temperature is plotted with respect to time and standard deviation from mean
is calculated to verify the closeness of the obtained values at each thermocouple location
(Figure 5.2). The measurements suggest that the temperature is nearly the same at each
thermocouple location in the two freezing trials. Also, the error bars again clearly point out
that the standard deviation from mean is marginal and therefore, reliable and reproducible
temperature measurements can be achieved using this experimental design.
Preparation of emulsion
The preparation of alumina emulsions (i.e. 0.2% (w/v), 1% (w/v), 2% (w/v) and
glycine-alumina emulsions (i.e. 1% (w/v) glycine - 1% (w/v) alumina and 5% (w/v) glycine -
1% (w/v) alumina) is carried out by using probe sonication (Vibrionics Ultrasonic processor,
India). The surfactant used is Span 20 and its concentration in the emulsions is 5% (w/v).
The other phase utilised for emulsion preparation is water. Prior to sonication, alumina, Span
20 and water are added in a beaker to form a mixture and stirred using a magnetic stirrer
for 10 minutes. Subsequently, the preparation of all alumina emulsions require a single
cycle of probe sonication for 20 minutes. The operating frequency of probe sonicator for
emulsion preparation is 20 kHz. It should be noted that in case of glycine-alumina emulsions,
glycine is first dissolved in water, then alumina and Span 20 are added before for emulsion
preparation using sonication as mentioned earlier. Table 5.1 summarises the composition of
the emulsions and the images of the prepared alumina emulsions are shown in Figure 5.3.
Measurement of thermal conductivity
The experimental determination of thermal conductivity is carried out by using the KD2
Pro thermal analyser at room temperature (Decagon Devices Inc, US). This probe utilises
the principle of line source method for estimation of thermal conductivity of the emulsion
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Figure 5.2: Repeatability in freezing to verify the accuracy in thermal history measurement
Table 5.1: Composition of the alumina emulsions
Emulsion Weight
(adjuvant) (g)
Surfactant(5%) Weight
(surfactant)(g)
Volume of
water used(ml)
0.2% (w/v)
Alumina
1.3 Span 20 32.5 650
1% (w/v)
Alumina
6.5 Span 20 32.5 650
2% (w/v)
Alumina
13 Span 20 32.5 650
1% (w/v)
Glycine 1%
(w/v) Alumina
Glycine- 6.5
Alumina- 6.5
Span 20 32.5 650
5% (w/v)
Glycine 1%
(w/v) Alumina
Glycine- 32.5
Alumina- 6.5
Span 20 32.5 650
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Figure 5.3: Images of alumina emulsions used as adjuvant during cryosurgery obtained by
a digital camera (Sony,WX80)
samples. The thermal conductivity measurements are determined out in triplicates using the
thermal analyser. Followed by that, the mean and standard deviation are calculated, based
on that the uncertainty in thermal conductivity is determined and the values obtained are
mentioned along with the mean thermal conductivity value in the results section.
Preparation and experimental design for cryosurgery of alumina containing gel
phantoms
The concentration of agarose in all gel phantoms is 1% (w/v) and is kept constant in the
entire study. For making the gel phantom containing adjuvants, agarose is weighed in a
concentration of 1% (w/v) and added to the prepared alumina emulsions. It is subsequently
heated for two minutes (900 W) in a microwave oven. The solution is then cooled and
poured into a container of 12 cm×12 cm×6 cm that is fabricated from the acryclic sheets.
The thermocouple fixtures that are fabricated and used in this study are illustrated in
Figure 5.1(a) and 5.1(b). Once the thermocouple fixture is placed on the acrylic container
(Figure5.1(a)), the adjuvant consisting gel solution is poured into the container and allowed
for solidification. The gel is solidified and freezing is carried out using the crysourgery
system for 10 minutes. The thermal history measurements are made using thermocouples
connected to a data acquisition system (connected to a computer). LabVIEW 2013 (a
software by National Instruments, US) is utilised to record and visualise the temperature
signals in the computer. Further, the accuracy of thermocouples is verified by dipping the
thermocouple in liquid nitrogen and recording the temperature by using LabVIEW 2013.
The temperature thus obtained in the thermocouples after a minute is −194oC. Hence, the
error in the temperature measurement using these thermocouples is ±2oC.
In case of perfluorohexane layer as an insulation to the gel phantom containing alumina
(Figure 5.1(b)), there are two parts in the thermocouple fixture (marked in Figure 5.1(b)
as 1 and 2 in the Top view). The first part of the thermocouple fixture contains all radial
thermocouples and a 5 mm axially placed thermocouple. After placing the first part of
the thermocouple fixture in the acrylic container, an acrylic fixture of 9 cm×9 cm×1 cm
is mounted over the container. Subsequently, the prepared gel with adjuvants is poured
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in the container. Once the solidification occurs, the acrylic fixture is slowly and carefully
removed without disturbing the earlier placed thermocouples. The cuboidal cavity, thus
formed is used for filling the perfluorohexane layer that acts as an insulation. Then,
the second part of the thermocouple fixture having 10 mm and 15 mm axially located
thermocouples is mounted over the gel phantom in such a way that these thermocouples are
placed in the perfluorohexane liquid layer while rest of the radial and axial thermocouples
are inside the adjuvant (alumina) containing gel phantom. Followed by the placement of
the thermocouples, the cryosurgery of gel phantom is performed for 10 minutes and the
temperature profile is recorded as mentioned earlier. The cryosurgical device along with the
experimental set up is shown in Figure 5.1(c).
5.3 Results and discussion
5.3.1 Agarose gel phantom cooling using cryosurgery
In the current study, 1% (w/v) agarose gel is used as tissue mimicking gel phantom as
it has a thermal conductivity of 0.541 ± 0.017 W/m.K (measured experimentally through
KD2 Pro thermal analyser, value mentioned along with standard deviation). This is in close
agreement to the thermal conductivity of biological tissue [137]. The insertion depth of the
cryoprobe is 1 cm and the cryosurgery of gel phantoms is carried out for a freezing cycle of
10 minutes. It should be noted down that the end temperature values reported in this study are
the temperature measurements obtained after the completion of a single freezing cycle of 10
minutes (Figure 5.4). From the results, it is evident that the probe experiences a temperature
of −53.1oC after 10 minutes of freezing as it is in direct contact with liquid nitrogen. The
transient temperature values obtained at a thermocouple location during freezing indicate that
the corresponding temperature isotherm has reached the particular location. Further, from
the temperature measurements it is seen that after 49 s, the ice front (0oC isotherm) travels a
radial distance of 5 mm (Figure 5.4(a)). Also, the temperature at this thermocouple location
reduces to −41.16oC after a complete freezing cycle of 10 minutes. With advancement in
time, the ice front (0oC) reaches the thermocouple placed at a radial location of 10 mm
and 15 mm in 251 s and 561 s respectively. Also, the end temperature achieved at a radial
location of 10 mm and 15 mm after 10 minutes of cryosurgery is −12.61oC and −1.27oC.
It is interesting to note that till a distance of 5 mm the cooling propagates swiftly and a lethal
temperature (40oC) is achieved at the end of a freezing cycle. Further, the axial temperature
at 15 mm, 10 mm and 5 mm is found to be 18.54oC, 0.03oC and −16.94oC respectively
(Figure 5.4(b)). When a comparison is made between the radial and axial temperature
measurements, the graph reveals that radial temperature values are substantially lower than
the axial ones at the same thermocouple location (Figure 5.4(a) and Figure 5.4(b)). This is
indicative of the fact that the cooling propagates more in the radial direction owing to the
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(a) Radial temperature profile
(b) Axial temperature profile
Figure 5.4: Temperature distribution radially and axially in agarose gel phantom during
cryosurgery
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larger surface area of the cryoprobe radially.
5.3.2 Decreased end temperature due to glycine
The effect of glycine is evaluated by adding it to the agarose solution before gel solidification.
After cooling the 1% (w/v) agarose gel containing 0.2% (w/v) glycine using the cryosurgery
system, the end temperature is found to be −1.15oC, −16.14oC, −46.18oC and −65.4oC
at the radial locations of 15 mm, 10 mm, 5 mm and probe respectively. When a
comparison is drawn between the radial temperature obtained in the present case and 1%
(w/v) agarose gel without any adjuvant like glycine, it is observed that there is a substantial
decrease in temperature (from −53.1oC to −65.4oC, i.e. around 12.3oC ) at probe (Figure
5.5(a) and Figure 5.4(a)). Further, for the thermocouple placed at 5 mm radial location
this temperature decrease is 5oC (Figure 5.5(a) and Figure 5.4(a)). This comparison of
temperature distribution also suggests that as the distance increases to 10 mm radially, the
temperature difference at the same location in agarose gel and gel with glycine as adjuvant
is marginal (around 3.54oC). This is due to meager temperature gradient as one proceeds
farther away from the cryoprobe. Also, the temperature at the axial locations of 15 mm, 10
mm and 5 mm is determined to be 14.19oC, −4.28oC and −21.34oC respectively (Figure
5.5(b)). A similar trend which was obtained earlier in case of agarose gels is evident here and
it is seen that at the same thermocouple location radial temperature is considerably lesser than
the axial temperature (Figure 5.5(a) and Figure 5.5(b)). As seen earlier, this higher cooling is
due to the cylindrical probe that provides more surface area for cooling in the radial direction
as compared to the axial one.
The axial temperature plot demonstrates a slight decrease in temperature due to addition
of 0.2% (w/v) glycine and this is obvious as glycine is an adjuvant that lowers the freezing
temperature and causes eutectic freezing. The results reveal a noteworthy trend of higher
temperature decrease with an increase in glycine concentration to 5% (w/v) in the gel (Figure
5.5(c) and Figure 5.5(d)). Figure 5.5(c) shows the radial temperature distribution during
cooling of 5% (w/v) glycine containing gel phantom. The graph demonstrates that the ice
front (0oC isotherm) reaches the radial position of 5 mm in merely 38 s. However, in the
case of agarose gel phantoms, the ice front reached the same location in 49 s. Therefore, with
addition of glycine to 5% (w/v), ice front moves quickly. A similar trend of faster ice front
movement is also visible when the front advances to a radial distance of 10 mm; it propagates
and reaches this location at 114 s while in agarose gel phantom similar distance is travelled
in 250 s. Hence, the temperature measurements reveal that glycine addition presents swifter
movement of the ice front in the gel phantoms.
When the radial temperature profile of glycine (5% (w/v)) containing gel phantom is
observed, the graph indicates an end temperature of −7.37oC, −27.68oC, −52.21oC and
−71.72oC with thermocouples located at 15 mm , 10 mm and 5 mm and probe respectively
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(a) 0.2% glycine radial temperature profile (b) 0.2% glycine axial temperature profile
(c) 5% glycine radial temperature profile (d) 5% glycine axial temperature profile
Figure 5.5: Effect of glycine concentration on enhancing the freezing of gels during
cryosurgery
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(Figure 5.5(c)). These temperature measurements are lower than the ones achieved while
cooling of 0.2% (w/v) glycine containing gel phantoms at the same thermocouple location.
When temperature distribution attained during 5% (w/v) glycine gel cooling is compared to
0.2% (w/v) gel cooling, it is observed that there is a significant reduction in end temperature
(from−65.4oC to−71.72oC, i.e. 6.3oC) at probe (Figure 5.5(a) and Figure 5.5(c)). Further,
at a radial location of 5 mm and 10 mm, the thermocouple experiences a temperature drop of
6.03oC and 11.54oC when compared to the previous case of 0.2% ( w/v) glycine gel cooling.
After cryosurgery of 5% (w/v) glycine consisting gel phantoms, the temperature measured at
an axial location of 15 mm, 10 mm and 5 mm is−26.14oC,−8.38oC and 7.99oC respectively
(Figure 5.5(d)). These values are lesser than the axial temperature readings obtained in 0.2%
(w/v) revealing that in all cases, both radially and axially, the addition of glycine results in a
reduction in the end temperature achieved after cryosurgery.
5.3.3 Effect of perfluorohexane layer on glycine consisting gel
phantoms
For studying the role of perfluorohexane as insulation, 1% (w/v) agarose with 5% (w/v)
glycine is cooled in its presence using cryosurgery. The cryosurgery of glycine gel with
perfluorohexane solution layer results in a temperature of −7.85°C, −28.15oC, −55.64oC
and −71.06oC at the radial location of 15 mm, 10 mm, 5 mm and probe respectively
(Figure 5.6(a)). These radial temperature measurements are marginally lower than those
obtained in glycine gel without the insulating layer of perfluorohexane. Furthermore, axial
measurement indicates a temperature of 23.83oC, 23.77oC and −26.84oC at a position of
15 mm, 10 mm and 5 mm respectively (Figure 5.6(a)). A comparison between the axial
end temperature of glycine containing gel with and without perfluorohexane suggests that
the two thermocouples placed at 10 mm and 15 mm in the cuboidal cavity containing
perfluorohexane solution have a higher temperature of 23.77oC and 23.83oC respectively
(Figure 5.6(a) and Figure 5.5(d)). On the other hand, in 5% (w/v) glycine gel, the axial
end temperature of thermocouples placed inside the gel at 10 mm and 15 mm is −8.38oC
and 7.88oC (Figure 5.5(d)). Since perfluorohexane possesses low thermal conductivity
(k = 0.093 W/m.K) it is clearly noticeable that the freezing front is unable to cross the
gel-perfluorohexane interface.
The images of the ice ball captured immediately after cryosurgery reveal an interesting
observation; when perfluorohexane is insulating the gel interface, the ice ball formed has a
depth of 13 mm whereas, in the absence of this insulating layer (1% (w/v) agarose with 5%
(w/v) glycine), the ice ball depth is 16 mm (Figure 5.6(b)). Thus, there is a difference of
3 mm in the ice ball depth owing to the insulating ability of perfluorohexane, which is also
noticed from the shape of the ice ball. Further, the ice ball obtained in the case of agarose gel
cooling also suggests a depth of 16 mm. In both cases, the cryosurgery of 1% (w/v) agarose
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(a) 5% Glycine gel phantom with perfluorohexane layer
(b) Comparison of ice ball
Figure 5.6: Temperature distribution of glycine gel phantom with perfluorohexane layer as
barrier during cryosurgery and ice ball comparison after cryosurgery of agarose gel phantom,
5% (w/v) glycine containing gel phantom in absence and presence of perfluorohexane layer
(ice ball images captured through a digital camera (SONY, WX80))
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Figure 5.7: Images of alumina ice ball obtained after cryosurgery obtained by a digital
camera (Sony,WX80)
gel and 1% (w/v) agarose gel with 5% (w/v) glycine reveals the same ice ball depth of 16 mm
(Figure 5.6(b)). However, in the presence of glycine it is fascinating to observe that there is
a considerable reduction in the end temperature obtained after cryosurgery. Therefore, this
indicates that although addition of glycine does not have any effect on the ice ball depth but it
results in substantial decrease in end temperature. The significance of this approach is that it
presents two-fold benefits: a) glycine induces a lower temperature at each thermocouple
location in the gel phantom as compared to the agarose gel and b) even with the lower
temperature experienced in the glycine gel phantom, perfluorohexane layer insulates the
gel phantom. Hence, this study provides a new strategy that aims at maximising freezing
inside a desired location while minimising its spread to its immediate surrounding region.
For the sake of better clarity, ice ball images are also represented in the form of bar graph
(Figure 5.7).
5.3.4 The use of alumina as an adjuvant with multiple strategies to
improve cryosurgery process
In the second half of this study, the amount of alumina (i.e. 0.2% (w/v), 1% (w/v), 2%
(w/v)) is varied in presence of surfactant (5% (w/v)) to formulate gel phantoms that have
optimal thermal conductivity. A higher value of thermal conductivity would result in a faster
propagation of heat inside the gel phantom, thereby, lowering the end temperature obtained
after the cryosurgical freezing. Therefore, after the formulation of alumina emulsions, 1%
(w/v) agarose is added to form alumina consisting gel phantoms. A detailed study is also
carried out to investigate the dependence of increase in alumina concentration on the end
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Table 5.2: Thermal conductivity of alumina gel phantoms
Gel phantom Thermal
conductivity
(W/mK)
0.2% alumina 0.69 ± 0.06
1% alumina 0.73 ± 0.04
2% alumina 0.64 ± 0.09
temperature obtained after cryosurgery in these alumina containing gel phantoms. The
thermal conductivity values of the gel phantom reveals that 1% (w/v) alumina containing
gel phantoms have a marginally higher thermal conductivity than the other gel phantoms.
Hence, for further studies, 1% (w/v) alumina containing gel phantoms are used. A parametric
study of cryosurgical freezing of the gel phantoms is carried out by increasing the insertion
depth of the cryoprobe (from 1 cm to 1.25 cm and subsequently to 1.5 cm). It is important
to limit the freezing injury to a desired region during cryosurgery. Therefore, the effect
of a low thermal conductivity layer of perfluorohexane as a barrier to adjuvant (alumina)
gel cooling is evaluated with increase in the insertion depth of the cryoprobe. Since the
primary objective of cryosurgery process is to increase the freezing for inducing damage, a
new method is proposed in this chapter that results in rapid freezing due to the combined
effect of adjuvants like alumina and glycine. Glycine is added in a concentration of 1% (w/v
) and 5% (w/v) keeping the amount of alumina and agarose constant (i.e. 1% (w/v)) during
the preparation of the gel phantom. Till date, adjuvants used in cryosurgery either result in
faster diffusion of heat or lower the end temperature, however, in this study, the freezing
of gel phantoms that contain glycine-alumina present a novel class of adjuvants that show
better outcome with regard to swifter freezing and attainment of lower end temperature, thus,
improving the outcome of the cryosurgery process.
5.3.5 Effect of alumina concentration on the freezing of gel phantom
during cryosurgery
The concentration of alumina in the emulsion plays a critical role in deciding the thermal
conductivity of the emulsions. Generally, emulsion preparation requires a surfactant
molecule that creates a steric hindrance between the two phases [150]. In this study, the
preparation of alumina emulsions (at 0.2% (w/v), 1% (w/v) and 2% (w/v)) is carried out
using probe sonication in presence of Span 20 (5% (w/v)) as the surfactant. Subsequently,
after the emulsion preparation, agarose is added to the alumina emulsion for the formation
of alumina containing gel phantoms. The thermal conductivity of alumina consisting gel
phantoms is measured using the KD2 probe thermal analyser (Table 5.2). It is observed that
the thermal conductivity value of 1% (w/v) alumina containing gel phantom is marginally
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higher than the other alumina consisting gels and found to be 0.73 ± 0.04 (W/mK) (Table
5.2). Also, in case of 2% (w/v) alumina emulsion, the surfactant volume (5% (w/v)) is not
sufficient enough to form emulsions and there is a settlement of pure alumina particles at the
bottom of the beaker as visible through naked eyes after the emulsion preparation. Therefore,
the thermal conductivity of the phase with higher concentration of alumina (i.e. more than
1% (w/v)) is marginally lower. For 1% (w/v) alumina emulsion, the alumina particles do not
sediment at the bottom of the beaker after emulsion preparation. Therefore, the emulsion
formation is homogenous leading to a better thermal conductivity. Therefore, 1% (w/v)
alumina consisting gel phantoms are used for further studies that deal with insertion depth
and adjuvant gel cooling in the presence of the perfluorohexane layer.
After freezing the gel phantoms containing alumina as adjuvant, the results of thermal
history indicate a same trend as seen from the values of thermal conductivity; the freezing of
gel phantoms consisting 1% (w/v) alumina reveals a lower end temperature in comparison
to 0.2% (w/v) and 2% (w/v) alumina gel phantoms after 10 minutes of cryosurgery (Figure
5.8). It should be noted that in all figures the caption probe represents the thermocouple
placed near the probe at a distance of nearly 1 mm and all other thermocouple distances
are relative to this thermocouple. Figure 5.8(a) depicts the comparison of cooling for 1%
(w/v) agarose gel phantom, 0.2% (w/v) alumina, 1% alumina (w/v) and 2% (w/v) alumina
containing gel phantom for the thermocouple placed near the probe. From Figure 5.8(a), it
is evident that after cryosurgery, the end temperature achieved in the alumina consisting gel
phantom is lesser than the agarose gel phantom. It is also observed that the end tempearature
is decreased from −52.56oC in the case of agarose gel phantoms to −60.72oC, −62.34oC
and −61.34oC for 0.2%, 1% and 2% (w/v) alumina containing gels. There is a very minor
tempearature decrease and this clearly suggests that with the addition of alumina to 1% (w/v),
there is a decrease in the end temperature. However, if the alumina concentration in the gel
phantom is enhanced to 2% (w/v), the end temperature does not decrease further. Thus,
indicating that 1% (w/v) alumina concentration is optimal for carrying out further studies.
A comparison of end temperature at 5 mm radially placed thermocouple in all cases
reveals a similar trend. The end temperature is found to be −41.16oC for agarose gel
phantoms. With the addition of alumina to the gel phantom there is a better diffusion of
cooling as visible from the temperature measurements. The temperature for 0.2% (w/v),
1% (w/v) and 2% (w/v) alumina containing gel phantoms at this location is found to be
−45.96oC, −49.06oC and −46.37oC respectively. It is clearly seen that there is a reduction
of around 4.8oC, 7.9oC and 5.2oC in comparison to the end temperature obtained after
cooling of agarose gel phantoms which substantiates the fact that alumina addition aids in
better diffusion of heat across the phantom (Figure 5.8(b)). Similar results are observed
when the end temperature is measured for the 10 mm radially placed thermocouple for
these gel phantoms (i.e. 1% (w/v) agarose, 0.2% (w/v), 1% (w/v) and 2%(w/v) alumina
containing gels). The temperature values are found to be −12.61oC, −22.64oC, −25.98oC
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Figure 5.8: Comparison of freezing of agarose and alumina consisting gel phantoms during
cryosurgery
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and −21.97oC respectively. Figure 5.8(c) shows that there is a decrease of 10oC in the end
temperature when a comparison is made between the agarose gel phantom and the 0.2%
(w/v) alumina containing gel phantom. This decrease is also observed when the alumina
concentration is increased to 1% (w/v) and 2% (w/v) in the gel phantoms with the maximum
end temperature decrease in the 1% (w/v) alumina containing gel phantoms. All these radial
measurements have a commonality; there is a visible decrease in the end temperature at both
5 mm and 10 mm radially placed thermcouples. Furthermore, it is interesting to note that
5 mm axially placed thermocouple also shows a marked decrease in the end temperature
measurement after cryosurgery. From figure 5.8(d), it is observed that agarose gel phantom
experiences an end temperature of−17.21oC while the alumina containing gels (0.2% (w/v),
1% (w/v) and 2% (w/v)) attain an end temperature of −22.01oC, −26.45oC and −23.78oC
respectively. In comparison to the agarose gel phantoms, at this particular location, the
maximum end temperature decrease of around 9.24oC is observed in case of 1% (w/v)
alumina containing gel phantoms.
When a comparison of thermal history is made between 0.2% (w/v), 1% (w/v) and 1%
(w/v) alumina containing gel phantom (Figure 5.8(a)-(d)), the temperature profile obtained
after cryosurgery for 1% alumina containing gel phantom at each thermocouple is marginally
lower than the 0.2% (w/v) and 2% (w/v) alumina containing gel phantom. The reason for this
is the marginlly higher thermal conductivity of the 1% alumina gel phantom in comparison
to the 0.2% (w/v) and 2% (w/v) alumina conisting gel phantoms (Table 5.2). Therefore,
from this section of the study, it is clear that the introduction of alumina in the gel phantoms
results in rapid freezing leading to proper diffusion of cooling to farther locations during
crysourgery freezing in comparison to the agarose gel phantoms. It is also observed that 1%
(w/v) alumina containing gel phantom has a better thermal conductivity and attains lower
end temperature after cryosurgery, therefore, for further parametric studies carried out in this
study, this alumina concentration is utilsed during gel phantom preparation.
5.3.6 Variation of insertion depth (id) during cryosurgery of alumina
containing gel phantoms
Earlier, in the case of variation of alumina in gel phantoms, the insertion depth (id) of the
cryoprobe used was 1 cm (Figure 5.8). Further, the results also revealed that 1% (w/v)
alumina gels experience a higher temperature drop as compared to 0.2% (w/v) and 2% (w/v)
alumina gels. However, for studying the role of insertion depth of the cryoprobe, it is varied
from 1 to 1.25 cm and subsequently to 1.5 cm, keeping the alumina concentration constant at
1% (w/v). Figure 5.9(a) represents the temperature distribution at probe in case of 1% (w/v)
alumina gel with variation depth from 1 cm to 1.5 cm.
From these results, it is interesting to observe that the end temperature at the probe
reduces by 22.6% as the insertion depth is increased from 1 cm to 1.25 cm. Further, a similar
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(a) Probe (b) 5 mm
(c) 10 mm (d) 15 mm
Figure 5.9: Variation of freezing due to change in insertion depth in agarose-alumina
containing gels during cryosurgery
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kind of reduction in the end temperature (in the order of 21.2%) is seen when the insertion
depth is varied from 1 cm to 1.5 cm. As one moves farther away from the probe radially,
it is noticed that in comparison to the insertion depth of 1 cm, the end temperature in these
alumina gel phantoms after cryosurgery decreases by 9.4% and 16.6% when the insertion
depth is 1.25 cm and 1.5 cm respectively (Figure 5.9(b)). The reason for the significant
temperature reduction at the probe and 5 mm radially placed thermocouple is the presence of
a higher thermal gradient. Since the probe is cylindrical, the a higher radial surface presents
a larger thermal gradient in the radial direction as compared to the axial one. This lesser axial
cooling can be verified if one keenly observes the axial thermal history. Even if there is an
increase in the insertion depth to 1.25 cm and 1.5 cm, the temperature decrease is found to be
1.8% and 10.5% respectively. This clearly states that as the insertion depth is increased from
1 cm to 1.5 cm, there is a reduction in the end temperature. However, the radial temperature
decrease is higher in comparison to the axial one owing to the higher surface area of cooling
as stated earlier.
It is natural for this freezing process to achieve steady state after few minutes of cooling
as liquid nitrogen is providing a constant cooling at temperature of−196oC (i.e. probe). For
a fixed cooling power, any biological material that has a finite thermal conductivity like this
gel phantom allows a particular amount of heat to flow or diffuse inside the gel. Therefore,
after a particular distance in the gel phantom heat does not diffuse and there is very meager
difference in the thermal history measurements at different thermocouples. In this case, it is
evident that the thermocouples at 10 mm, 15 mm radial and axial locations show a marginal
decrease in temperature even with the increase in the insertion depth unlike the regions (probe
and 5 mm) that receive a higher gradient as discussed earlier. For example, in case of 10 mm
and 15 mm radially placed thermocouple, for an insertion depth of 1 cm, the end temperature
obtained is found to be −25.98oC and −2.5oC. Even with the increase in insertion depth
to 1.5 cm, the temperature values at 10 mm and 15 mm thermocouples are determined to
be −27.32oC and −4.98oC respectively (Figure 5.9(c)-(d)) indicating a mild decrement in
temperature.
The ice ball images clearly suggest the effect of the increase in insertion depth (Figure
5.10). Since the probe is inserted deeper into the gel phantom, the ice ball formed in case
of a higher insertion depth is larger axially. Figure 5.10(a) and (b) show that the axial depth
of the ice ball obtained after freezing 1% alumina gel phantom with an insertion depth of
1 cm is found to be 16 mm and its radial spread is also 16 mm. It is observed that as the
insertion depth is increased to 1.25 cm, there is an increment in the ice ball axial depth and
it is determined to be 19 mm. This is understandable from the fact that there is an increment
of 0.25 cm (2.5 mm) axial penetration with the increase in depth of the cryoprobe which
results in the larger axial ice ball (3 mm larger), changing its shape from a hemispherical
profile to a slightly elliptical one. Thus, showing that this approach is beneficial in cases
where more axial penetration is required while keeping the concentration of alumina same
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c) 1% agarose 1% alumina-
        1cm id iceball radial
a)  1% agarose 1% alumina-  
             1 cm  id iceball
d) 1% agarose 1% alumina-
        1.25 cm id iceball
b) 1% agarose 1% alumina- 
        1cm id iceball depth
e) 1% agarose 1% alumina -
      1.25 cm id iceball depth 
f) 1% agarose 1% alumina- 
     1.25 cm id iceball radial
(a) Images obtained through a digital camera (SONY, WX80)
(b) Bar graph showing the dimensions of the ice ball
Figure 5.10: Changes in ice ball shape due to insertion depth
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in the gel phantom.
5.3.7 Combinative approach using alumina as adjuvant and
perfluorohexane layer as barrier
The major drawback during cryosurgery is the destruction to the healthy tissue surrounding
the tumour. To improve the efficacy of this technique, limiting the ice formation to the
desired region while increasing the rate of ablation inside the tumour is necessary. In the
same context, this study proposes a combinative approach that involves the increment in
freezing inside the gel phantoms while minimising the gel freezing by using an insulating
layer of perfluorohexane (perfluorocarbon) solution at the gel boundary. This strategy has
two benefits: a) the alumina in the gel phantoms results in increased freezing, and b) the
perfluorohexane layer at the gel interface insulates and acts as a barrier to freezing during
cryosurgery. To verify the effectiveness of the perfluorohexane solution layer (0.091 W/mK)
in insulating the gel, cooling of alumina gels is carried out by varying the insertion depth of
the cryoprobe in presence of perfluorohexane layer. Immediately after the 5 mm axially
placed thermocouple, a cuboidal cavity is present in the gel. Within this cuboidal cavity,
perfluorohexane (liquid) is filled and the 10 mm and 15 mm axial thermocouples are placed.
When cryosurgery is performed on 1% (w/v) alumina consisting gels in presence of the
perfluorohexane layer as a barrier at an insertion depth of 1 cm, it is fascinating to note that
the 10 mm and 15 mm axially located thermocouples that lie in the perfluorohexane layer
show an end temperature of 24.82oC and 26.22oC respectively (Figure 5.11(a)). This clearly
points out the role that perfluorohexane layer plays in acting as a barrier to gel cooling.
Also, the thermocouple located axially at 5 mm that lies in the gel phantom experiences
an end temperature of −25.48oC. This temperature measurement is similar to the one
obtained while freezing 1% (w/v) alumina containing gels (Figure 5.8(c)), thus, suggesting
the enhanced freezing in the gel phantom as seen earlier.
Similar results are obtained with further increase in insertion depth to 1.25 cm during
cryosurgery in the presence of perfluorohexane layer at the gel interface. The axial
temperature measurements demonstrate a significant trend; even with the increment in
insertion depth to 1.25 cm, the axial thermocouples placed at a location 10 mm and 15 mm
attain a temperature of 24.51oC and 25.83oC respectively. Without the layer, temperature at
the same 10 mm and 15 mm axial location is found to be−5.47oC and 12.18oC respectively
(Figure 5.9(c)-(d)). This again reiterates the fact that perfluorohexane solution is able to
insulate the gel. Similar inference can also be drawn for gel cooling results with insertion
depth of 1.5 cm in presence of the perfluorohexane layer (Figure 5.11(c)). Hence, this
particular section of the study advocates that even with alumina as an adjuvant that results
in enhanced freezing, insulation to the gel interface can be achieved during cryosurgery
by the use of perfluorohexane layer as a barrier, thus, providing a new approach which
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(a) Perfluorohexane layer with 1 cm id (b) Perfluorohexane layer with 1.25 cm id
(c) Perfluorohexane layer with 1.5 cm id
Figure 5.11: Effect of perfluorohexane insulation layer with variation in insertion depth
during cryosurgery
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c) 1% agarose 1% alumina-
  1cm sol layer id iceball radial
a)  1% agarose 1% alumina-  
     1 cm id  sol layer ice ball
d) 1% agarose 1% alumina-
     1.25 cm id sol layer iceball
b) 1% agarose 1% alumina- 
 1cm id sol layer iceball depth
e) 1% agarose 1% alumina -
1.25 cm id sol layer iceball depth 
f) 1% agarose 1% alumina- 
1.25 cm id sol layer iceball radial
(a) Images captured through a digital camera (SONY, WX80)
(b) Bar graph showing the dimensions of the ice ball
Figure 5.12: Change in ice ball shape in presence of perfluorohexane layer and increasing
insertion depth
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Figure 5.13: Distance travelled and time taken by the fronts with and without
perfluorohexane layer
improves the efficacy of cryosurgery immensely. The comparison of the ice ball images
with an insertion depth of 1 cm and 1.25 cm in presence of perfluorohexane layer presents
an interesting observation which indicates that the axial depth of ice ball is similar in both
cases (i.e 15 mm) in spite of the increase in depth of the cryoprobe (Figure 5.12(a) and (b)). In
the previous section, it was observed that the ice ball had an axial depth of 16 mm and 19 mm
for an insertion depth of 1 cm and 1.25 cm respectively. This is obvious as the low thermal
conductivity perfluorohexane layer limits the ice to the desired region as seen earlier from
the temperature profile. In conclusion, it is interesting to note that the visual observation of
ice shape and size corroborates with the temperature distribution of the alumina containing
gel phantoms while being cooled in presence of the this layer.
A deeper analysis of thermal history helps in understanding the distance covered by
various fronts at different time intervals. In the same context, figure 5.13 illustrates the
difference in distance covered by the isotherms in the alumina containing gels in absence
and presence of perfluorohexane solution layer. It can be seen that in case of alumina gels,
the freezing front (0oC isotherm) reaches the axial thermocouple at 10 mm in 440 s while in
case of perfluorohexane layer at the same location and time point, the temperature is found
to be between 25oC − 26oC. After 600 s of cryosurgery, the temperature in the alumina
gels is 13oC while it is interesting to note that the thermocouples in the perfluorohexane
solution experience a temperature of 25oC. Thus, suggesting that perfluorohexane can be
used to inhibit ice formation and limit freezing to a specific location which of great practical
significance inside the biological systems.
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Figure 5.14: Role of glycine in increasing the freezing of alumina gels during cryosurgery
5.3.8 Glycine-Alumina adjuvant strategy for improving the
effectiveness of cryosurgery
Till date, adjuvants that have been formulated that are either thermophysical or eutectic.
However, the synthesis of glycine-alumina emulsions results in the formation of gel
phantoms that lead to faster diffusion of cooling due to alumina and the presence of eutectic
glycine reduces the end temperature even further during cryosurgery. In earlier section of
this study, it has been reported that the addition of alumina increases the rate of cooling
inside the gel phantoms. This study further reports that eutectic adjuvant glycine in presence
of alumina decreases the end temperature even more drastically when compared to alumina
containing gel phantoms, thereby, improving the effectiveness of the cryosurgery process
significantly.
After adding 1% (w/v) agarose to the glycine alumina emulsion, glycine- alumina
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containing gel phantoms are formed. When a comparison is carried out between the
temperature distribution of 1%(w/v) alumina, 1% (w/v) glycine 1% (w/v) alumina and
1% (w/v) alumina 5% (w/v) glycine containing gel phantoms, it is observed that after
cryosurgery, the end temperature obtained at the thermocouple placed near the probe reveals
a value of −62.34oC, −66.12oC, −79.39oC respectively (Figure 5.14(a)). With increase
in amount of glycine to 1% (w/v), as observed from the thermal history there is a marginal
decrease in temperature. Further, the addition of glycine to 5% (w/v) in the gel phantoms
decreases the temperature by 17.05oC (from −62.34oC in the alumina containing gel
phantom to −79.39oC in the 1% (w/v) alumina 5%(w/v) glycine containing gel phantom),
thus, showing that the rate of decrease is substantial and causes a sharp decrement in the end
temperature attained after cryosurgery.
It is also observed that the thermocouple placed at a distances of 5 mm from the probe
in the radial direction shows a decrease in the end temperature of gel phantoms after
cryosurgery. When a comparison is made between the thermal history of 1%(w/v) alumina,
1% (w/v) glycine 1% (w/v) alumina and 1% (w/v) alumina 5% (w/v) glycine containing gel
phantoms, it is seen that the value of end temperature is found to be −49.06oC, −53.76oC
and −56.96oC respectively at this particlular location (Figure 5.14(b)). This shows that
even at this thermocouple position, glycine influences the end temperature and decreases
the temperature by 7.9oC (from −49.06oC to −56.96oC). It is interesting to note the
thermal history of these gel phantoms in the thermocouple placed in the 5 mm axial direction
suggests a very miniscule reduction in the end temperature after cryosurgery and there is a
very marginal decrease of around 1oC after the addition of glycine (Figure 5.14(c)). The
glycine incorporated gel phantoms have miniscule decrease in the end temperature in the
axial direction than the alumina gel phantoms. Since the probe is cylindrical, the radial
surface available for cooling is more. Thus, radially the temperature gradient is more and
the effect of freezing is more pronounced than the axial one. Also, alumina results in a faster
diffusion of cooling and therefore in comparison to the agarose gel phantoms there is better
diffusion of cooling leading to a lower end temperature. However, in a combinative system
where both alumina and glycine are present in the gel phantom, like the present case, there is
a faster diffsion of cooling but the presence of glycine leads to lowering of end temperature
in regions where there is a higher cooling rate like thermocouples placed near the probe
and 5 mm radial position. There is no or miminal effect seen in the thermcocouples placed
farther away from the probe. For glycine to play an important as an eutectic adjuvant, lower
temperature is needed and in this particular case, therefore, it is observed that the effect of
glycine in lowering the temperature is predominant at a location near the probe. From the
results of this study, it can be concluded that higher concentration of glycine in the alumina
gel phantoms can cause rapid freezing in a defined region, thus, providing a better outcome
during cryosurgery.
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Table 5.3: Transient temperature readings obtained during cryosurgery of different gel
phantoms at various thermocouple locations
Gel Phantom Time (s) TProbe
(oC)
∆TProbe
(oC)
T5mm
(oC)
∆T5mm
(oC)
1% (w/v) agarose
0 29.13 58.18 29.95 43.55
60 -29.05 9.25 -13.6 10.34
120 -38.3 4.98 -23.94 5.37
180 -43.28 3.29 -29.31 3.78
240 -46.57 1.3 -33.09 2.11
300 -47.87 1.27 -35.02 1.69
360 -49.14 1.12 -36.89 1.21
1% (w/v) alumina
0 29.47 68.64 29.47 51.49
60 -39.17 9.42 -22.02 10.46
120 -48.59 3.56 -32.48 4.54
180 -52.15 3.11 -37.02 3.7
240 -55.26 2.1 -40.72 2.23
300 -57.36 1.09 -42.95 1.42
360 -58.45 2.01 -44.37 1.87
1% (w/v) alumina 5%
(w/v) glycine
0 29.73 90.86 29.82 58.96
60 -61.13 8.96 -29.14 11.58
120 -70.09 3.07 -40.72 4.9
180 -73.16 0.03 -45.62 2.95
240 -73.19 2.38 -48.57 1.76
300 -75.57 0.14 -50.33 1.29
360 -76.61 0.96 -51.62 0.47
5.3.9 Comparison of temperature distribution in agarose gel
phantoms, alumina containing gel and alumina-glycine consisting
gel phantoms
The comparison of thermal history of agarose gel phantoms, alumina consisting gels and
glycine-alumina consisting gels for the first 6 minutes of cooling using cryosurgery helps
in a better understanding of the role played by adjuvants in increased freezing (after 6
minutes of freezing, there is no drastic change in the thermal gradient with respect to time
as seen from the temperature profile of these gel phantoms experimentally). For simplicity
and ease of explanation, the temperature measurements of probe and 5 mm radially placed
thermocouples are only taken into consideration. Table 5.3 shows the temperature values
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obtained during cryosurgery for 6 minutes. In table 5.3, Tprobe represents the temperature
at the probe and △Tprobe indicates the difference between the consecutive temperature
measurements at the probe. Similarly, T5mm presents the temperature measurement at a
radial distance of 5 mm and △T5mm suggest the temperature gradient at the same distance.
For 1% agarose gel phantoms (Table 5.3) after 60 s, a steep temperature gradient (△Tprobe
and △T5mm) of 58.18oC and 29.95oC is observed at the probe and a radial location of 5
mm. Further, this temperature gradient reduces to 1.12oC and 1.21oC after 360 s at the
previously mentioned thermocouple positions. With the incorporation of alumina (1% (w/v)
alumina) in the agarose gel phantom, a substantial temperature gradient is observed from the
temperature measurements (Table 5.3).
The temperature gradient evident at the probe and a radial location of 5 mm is 68.64oC
and 51.49oC respectively. This again reiterates that incorporation of alumina results in
increased freezing of gel phantom. The increment in freezing can also be seen when
a comparison is made between temperature measurements for agarose and alumina gel
phantoms after 360 s of freezing (Table 5.3). The addition of glycine to the alumina gel
phantoms results in the eutectic freezing in cryosurgery and also points out the usefulness
of combined thermal-eutectic adjuvants in lowering the temperature. In the presence of
glycine, after 60 s, a drastic temperature gradient (△Tprobe and △T5mm) of 90.86oC and
58.96oC is found at the probe and a radial thermocouple position of 5 mm. Also, the
temperature readings after 360 s of freezing indicate a value of −76.61oC and −51.62oC.
When compared to both alumina and agarose gel phantoms, glycine added gel phantoms
show an enhanced freezing as clearly seen from the lower temperature values obtained after
cryosurgery (Table 5.3). Therefore, the results from this part of the study suggest that the
adjuvants added in the gel phantoms lower the temperature substantially, thus, enhancing
the freezing during cryosurgery.
After cryosurgery, a noteworthy observation can be made, it is very important to note
that the ice ball size is different in gel phantoms for various cases studied above. In order
to have a qualitative understanding of the shape and size of ice ball formed, immediately
after cryosurgery for 10 minutes, the ice ball is carefully removed from the gel phantom.
The ice ball is then imaged with a digital camera to calculate the depth (z axis, axially)
and radial spread (x axis). Figure 5.15 shows the ice ball obtained after cryosurgery for
various cases ((a)-(c) Ice ball of 1% (w/v) agarose (insertion depth of 1 cm), (d)-(f) 1%
(w/v) alumina (insertion depth 1 cm), (g)-(i) 1% (w/v) alumina with insertion depth of 1.5
cm, (j)-(l) 1% (w/v) alumina insertion depth of 1.5 cm with perfluorohexane layer, (m)-(o)
1% (w/v) alumina- 5% (w/v) glycine (insertion depth 1 cm)).
Further, the ice ball weight and the dimensional measurements are carried out with the
help of a weighing balance and steel ruler (Table 5.4). Figure 5.15(a) represents the complete
shape of the ice ball, (b) depth of the ice ball and (c) the radial spread of the ice ball after
cryosurgery. The ice ball obtained for 1% (w/v) agarose gel phantom has a radial and axial
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Figure 5.15: Comparison of ice ball images after cryosurgery of gel phantoms for various
cases (obtained through a digital camera (SONY WX 80))
spread of 1.7 cm and 1.6 cm respectively (Figure 5.15(a)-(c)) and the weight of the ice ball
is found to be 9.80 g (Table 5.4). When the adjuvant gel phantom consisting of alumina is
frozen using cryosurgery, the freezing results in radial and axial spread of 1.7 cm and 1.6 cm
respectively. The addition of alumina makes the ice ball look white in appearance while the
ice ball obtained in the previous case is translucent (Figure 5.15(d)-(f)). It is seen that with
the addition of alumina, the weight of the ice ball is 11.50 g. This is understood as the gel
phantom which was earlier devoid of alumina as an adjuvant now has alumina particles in
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Table 5.4: Measurement of dimensions and determination of weight of ice ball obtained after
cryosurgery
Iceball Depth (rz, in cm) Radial (rx, in cm) Weight (g)
1% (w/v) agarose 1.6 1.7 9.8
1% (w/v) alumina 1.6 1.7 11.5
1% (w/v) alumina
1.5 cm id
2.0 1.8 16.9
1% (w/v) alumina
1.5 cm id
perfluorocarbon
layer
1.5 1.7 13.3
1% (w/v) alumina
5% (w/v) glycine
1.6 1.7 12.8
its matrix.
A key inference can be drawn with the increase in insertion depth to 1.5 cm; it is observed
that the ice ball has a axial spread of 2.0 cm while the radial length is 1.8 cm (Figure
5.15(g)-(i)). It is quite clear as stated earlier that increase in insertion depth amounts to
higher surface area of cooling by the cryoprobe. Therefore, the ice ball is larger in size and
this can also be seen in terms of weight of the ice ball as it weighs 16.90 g (Table 5.4). The
ice ball in case of insertion depth of 1.5 cm with perfluorohexane solution as a barrier to gel
cooling reveals a very significant observation; it is seen that the ice ball formed is smaller in
size in comparison to the previous case (Figure 5.15(j)-(l) and Figure 5.15(g)-(i)). The ice
ball has a radial and axial length of 1.7 cm and 1.5 cm respectively (Figure 5.15(j)-(l)). The
axial length with insertion depth and perfluorohexane layer is lesser than the ice ball axial
measurement (i.e 2.0 cm) obtained in case of insertion depth without perfluorohexane layer.
It is quite interesting to observe that the ice ball axial length in presence of perfluorohexane
solution is 0.5 cm (or 5 mm) lesser in comparison to the case where perfluorohexane layer is
absent. Also, since the perfluorohexane layer is present after an axial distance of 5 mm from
the probe, radially, all thermocouples are inside the gel, therefore, the ice ball obtained has
a similar length in the radial direction (1.7 cm). These results corroborate with the findings
of temperature distribution of gel phantoms and clearly indicate that perfluorohexane layer
is able to insulate the gel phantom.
Another important objective of this study is to suggest the use of combined
glycine-alumina adjuvant as that leads to increased freezing in the gel phantoms. It can be
seen that the ice ball obtained in glycine alumina gel phantom (5% (w/v) glycine 1% (w/v)
alumina) has a radial and axial length of 1.7 cm and 1.6 cm respectively (Figure 5.15(m)-(o)).
This is similar to the measurements of ice ball found in alumina gel phantoms and agarose
gel phantoms (Figure 5.15(a)-(c) and Figure 5.15(d)-(f)). Hence, this study provides the
images of ice ball that indicate its shape, size and appearance in various cases of cryosurgical
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cooling. Therefore, this work would enable the surgeons with a better idea of the zone of
freezing after cryosurgery and would also suggest different methods that can be utilised for
the improvement of cryosurgery process.
5.4 Summary
In conclusion, the results obtained in the study reveal that the addition of glycine in a
higher concentration (5% (w/v)) results in considerable temperature decrease at various
thermocouple locations in the gel phantoms. This study also suggests that perfluorohexane
solution layer insulates the glycine gel effectively during cryosurgical cooling. Due to this
insulation, the ice ball formed has a depth of 13 mm, i.e. 3 mm lesser than the normal ice
ball observed after cryosurgery of glycine consisting gel phantom. It can also be concluded
that 1% (w/v) alumina gel phantoms possess superior thermophysical properties that makes
it useful as an adjuvant that enhances the freezing inside the gel phantoms. Therefore,
heat diffuses in a better way in these gel phantoms leading to achievement of lower end
temperature after cryosurgery. It is fascinating to observe that with the increase in insertion
depth of the cryoprobe in the alumina gel phantoms (from 1 cm to 1.25 cm and further to 1.5
cm), there is a decrease in temperature at each thermocouple location in the gel phantom.
This is understood from the fact that higher surface area of the probe results in more cooling.
This study also proposes a novel concept that suggests cooling of 1% (w/v) alumina gel
phantom in presence of perfluorohexane layer as a barrier. It is quite clearly evident that in
presence of a barrier of perfluorhexane solution, the axial temperature measurement at the
thermocouple placed at 10 mm indicates a value of 25oC while in its absence (alumina gel
phantom without layer) at the same location the temperature is found to be−5.47oC (Figure
5.9(c)). It is interesting to note that the axial depth of ice ball is also reduced from 2 cm to
1.5 cm owing to the perfluorohexane insulation at the gel interface (Figure5.15(g)-(i) and
Figure 5.15(j)-(l)). In this chapter, another new strategy has been proposed that advocates
the use of a combined thermo-eutectic adjuvant (glycine-alumina gel phantom) in lowering
the end temperature after cryosurgery. Alumina helps in faster diffusion of cooling and
glycine induces eutectic freezing lowering the end temperature further. After cryosurgery of
glycine-alumina containing gel phantoms (5% (w/v) glycine 1% (w/v) alumina), it is noticed
that a substantial temperature decrease is visible at the probe and thermocouple located at
a radial and axial position of 5 mm. In conclusion, this study demonstrates the use of new
methods to improve the cryosurgery in tissue mimicking gel phantoms (gel phantoms that
mimick the thermophysical property of tissue). In near future, these studies can be extended
into in-vivo animal models so that the proposed approaches become a routine clinical practice
in cryosurgical tumour ablation. Hence, this study presents a novel combinative approach
that focuses on maximising freezing inside the gel phantom using glycine and alumina and
limits the freezing to a desired region by using an insulating perfluorohexane layer at the gel
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interface, thereby, improving the efficacy of cryosurgery significantly.
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Conclusion
One of the major drawbacks faced by the surgeons while performing cryosurgery is the
inability to monitor freezing which leads to destruction of the healthy tissue surrounding
the tumour. This problem can be solved if the cooling can be restricted to a particular
region. In the same context, this thesis presents new approaches through which the cooling
can be enhanced and at the same time be restricted to a particular region. In this thesis, a
numerical study is carried out to study the freezing process during cryosurgery of tumour in
presence of a perfluorocarbon (liquid) layer. During the presence of this perfluorocarbon
layer, the time taken to achieve lethal temperature is lesser and lethal front reaches the
tumour boundary quickly. However, in the absence of this layer, the time taken for ablation
is more and the chances of destruction to the healthy tissue neigbouring the tumour is
higher. For a particular configuration, there exists an offset that provides uniform cooling
to the entire volume of tissue, this offset which is termed as optimal offset decreases
linearly with an increase in the active length for a given radius of the tumour. For every
2.5 mm increase in the tumour radius with same active length of the cryoprobe, the time
taken for complete ablation by the larger tumour is nearly 2.7 times the time taken by the
smaller one. It is also observed that the most suitable substance required for making this
insulating layer is perfluorohexane and the optimal thickness of this layer is found to be
1 mm. Emulsion systems of perfluorocarbon (perfluorohexane and perfluorodecalin) have
been synthesised and perfluorodecalin emulsions made with Span 20 seem to possess lower
thermal conductivity and are found suitable for application in cryosurgery. It is also observed
that in presence of a low thermal conductivity emulsion (90% (w/v)), the freezing front is not
able to penetrate the gel-emulsion interface. Normally, in the absence of emulsion layer, the
temperature is found to be−4oC at a 10 mm axially placed thermocouple (from probe), while
with the use of this emulsion, the temperature at the same location is found to be 11oC. From
this part of the study, it can be concluded that highly concentrated perfluorocarbon emulsion
can be used as an insulating layer during cryosurgery of gel phantoms.
This thesis also suggests the use of adjuvants to enhance the freezing in a particular
region and the use of perfluorocarbon layer to confine the cooling to a defined region
during cryosurgery of gel phantoms. From the results, it can be concluded that the addition
121
of glycine in a higher concentration (5% (w/v)) to the gel phantoms causes considerable
temperature decrease at all thermocouple locations. In addition, this study indicates that
perfluorohexane layer insulates the glycine containing gel phantom effectively during
cryosurgery. Due to this insulation, the ice ball formed has a depth that is lesser than the
normal ice ball. It can also be concluded that 1% (w/v) alumina gel phantoms possess
superior thermophysical properties. This makes it useful for being used as an adjuvant
that enhances the freezing inside the gel phantoms. It is fascinating to observe that with
the increase in insertion depth of the cryoprobe in the alumina containing gel phantoms,
there is a decrease in temperature at each thermocouple. To verify the effectiveness of
perfluorohexane as an insulating layer, 1% (w/v) alumina gel phantom is cooled using
cryosurgery. It is quite clearly evident that in presence of perfluorohexane (perfluorocarbon)
layer, the axial temperature measurement at the thermocouple placed at 10 mm indicates a
value of 25oC, while in its absence (alumina gel phantom without layer) at the same location
the temperature is found to be−5.47oC. The axial depth of ice ball is also reduced by 5 mm
due to this insulating layer. Furthermore, after cryosurgery of glycine-alumina containing gel
phantoms (5% (w/v) glycine 1% (w/v) alumina), it is noticed that a substantial temperature
decrease is visible at the probe and thermocouple located at a radial and axial position
of 5 mm. In conclusion, this thesis demonstrates the use of new approaches to improve
the cryosurgery process by enhancing the freezing and confining it to particular region
through the use of various strategies mentioned above, thus, providing ways to improve
the cryosurgical outcome.
Scope for Further Research
In near future, these studies can be extended into in-vivo animal models so that the proposed
concept of perfluorohexane (perfluorocarbon) layer of low thermal conductivity can be used
along the tumour boundary. This would eventually lead to cryosurgery becoming a routine
clinical practice for tumour ablation. The maintenance of the perfluorohexane layer along
the tumour boundary is a challenge. Therefore, studies have to be carried out for developing
methods for maintaining the layer at the tumour boundary using specific reactions in mice
models so that this study can move on to its next phase, i.e. experimental human trials
culminating in clinical practice.
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